data_1kik_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kik _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 66' ' ' VAL . 28.6 tp . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.937 0.875 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -124.86 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.78 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.24 126.7 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.668 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.99 151.73 42.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.992 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.9 13.33 12.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.862 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.585 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.93 141.1 2.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.661 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.65 124.08 17.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.308 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.0 t80 -103.27 145.46 29.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -135.73 94.3 15.03 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.91 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.21 126.22 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.327 3.351 . . . . 0.0 113.327 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -124.01 -41.83 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.631 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.407 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -79.98 159.09 26.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.704 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 141.67 56.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.923 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 63.88 39.11 97.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.613 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.12 155.49 19.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.059 0.456 . . . . 0.0 111.141 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 3.5 tp -111.15 129.91 55.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.53 142.19 15.92 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.57 176.2 9.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.993 0.425 . . . . 0.0 110.711 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.73 171.59 7.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -70.98 128.58 36.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.29 -13.4 55.2 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.427 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.87 165.61 0.61 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.428 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.5 mt-30 -123.21 146.48 47.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.67 0.748 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.44 128.55 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.177 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -79.89 103.59 9.88 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 26.2 mm -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.17 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.688 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.2 mt -79.53 -47.76 15.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.722 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.5 135.48 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.807 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.8 pt20 -121.94 35.92 4.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.369 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.65 122.23 38.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.92 158.54 34.61 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.691 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.3 tt0 -48.55 -21.51 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.457 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.483 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.1 m95 -112.46 109.69 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.717 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -91.38 139.34 30.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.199 0.524 . . . . 0.0 112.184 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.72 114.35 22.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.239 177.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.85 144.68 47.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 0.0 111.785 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.528 ' HB2' HD13 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.87 110.7 21.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.599 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.35 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.186 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.88 -23.66 3.93 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.007 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -40.21 20.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.959 0.885 . . . . 0.0 108.914 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -35.78 6.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.411 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.83 -0.18 88.65 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 113.285 -1.78 . . . . 0.0 113.384 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 122.8 8.17 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.236 0.541 . . . . 0.0 111.003 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.95 144.2 26.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.47 177.59 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.199 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -86.18 152.38 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.661 0.267 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 6.2 pt -148.14 143.49 17.65 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 112.086 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.483 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.4 Cg_endo -52.64 108.34 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.152 2.568 . . . . 0.0 111.281 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -50.64 -24.9 3.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.4 p30 -98.97 30.36 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.451 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -118.0 -24.41 7.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.01 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.7 m -115.46 150.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 142.58 44.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.487 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -39.67 139.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.35 54.44 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.003 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 66' ' ' VAL . 26.6 tp . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.86 0.838 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -125.28 -176.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.856 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.97 126.66 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.62 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.67 152.23 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.01 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.48 14.2 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.884 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.578 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 140.76 2.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.672 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.87 124.13 17.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.244 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.551 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 13.1 t80 -103.78 146.19 28.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -137.15 94.31 12.55 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.914 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 6.0 Cg_exo -37.65 120.45 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.259 3.306 . . . . 0.0 113.426 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -118.79 -36.79 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.413 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.7 m80 -81.35 172.68 13.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.624 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -80.07 142.82 34.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.28 38.08 94.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.438 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.73 155.55 18.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 111.211 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.458 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -111.42 128.58 56.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.082 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.08 144.71 17.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.354 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -147.82 176.22 10.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.989 0.423 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -107.15 173.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.729 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -72.58 129.08 37.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.86 -11.0 58.59 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.512 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.47 165.56 1.08 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.417 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 3.3 mt-30 -122.77 146.6 47.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.552 0.691 . . . . 0.0 111.212 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.99 128.07 14.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.204 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -79.85 103.52 9.8 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 29.1 mm -57.77 112.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.223 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.1 mt -79.41 -46.87 16.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.704 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.32 135.69 27.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.626 178.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.3 pt20 -122.26 35.69 4.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.076 0.465 . . . . 0.0 111.239 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 122.66 38.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.876 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.19 158.65 34.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.613 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.8 tt0 -49.38 -20.84 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.435 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.17 107.78 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.9 m0 -89.34 140.41 29.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 112.201 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.7 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.82 115.73 24.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.191 178.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.43 144.14 48.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.937 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.528 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.6 110.93 22.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.576 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.98 167.81 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.123 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.79 -24.04 3.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.914 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -83.15 -40.47 19.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.913 0.863 . . . . 0.0 108.942 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.84 -35.47 6.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.502 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.77 -2.89 85.29 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.035 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -48.8 124.75 8.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.98 151.05 20.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.716 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 167.61 176.91 38.68 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.61 142.69 28.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.69 0.281 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.45 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.0 pt -136.76 144.57 47.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.62 . . . . 0.0 112.176 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 9.0 Cg_endo -53.62 109.77 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.195 2.597 . . . . 0.0 111.29 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.54 -23.85 7.09 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.814 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.1 p-10 -99.12 30.87 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.99 -22.73 6.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.043 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.5 m -117.23 150.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.43 142.36 43.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.39 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -39.59 139.09 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.01 53.98 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.075 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' VAL . 29.8 tp . . . . . 0 N--CA 1.445 -0.697 0 CA-C-O 121.982 0.896 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.527 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.5 m -125.48 -177.28 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 113.826 -1.533 . . . . 0.0 111.779 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.28 126.1 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.636 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.84 151.93 41.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.091 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.17 14.38 12.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.94 141.12 2.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.14 124.6 19.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.325 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.6 t80 -103.92 146.09 29.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.89 94.44 12.86 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.963 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 4.6 Cg_exo -36.34 132.43 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.336 3.358 . . . . 0.0 113.381 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 t -130.53 -43.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.741 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.417 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.8 m80 -79.96 149.09 30.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 129.76 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.044 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.82 28.78 49.75 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.624 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 3.2 m-20 -96.98 158.47 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER -116.2 132.73 56.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.831 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.33 141.87 15.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.626 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.566 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -144.8 176.8 9.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.471 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.09 170.5 8.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.055 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -69.71 126.63 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.72 -15.65 50.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.323 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.486 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.17 166.21 0.26 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.6 mt-30 -123.34 145.81 48.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.5 0.667 . . . . 0.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.26 127.69 15.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.258 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -79.74 103.41 9.62 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 23.0 mm -58.25 111.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.119 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.726 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.7 mt -79.34 -46.68 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.554 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.24 154.89 44.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -140.25 36.7 1.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 0.0 111.863 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.33 131.28 34.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.93 166.81 18.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.027 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.04 -20.36 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.662 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 71.2 m95 -110.18 116.85 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.469 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.0 m0 -99.74 140.5 33.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.084 0.469 . . . . 0.0 111.994 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.726 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.81 116.76 25.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.54 178.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -123.2 144.6 49.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.031 0.443 . . . . 0.0 111.722 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.493 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.65 111.24 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.597 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.52 167.09 0.07 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.871 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.62 -23.41 4.39 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.426 -0.51 . . . . 0.0 112.105 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.84 -41.15 17.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 0.0 108.989 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.12 -35.57 6.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.427 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.63 -1.74 84.98 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.239 -1.801 . . . . 0.0 113.218 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -49.37 123.37 7.41 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.177 0.513 . . . . 0.0 111.15 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.79 149.5 21.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.607 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 168.46 177.02 39.22 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.313 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.35 143.42 28.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.658 0.266 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.4 pt -137.84 142.14 35.25 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 0.0 112.126 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.26 112.06 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.264 2.643 . . . . 0.0 111.242 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -49.84 -24.87 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.3 p-10 -100.52 31.42 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.492 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.39 17.07 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.946 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.8 m -154.23 150.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.23 140.75 37.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.548 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -39.53 138.91 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.25 54.38 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.89 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 66' ' ' VAL . 26.2 tp . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.951 0.881 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.5 m -124.04 -176.64 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.894 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.48 128.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.749 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.62 150.55 48.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.641 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.98 -6.22 15.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.482 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -153.52 172.89 16.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.676 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.05 123.99 27.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.513 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.58 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 20.4 t80 -101.51 145.96 28.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.289 0.566 . . . . 0.0 112.331 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.24 15.15 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.038 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.22 129.36 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.368 3.379 . . . . 0.0 113.293 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -125.76 -40.7 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.791 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -79.94 174.99 11.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.695 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.21 144.9 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.97 37.29 84.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.634 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -98.47 156.2 16.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.168 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -115.2 125.23 53.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.54 141.35 15.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.108 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -141.19 175.62 9.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -107.05 172.7 6.68 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.813 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.18 127.92 34.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.63 59.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.355 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.74 165.59 1.15 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.409 ' HG2' HG13 ' A' ' 67' ' ' ILE . 3.0 mt-30 -123.9 146.71 48.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.521 0.677 . . . . 0.0 111.202 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.12 128.47 15.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -80.03 103.31 9.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.5 mm -59.36 111.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.216 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.72 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.5 mt -79.55 -47.25 15.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.813 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.43 136.37 29.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.739 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -124.19 35.92 4.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.473 . . . . 0.0 111.32 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 122.41 38.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.959 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.58 160.91 36.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.798 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.0 tt0 -48.79 -20.96 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.501 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.25 117.19 31.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.7 m0 -98.82 137.57 37.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.13 0.49 . . . . 0.0 112.169 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.72 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.92 112.68 20.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.061 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -118.96 143.28 47.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.514 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.93 110.53 21.87 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.618 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.08 167.17 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.104 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.45 -23.7 4.06 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.099 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.73 -40.49 20.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.909 0.861 . . . . 0.0 108.936 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.37 -35.57 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.408 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.46 -0.0 88.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.299 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.24 121.63 6.51 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.261 0.553 . . . . 0.0 111.058 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.93 142.55 27.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.601 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 177.09 -179.94 47.75 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.249 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.34 139.8 30.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.695 0.284 . . . . 0.0 110.97 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 6.0 pt -134.26 144.18 50.16 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.421 0.629 . . . . 0.0 111.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.4 Cg_endo -53.11 119.18 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.218 2.612 . . . . 0.0 111.265 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.69 -20.97 16.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -105.18 35.4 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.244 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -120.96 -17.49 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 14.8 m -126.88 152.33 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.62 143.27 43.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.388 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -39.59 139.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.19 54.51 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.046 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.864 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 66' ' ' VAL . 25.4 tp . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 121.877 0.846 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.9 m -126.72 -176.89 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.894 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.63 125.94 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.629 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB1' ' CD2' ' A' ' 82' ' ' PHE . . . -57.67 146.85 29.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.466 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 mt -97.98 -24.54 15.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.418 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -145.87 -177.37 5.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.965 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.31 125.22 29.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.214 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -103.64 145.39 30.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.34 94.13 15.9 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.046 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -37.14 133.58 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.304 3.336 . . . . 0.0 113.432 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.46 -43.57 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.0 150.57 30.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.722 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -62.31 136.16 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 74.39 29.96 61.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.6 m-20 -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 0.0 111.024 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.498 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.1 tp -116.34 123.99 48.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.899 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -90.3 143.12 16.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.137 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p90 -143.93 178.19 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -108.3 172.98 6.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.89 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -72.71 128.77 36.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 -10.73 59.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.286 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.33 165.5 1.44 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.411 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.3 mt-30 -123.69 147.33 47.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.465 0.65 . . . . 0.0 111.111 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.48 127.67 14.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.951 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -79.84 101.37 8.48 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.418 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 37.0 mm -55.4 112.11 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.079 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.2 mt -79.4 -46.5 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.578 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -145.71 148.36 32.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.344 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.513 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -132.1 37.14 3.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.23 131.78 34.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.91 164.57 20.75 Favored Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.979 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -48.43 -20.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.59 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.507 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.0 m95 -111.1 119.47 39.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.513 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.0 m0 -101.53 142.26 33.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.109 0.481 . . . . 0.0 112.21 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.7 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.99 114.74 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.2 178.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.62 143.31 48.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 111.814 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.521 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.37 110.83 22.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.604 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.51 166.66 0.05 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.101 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 mp -125.04 -23.95 4.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.055 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.95 -39.98 20.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.841 . . . . 0.0 109.046 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.4 -35.47 6.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.554 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.56 -1.23 88.27 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.154 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 123.16 7.96 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 146.65 23.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.734 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.09 179.44 43.77 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.111 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.2 m-85 -90.39 139.83 30.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.789 0.328 . . . . 0.0 110.737 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.432 HG23 ' CE1' ' A' ' 82' ' ' PHE . 7.5 pt -133.69 144.48 52.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.5 116.77 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.263 2.642 . . . . 0.0 111.182 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.31 -19.9 16.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 5.9 p-10 -101.99 33.75 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.069 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.82 -30.33 4.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.651 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 27.4 m -111.13 148.61 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.69 142.21 45.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.408 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -39.36 137.98 0.71 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.08 54.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.061 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 66' ' ' VAL . 27.2 tp . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.988 0.899 . . . . 0.0 112.109 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.544 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.8 m -125.08 -176.64 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.594 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.69 125.13 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.733 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.94 29.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.928 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.81 10.68 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -167.43 142.85 4.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.653 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.5 124.82 20.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.384 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -104.62 146.8 28.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.419 0.628 . . . . 0.0 112.658 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -138.11 94.53 11.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.954 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.4 Cg_exo -36.83 127.56 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.304 3.336 . . . . 0.0 113.33 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.37 -40.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.403 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m80 -79.85 170.83 15.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.768 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.99 137.2 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.76 38.57 94.57 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.607 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -104.17 154.45 19.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 4.9 tp -110.48 133.01 53.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.089 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.1 143.74 16.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.402 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.593 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.78 176.7 9.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.79 172.96 6.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.863 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.93 128.84 37.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.85 -15.02 50.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.327 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.16 165.75 0.47 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 67' ' ' ILE . 0.9 OUTLIER -123.58 145.98 48.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.58 0.705 . . . . 0.0 111.29 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.31 128.36 15.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.149 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -79.84 103.77 9.97 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 23.2 mm -58.92 111.47 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.148 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.694 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 24.5 mt -79.56 -47.4 15.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.821 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.73 137.79 33.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.861 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.547 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -125.29 35.71 4.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.61 122.55 38.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.936 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.84 159.09 35.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.724 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.483 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.4 tt0 -48.49 -20.92 0.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.42 -0.39 . . . . 0.0 111.476 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.6 m95 -112.59 111.98 23.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.679 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -93.97 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.694 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.75 114.85 24.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.194 178.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.43 143.04 48.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.048 0.451 . . . . 0.0 111.774 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.1 tt0 -107.93 110.88 22.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.61 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.42 167.64 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.95 -24.06 3.84 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.968 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.44 -40.64 20.9 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.906 0.86 . . . . 0.0 108.919 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.22 -35.3 6.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.29 -1.23 86.0 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -50.53 121.86 6.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 0.0 111.082 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.47 145.13 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.619 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.66 176.63 42.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.78 151.78 24.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.609 0.242 . . . . 0.0 110.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 111' ' ' ILE . 5.7 pt -148.08 143.11 17.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.292 0.568 . . . . 0.0 112.148 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.493 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.7 Cg_endo -51.8 112.59 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.235 2.623 . . . . 0.0 111.339 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.47 -23.7 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 14.1 p30 -101.83 32.45 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.74 -17.06 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.7 m -121.61 150.42 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.24 140.77 41.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.477 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -39.46 139.48 0.56 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.84 53.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.966 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD11 ' O ' ' A' ' 66' ' ' VAL . 26.5 tp . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.904 0.859 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -125.23 -176.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.884 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.7 124.92 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.61 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.84 152.96 21.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.03 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -121.4 8.9 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.916 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.596 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -166.32 143.36 5.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.24 123.74 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.332 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.575 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -103.03 146.94 27.59 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -138.2 94.53 10.99 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.847 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.4 Cg_exo -36.27 131.69 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.45 3.434 . . . . 0.0 113.299 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -130.1 -43.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 13.1 m-70 -79.96 157.31 26.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.33 128.45 36.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.64 47.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.657 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.3 m-20 -96.27 156.9 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.109 0.48 . . . . 0.0 110.991 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.4 tp -114.69 130.13 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.38 141.67 15.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.391 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -146.57 176.89 9.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -108.83 172.03 7.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.003 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -71.56 127.23 31.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.5 -15.32 55.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.286 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.522 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.41 165.53 0.36 Allowed 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.7 mt-30 -122.68 146.7 47.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.567 0.699 . . . . 0.0 111.216 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.77 127.97 14.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -79.93 103.07 9.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 25.0 mm -58.67 113.48 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.141 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.716 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 39.2 mt -79.51 -46.37 17.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.748 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -145.2 134.56 23.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.911 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.9 OUTLIER -119.77 36.05 4.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.77 122.24 37.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.925 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.39 159.53 35.61 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.696 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.85 -20.81 0.54 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.479 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 68.4 m95 -113.03 110.95 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.539 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -92.66 136.86 32.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 114.84 21.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.239 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.87 143.74 47.76 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.073 0.463 . . . . 0.0 111.745 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.96 110.58 21.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.59 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.41 168.4 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.223 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.12 -23.55 3.88 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.015 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.86 -40.4 20.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.868 0.842 . . . . 0.0 108.923 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -35.8 6.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.471 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.1 -0.62 88.48 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.271 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.45 123.17 8.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.231 0.539 . . . . 0.0 111.097 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -90.01 144.54 25.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.562 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.52 178.64 44.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.372 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -87.52 146.53 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.618 0.247 . . . . 0.0 110.643 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 111' ' ' ILE . 4.9 pt -142.25 142.07 23.05 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.0 112.125 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.1 Cg_endo -51.94 112.24 0.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.193 2.595 . . . . 0.0 111.385 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.64 -23.76 7.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p-10 -100.57 31.6 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.467 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.09 -25.63 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.1 m -114.32 149.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 141.81 44.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.478 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -39.58 138.94 0.64 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.61 54.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.083 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.975 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 66' ' ' VAL . 22.9 tp . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.745 0.783 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.535 ' O ' HD13 ' A' ' 65' ' ' LEU . 2.7 m -125.24 -177.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.105 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.51 126.03 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.608 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.82 152.03 37.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.132 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.05 12.69 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.26 142.73 3.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.585 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 124.19 18.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.389 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.4 t80 -104.07 146.18 29.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.69 94.38 13.26 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.927 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.5 Cg_exo -37.04 122.14 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.313 3.342 . . . . 0.0 113.336 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -41.16 2.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.508 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.406 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m-70 -80.51 159.05 25.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.21 143.48 56.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.17 41.65 99.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.593 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.59 155.61 21.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.162 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.6 tp -111.41 131.56 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.75 144.59 17.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.401 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.75 176.66 9.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -109.42 172.35 6.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.802 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -71.31 127.33 32.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.3 -14.34 57.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.347 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.9 165.61 0.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.429 ' HG2' HG13 ' A' ' 67' ' ' ILE . 3.3 mt-30 -123.2 147.49 46.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.668 . . . . 0.0 111.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.31 127.96 14.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.102 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -79.82 103.46 9.74 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 28.1 mm -59.07 111.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.202 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.707 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.6 mt -79.34 -47.02 16.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.505 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.97 154.24 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.336 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -139.47 36.71 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.842 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.56 131.26 34.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.235 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.75 15.93 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.108 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -47.46 -21.19 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.084 -0.558 . . . . 0.0 111.625 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.49 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m95 -109.99 118.1 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.471 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.7 m0 -100.4 143.18 30.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 112.021 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.707 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.22 114.71 25.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.468 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.9 142.98 49.18 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.051 0.453 . . . . 0.0 111.77 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.497 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.23 111.08 22.87 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.57 167.43 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.114 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.43 -23.52 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.056 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -41.06 19.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.919 0.866 . . . . 0.0 108.881 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.13 -35.66 6.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.419 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.98 -1.45 86.62 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.329 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -49.77 122.06 6.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.289 0.566 . . . . 0.0 111.07 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.44 145.03 26.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.665 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.62 42.24 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.6 m-85 -86.36 155.39 20.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.614 0.245 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.437 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 4.5 pt -150.11 144.25 17.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.609 . . . . 0.0 112.157 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.5 Cg_endo -52.88 111.15 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.226 2.617 . . . . 0.0 111.25 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.03 -22.97 6.55 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.6 p-10 -101.04 30.97 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.37 -19.75 8.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.985 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.2 m -119.7 150.63 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.81 141.34 42.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.325 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.65 140.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.8 50.89 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.897 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 66' ' ' VAL . 29.1 tp . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.063 0.935 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -124.7 -176.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.546 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 126.46 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.687 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 147.97 25.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.401 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 mt -100.43 -23.07 14.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -145.54 -176.72 5.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.888 0.375 . . . . 0.0 110.776 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.25 125.26 30.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.9 t80 -104.66 146.57 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 mt-10 -136.41 94.13 13.97 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.024 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 6.0 Cg_exo -37.72 120.02 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.327 3.352 . . . . 0.0 113.366 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -117.07 -34.75 4.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.539 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -84.12 169.72 14.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -79.0 143.43 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.91 35.95 92.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.354 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -104.29 155.75 18.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 111.202 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.477 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.9 tp -111.85 127.45 55.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.136 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.77 144.2 16.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.03 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.543 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.9 OUTLIER -145.21 179.21 7.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.924 0.392 . . . . 0.0 110.949 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.89 175.41 5.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.956 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 131.22 41.28 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.34 -9.1 56.39 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.331 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.63 165.6 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.407 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 2.6 mt-30 -124.58 146.07 49.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 111.258 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.15 128.04 15.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.272 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -79.67 104.27 10.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 25.3 mm -59.57 112.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.388 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.681 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.8 mt -79.44 -47.43 15.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.475 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 154.27 43.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.413 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.491 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -138.61 38.02 2.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 111.888 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 131.27 34.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.283 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.8 166.42 9.7 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.12 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -46.77 -21.55 0.21 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.52 . . . . 0.0 111.655 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 80.3 m95 -108.52 121.01 44.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.491 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.97 143.14 33.27 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.681 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.39 113.94 24.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.228 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.9 145.64 47.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.136 0.493 . . . . 0.0 111.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.537 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.84 110.88 22.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.599 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.86 167.75 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.043 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.63 -23.49 4.04 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.073 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -83.12 -39.91 20.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.863 0.84 . . . . 0.0 109.015 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.21 -35.8 5.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.428 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.76 -0.34 88.37 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.286 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.03 122.62 7.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.225 0.536 . . . . 0.0 111.098 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.81 146.03 25.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.51 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.0 177.33 42.2 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.69 140.38 29.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.659 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 8.6 pt -134.78 145.34 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 112.161 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.9 Cg_endo -56.06 114.04 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.164 2.576 . . . . 0.0 111.156 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -21.64 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.426 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.5 p30 -98.81 31.63 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.851 0.357 . . . . 0.0 111.041 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.51 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -120.99 -27.13 5.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.632 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 23.0 m -112.9 148.74 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.3 141.35 41.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.374 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -39.4 138.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.56 54.41 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.029 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.923 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 66' ' ' VAL . 27.9 tp . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 121.985 0.898 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -124.19 -177.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.672 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.09 125.33 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.753 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . . . -57.12 147.24 25.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.508 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.14 -24.4 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.419 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -146.39 -177.17 5.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.991 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 125.47 29.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.305 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -104.05 145.72 29.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.43 94.1 15.78 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.996 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.4 Cg_exo -36.92 124.46 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.387 3.392 . . . . 0.0 113.365 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -40.44 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.74 157.19 22.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.87 147.3 53.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.09 33.87 85.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.599 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -101.55 156.86 17.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.178 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.3 tp -114.36 125.04 53.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.095 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.92 142.64 16.14 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.176 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.1 p90 -143.06 178.35 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.922 0.391 . . . . 0.0 110.939 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -108.32 174.89 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.838 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.27 130.04 38.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.25 -8.76 60.06 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.382 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.75 165.4 2.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.6 mt-30 -124.31 146.12 49.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.651 0.738 . . . . 0.0 111.142 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.78 128.23 15.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -79.99 104.21 10.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 24.9 mm -59.5 112.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.34 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.684 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 21.9 mt -79.54 -46.94 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.388 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.85 155.02 43.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.347 178.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.488 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -139.74 37.56 2.0 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.836 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.08 131.01 34.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.358 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.84 167.14 14.47 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.086 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.5 tt0 -47.29 -21.29 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.605 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.7 m95 -109.25 121.67 45.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.488 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.4 m0 -104.29 142.65 34.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.043 0.449 . . . . 0.0 112.144 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.684 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.8 113.97 23.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.334 178.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.9 145.28 47.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 111.817 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.526 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.88 111.02 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.596 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.69 167.7 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.064 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.42 -23.61 4.08 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.084 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.99 -40.87 19.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.943 0.878 . . . . 0.0 109.013 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.12 -36.07 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.43 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.14 -0.27 88.91 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.288 -1.778 . . . . 0.0 113.257 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 123.3 8.96 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.229 0.538 . . . . 0.0 111.018 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 145.95 24.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.582 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.15 178.62 43.27 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -90.3 140.81 29.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 110.622 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.7 pt -134.74 145.31 54.29 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.347 0.594 . . . . 0.0 112.152 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 11.0 Cg_endo -55.89 115.36 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.238 2.626 . . . . 0.0 111.157 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.83 -19.72 12.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 13.9 p30 -101.22 32.5 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.509 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.18 -30.45 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.536 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 31.1 m -109.67 149.27 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.13 139.88 41.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.364 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -39.38 138.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.32 54.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD11 ' O ' ' A' ' 66' ' ' VAL . 27.3 tp . . . . . 0 N--CA 1.447 -0.622 0 CA-C-O 121.937 0.875 . . . . 0.0 112.017 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.539 ' O ' HD11 ' A' ' 65' ' ' LEU . 2.6 m -125.58 -177.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.746 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.55 126.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.601 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.07 151.53 39.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.212 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.08 13.67 12.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.757 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.87 141.35 2.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.736 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.35 124.27 18.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.408 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.8 t80 -103.73 146.26 28.87 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.3 94.32 14.0 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.01 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.4 Cg_exo -36.77 123.93 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.382 3.388 . . . . 0.0 113.292 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -122.34 -39.35 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.804 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.402 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.9 m80 -79.93 174.39 11.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.89 141.99 35.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.22 40.24 97.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -105.15 154.53 20.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.147 0.499 . . . . 0.0 111.189 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -110.64 131.75 54.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.907 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.59 16.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.369 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.3 175.97 9.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.802 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.1 173.22 6.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -71.65 128.45 35.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.95 -13.92 54.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.407 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.02 165.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.437 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.3 mt-30 -123.52 146.52 48.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.59 128.43 15.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.25 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -79.92 103.62 9.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 25.9 mm -59.57 111.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.232 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.702 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.8 mt -79.65 -47.93 14.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.786 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.74 136.99 34.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.849 178.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.534 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.0 pt20 -124.84 35.88 4.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.107 0.479 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.4 122.44 39.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.92 159.69 35.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.672 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.29 -21.29 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.351 -0.425 . . . . 0.0 111.538 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.1 m95 -111.75 113.3 25.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.534 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -95.59 136.46 35.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.069 0.461 . . . . 0.0 112.156 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.702 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 113.24 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.104 177.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.29 142.99 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 111.675 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.51 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.36 110.7 22.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.611 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 167.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.165 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.82 -23.71 3.94 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.968 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -82.7 -40.69 20.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.868 0.842 . . . . 0.0 108.859 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 -35.74 6.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.395 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 -0.85 87.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.293 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -50.21 121.94 6.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.82 143.35 26.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.579 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.99 177.51 44.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.341 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.64 149.18 25.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.68 0.276 . . . . 0.0 110.614 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 111' ' ' ILE . 7.1 pt -145.31 143.15 19.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.355 0.598 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.8 Cg_endo -51.68 109.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.45 -26.12 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -98.69 30.37 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 0.0 111.205 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.79 10.93 10.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.987 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.9 m -147.53 151.01 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.86 140.49 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.592 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -39.47 139.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 53.95 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.077 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.923 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 66' ' ' VAL . 24.8 tp . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.848 0.832 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.545 ' O ' HD11 ' A' ' 65' ' ' LEU . 2.9 m -127.08 -176.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.968 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.24 124.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.01 152.05 20.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.786 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.22 7.48 10.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.983 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.14 143.88 6.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.14 124.13 17.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.318 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.56 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.96 146.96 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -138.59 94.51 10.46 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.886 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.95 131.38 0.33 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.359 3.372 . . . . 0.0 113.44 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -130.01 -43.48 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.711 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.426 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.5 m-70 -79.84 156.38 27.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.35 130.59 43.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.017 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.81 55.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.65 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -97.1 157.23 16.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 110.973 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -114.19 131.15 56.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.967 179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.31 142.31 16.01 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.489 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.56 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -148.13 177.13 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -108.12 176.48 5.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.702 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -74.24 134.36 42.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.39 -8.78 38.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.566 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.7 165.65 2.18 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.433 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.2 mt-30 -122.07 146.76 46.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.676 . . . . 0.0 111.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.95 127.44 14.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.931 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -79.63 101.43 8.34 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.523 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 36.8 mm -55.43 111.76 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.038 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.712 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 33.8 mt -79.45 -46.0 18.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.675 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.79 135.95 26.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.735 178.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.542 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -122.31 35.96 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.073 0.463 . . . . 0.0 111.437 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.35 122.49 39.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.834 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.17 159.51 35.32 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.756 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -49.73 -20.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.312 -0.444 . . . . 0.0 111.476 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.486 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 65.2 m95 -113.95 108.3 16.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.676 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -90.3 138.27 31.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.083 0.468 . . . . 0.0 112.08 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.712 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.55 116.6 23.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.09 178.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.64 142.65 49.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.794 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.514 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.17 110.76 22.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.583 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.7 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 -179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.56 -23.9 3.98 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.953 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.9 -40.22 20.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 108.986 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.28 -35.75 5.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.63 -1.29 88.26 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.175 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.78 123.16 7.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.251 0.548 . . . . 0.0 111.114 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.28 146.92 23.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.686 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.64 177.36 41.27 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.211 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.43 143.83 28.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.641 0.257 . . . . 0.0 110.475 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.4 pt -138.17 142.31 35.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.307 0.575 . . . . 0.0 112.205 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.7 Cg_endo -52.41 113.17 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.222 2.614 . . . . 0.0 111.312 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.85 -23.09 6.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -101.28 32.68 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 111.08 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.487 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.37 -17.71 7.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 30.5 m -121.27 149.04 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.68 140.91 44.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.594 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -39.52 138.76 0.65 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.67 53.78 0.12 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.946 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' VAL . 29.7 tp . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.966 0.888 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -125.46 -176.64 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -145.55 126.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.723 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.64 148.3 29.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.464 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 mt -101.67 -22.81 14.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -143.36 -178.12 5.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.813 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.3 125.52 31.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.273 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.4 t80 -104.67 146.37 29.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.62 93.99 13.69 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.4 123.19 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.338 3.359 . . . . 0.0 113.34 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -39.05 2.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.84 19.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.12 143.11 41.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.07 38.97 96.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -106.07 155.21 19.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.489 . . . . 0.0 111.087 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -111.29 128.95 56.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.062 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.56 146.61 18.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.088 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -147.95 178.55 8.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.981 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.55 173.35 6.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.32 128.71 36.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 -13.24 56.16 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.288 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.12 165.63 0.96 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.405 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 2.9 mt-30 -124.71 146.79 48.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.605 0.717 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.57 128.2 15.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.983 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -79.8 103.85 9.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.3 mm -58.72 112.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.222 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 22.9 mt -79.39 -46.9 16.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.53 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 151.25 39.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.494 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.9 pt20 -135.67 37.63 2.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.37 131.26 34.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.331 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.67 15.67 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.0 tt0 -47.66 -21.53 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.106 -0.547 . . . . 0.0 111.586 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.0 m95 -109.63 120.9 43.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 110.738 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.507 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.33 143.92 32.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.102 0.477 . . . . 0.0 112.212 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -89.03 114.55 25.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.256 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.02 144.2 48.66 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.055 0.455 . . . . 0.0 111.851 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.541 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.49 111.01 22.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.613 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.75 166.96 0.05 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.042 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.36 -23.76 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.603 -0.439 . . . . 0.0 112.091 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.64 -40.09 21.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.88 0.848 . . . . 0.0 108.911 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.04 -35.9 6.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.471 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.32 -0.7 88.69 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.243 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.02 122.9 8.22 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.246 0.546 . . . . 0.0 111.067 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -88.98 146.56 24.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.588 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.74 177.49 42.13 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.191 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.48 142.51 27.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.72 0.295 . . . . 0.0 110.779 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.434 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.8 pt -136.7 144.88 48.77 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.453 0.644 . . . . 0.0 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.513 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.8 Cg_endo -55.63 116.18 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.293 2.662 . . . . 0.0 111.154 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.63 -19.6 17.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.412 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 p-10 -100.62 32.3 3.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.22 -29.57 4.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.732 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.9 m -110.21 152.13 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.39 141.17 35.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.346 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -39.42 139.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.94 54.0 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.925 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 66' ' ' VAL . 28.3 tp . . . . . 0 N--CA 1.446 -0.653 0 CA-C-O 122.019 0.914 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.536 ' O ' HD11 ' A' ' 65' ' ' LEU . 2.7 m -125.51 -177.65 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.774 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.92 124.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.774 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.86 151.34 25.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.35 12.45 12.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.772 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.68 141.94 2.96 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.665 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.1 124.47 19.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.4 t80 -103.98 147.15 27.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.6 mt-10 -137.63 94.42 11.82 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.926 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.1 Cg_exo -36.73 126.81 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.354 3.369 . . . . 0.0 113.377 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -124.67 -40.75 2.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -79.89 171.38 15.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.42 142.65 39.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.56 40.71 98.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.376 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -106.21 155.12 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.192 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.9 tp -111.04 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.982 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.24 16.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.273 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.574 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.54 176.5 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.01 0.433 . . . . 0.0 110.736 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.39 174.34 5.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.751 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.02 129.91 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.79 -11.58 56.17 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.419 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.482 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.52 165.85 1.03 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.438 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.2 mt-30 -122.78 146.21 47.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.509 0.671 . . . . 0.0 111.163 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.6 128.06 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.385 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -79.88 103.57 9.87 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 22.3 mm -59.94 112.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.218 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.714 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.4 mt -79.52 -47.35 15.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.713 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.93 139.87 34.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.936 178.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.551 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -126.18 35.38 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 111.23 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 122.2 37.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.021 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.89 160.77 36.86 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.775 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.9 tt0 -49.63 -19.95 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.277 -0.462 . . . . 0.0 111.383 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.3 m95 -113.17 112.93 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.327 . . . . 0.0 110.573 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -94.73 136.92 34.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.108 0.48 . . . . 0.0 112.228 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.714 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.3 113.33 20.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.234 178.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.65 143.36 47.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.024 0.44 . . . . 0.0 111.678 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.84 110.78 22.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.607 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 168.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.136 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.69 -23.74 3.97 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.939 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.83 -41.05 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.009 0.909 . . . . 0.0 108.913 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.69 -35.62 6.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.04 -0.77 86.81 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.203 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -50.34 121.71 5.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.265 0.555 . . . . 0.0 111.078 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.71 143.76 26.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.525 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 178.52 44.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.71 149.02 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.704 0.288 . . . . 0.0 110.67 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 111' ' ' ILE . 5.1 pt -143.99 143.24 22.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 112.065 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.6 Cg_endo -51.3 111.5 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.175 2.584 . . . . 0.0 111.299 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.75 -25.74 1.98 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.8 p-10 -98.99 30.83 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 111.062 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.504 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -124.06 19.84 9.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.9 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.1 m -153.63 150.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.1 138.05 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.619 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -39.38 139.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.14 53.67 0.13 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.913 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 66' ' ' VAL . 24.5 tp . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.911 0.862 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 65' ' ' LEU . 3.0 m -127.04 -176.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.176 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.47 128.06 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.622 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.83 150.71 47.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.66 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 mt -109.9 -6.94 15.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.964 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.487 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -152.19 173.44 14.97 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.598 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.34 124.47 28.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.533 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 18.7 t80 -102.69 146.7 27.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.207 0.527 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.13 15.25 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.148 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 6.2 Cg_exo -37.9 123.71 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.28 3.32 . . . . 0.0 113.223 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -40.67 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.559 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -80.37 157.18 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.17 142.99 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 63.22 39.69 98.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.545 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.22 155.31 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.21 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 7.2 tp -110.83 129.15 55.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.0 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.2 144.9 17.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.112 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.66 175.47 10.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.952 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.08 173.53 6.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.859 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -72.01 127.33 32.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.32 -11.86 59.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.354 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.53 165.52 1.11 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.422 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.1 mt-30 -123.76 147.85 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.31 127.22 13.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.95 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -79.87 102.28 9.04 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.389 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.5 mm -56.82 111.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.171 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.704 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.7 mt -79.52 -46.89 16.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.443 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.61 154.04 43.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.241 178.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.472 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.5 pt20 -139.44 37.33 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 0.0 111.819 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.3 131.2 34.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.9 166.6 17.63 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.041 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.7 tt0 -47.51 -20.91 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.608 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 77.7 m95 -110.42 120.27 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.764 0.316 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.472 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.5 m0 -102.72 142.34 34.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.151 0.501 . . . . 0.0 112.101 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.06 114.46 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.374 178.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.45 142.8 48.92 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.0 111.635 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.487 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.3 tt0 -107.57 110.97 23.0 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.622 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.82 166.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.048 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.9 -23.75 4.22 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.066 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.92 -40.56 19.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.891 0.853 . . . . 0.0 108.881 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.19 -35.61 6.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.445 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.64 -0.24 88.36 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.283 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.95 122.36 7.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.271 0.558 . . . . 0.0 110.971 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.75 145.41 25.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.541 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.37 177.4 42.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.15 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.0 m-85 -89.63 142.69 27.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.796 0.332 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.456 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.0 pt -135.99 145.05 50.9 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.38 0.609 . . . . 0.0 112.109 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.546 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.18 114.93 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.318 2.679 . . . . 0.0 111.125 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.94 -22.89 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 18.3 p-10 -102.56 34.92 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.339 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -122.45 -9.01 8.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.121 -179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 14.5 m -133.76 153.11 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.59 143.17 41.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.488 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -39.53 139.4 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.59 53.47 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.875 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 66' ' ' VAL . 23.3 tp . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.832 0.825 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.536 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.8 m -125.91 -177.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.981 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 125.29 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.654 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.32 149.06 21.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.479 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.5 -25.41 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.737 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.427 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -144.3 -177.25 5.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.57 125.01 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 19.5 t80 -103.68 145.58 29.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.311 0.576 . . . . 0.0 112.496 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.35 94.58 15.44 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.76 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 2.6 Cg_exo -35.03 126.73 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.384 3.39 . . . . 0.0 113.359 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -121.9 -42.45 2.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.729 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.13 170.85 15.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.74 145.59 40.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.03 35.37 83.48 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.405 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.418 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.2 m-20 -97.99 156.73 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.414 . . . . 0.0 111.176 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.488 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 4.4 tp -115.63 127.53 55.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.889 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.84 142.6 16.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.118 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.2 p90 -142.04 177.52 8.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.014 0.435 . . . . 0.0 110.899 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -108.26 172.71 6.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.838 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -72.36 128.98 37.31 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.58 -10.23 59.96 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.4 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.29 165.38 2.04 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.427 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 1.9 mt-30 -123.52 147.88 46.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 111.215 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.61 127.84 13.84 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -79.81 103.63 9.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 30.4 mm -58.42 111.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.313 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.6 mt -79.55 -46.21 17.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.603 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.37 137.07 30.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.8 178.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.52 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.6 pt20 -125.73 36.15 4.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 0.0 111.34 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.29 122.81 38.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.6 161.26 37.28 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.7 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -48.47 -21.15 0.5 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.449 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.503 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.9 m95 -112.03 119.86 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.297 . . . . 0.0 110.529 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.52 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -101.8 138.21 39.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 112.223 -179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.728 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.91 114.4 22.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.954 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.88 143.12 49.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.995 0.426 . . . . 0.0 111.839 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.4 tt0 -106.61 111.16 23.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.634 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.38 165.38 0.1 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.787 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.26 -23.59 4.48 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.218 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.02 -40.41 19.98 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.881 0.848 . . . . 0.0 108.983 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -35.74 6.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.498 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.67 -1.37 88.15 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.134 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.31 122.64 7.21 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.173 0.511 . . . . 0.0 110.946 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.94 149.19 21.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.598 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.44 178.78 41.45 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.38 139.57 30.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.752 0.31 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.433 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 6.1 pt -133.46 145.68 57.48 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.421 0.629 . . . . 0.0 111.998 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.69 119.61 6.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.198 2.599 . . . . 0.0 111.398 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.4 -19.13 33.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -103.45 34.9 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.66 -30.25 3.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.661 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 31.5 m -111.43 147.73 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.48 141.01 46.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.365 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -39.47 138.24 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.8 54.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.949 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 66' ' ' VAL . 27.7 tp . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 122.03 0.919 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.545 ' O ' HD13 ' A' ' 65' ' ' LEU . 2.7 m -124.11 -176.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.402 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.85 125.22 5.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.813 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.58 152.11 27.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.918 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.6 mt -119.63 8.46 11.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.864 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.88 142.52 5.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.63 124.46 18.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.421 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -104.14 146.6 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -137.28 94.25 12.42 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.924 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.1 Cg_exo -36.48 128.22 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 124.396 3.397 . . . . 0.0 113.346 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -126.35 -41.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.406 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.2 m-70 -79.85 156.11 27.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.66 130.49 43.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.832 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.71 33.41 42.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.457 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.32 154.6 19.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.15 0.5 . . . . 0.0 111.112 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.8 tp -110.08 131.8 54.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.71 143.91 16.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.358 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.63 176.62 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.66 171.58 7.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.879 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -70.39 126.84 30.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.42 -16.53 52.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.291 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.09 165.72 0.29 Allowed 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.8 mt-30 -123.92 145.96 48.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.629 0.728 . . . . 0.0 111.324 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.6 128.69 16.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.162 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -79.95 103.53 9.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 22.5 mm -58.98 111.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.184 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.4 mt -79.63 -47.12 15.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.685 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -141.23 137.08 32.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.798 178.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.535 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.84 36.1 4.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.09 122.37 38.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.896 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.3 159.4 35.53 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.707 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.6 tt0 -48.33 -21.22 0.49 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.498 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.0 m95 -112.51 112.4 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.741 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.535 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -94.32 139.66 30.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 112.166 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.07 114.96 23.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.03 178.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.51 142.76 49.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.991 0.424 . . . . 0.0 111.808 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.512 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.01 110.7 22.48 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.606 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.21 167.58 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.149 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.9 -23.58 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.577 -0.449 . . . . 0.0 112.013 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.88 -40.4 20.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.851 0.834 . . . . 0.0 108.9 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 -35.83 6.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.328 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.08 -0.5 88.57 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.268 -1.787 . . . . 0.0 113.297 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.91 123.23 8.74 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.22 0.533 . . . . 0.0 110.995 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.79 144.19 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.628 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.56 177.68 43.88 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.169 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.02 152.0 23.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 110.686 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.2 pt -148.02 142.96 17.05 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.264 0.554 . . . . 0.0 112.08 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.9 Cg_endo -52.67 112.32 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.171 2.58 . . . . 0.0 111.369 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.24 -23.52 9.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.819 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.1 p-10 -100.13 31.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.38 -22.78 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.957 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -115.6 151.24 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.2 140.17 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.388 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.48 140.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.31 51.4 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.993 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.956 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 66' ' ' VAL . 28.7 tp . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 121.98 0.895 . . . . 0.0 112.042 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.536 ' O ' HD13 ' A' ' 65' ' ' LEU . 2.7 m -125.94 -177.67 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.832 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.18 126.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.64 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.61 151.84 36.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -120.04 13.0 12.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.778 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.51 141.74 3.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.715 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.33 124.27 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.448 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.0 t80 -104.12 146.37 28.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.9 94.45 12.84 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.918 178.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.12 125.86 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.299 3.332 . . . . 0.0 113.364 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -40.34 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -79.93 167.64 20.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.692 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.46 142.49 44.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.62 41.9 99.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.425 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.31 155.35 20.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.069 0.461 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -110.96 132.27 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.059 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.59 143.02 16.47 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.461 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.32 176.11 10.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.07 175.14 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.656 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -72.84 131.98 42.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.79 -11.23 48.14 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.488 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.18 165.79 1.28 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.432 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.2 mt-30 -123.04 146.54 47.58 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.436 0.636 . . . . 0.0 111.183 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.91 128.13 14.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.259 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -79.93 103.81 10.07 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 26.8 mm -59.81 111.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.215 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.697 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.56 -47.82 14.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.29 136.47 33.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.841 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.532 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.1 pt20 -123.95 36.03 4.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.06 0.457 . . . . 0.0 111.355 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.0 122.36 39.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.907 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.33 159.87 35.52 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.758 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 tt0 -49.77 -20.11 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.383 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.509 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.9 m95 -113.62 112.01 22.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.532 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -93.51 138.39 31.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 112.307 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.697 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.14 112.96 21.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.158 178.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.39 143.25 47.55 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 120.999 0.428 . . . . 0.0 111.692 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.505 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.52 110.81 22.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.54 167.96 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.089 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.76 -23.79 3.95 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.994 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.67 -40.98 19.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.974 0.892 . . . . 0.0 108.883 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.77 -35.66 6.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.947 -1.478 . . . . 0.0 109.407 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.01 -0.44 87.3 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.286 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -50.89 121.53 6.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.222 0.534 . . . . 0.0 111.061 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.09 143.75 26.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.556 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.16 177.52 43.39 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.79 149.72 24.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 111' ' ' ILE . 4.9 pt -144.87 143.46 20.96 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.371 0.605 . . . . 0.0 112.137 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.509 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.14 111.38 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.257 2.638 . . . . 0.0 111.315 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p30 -99.84 31.7 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.494 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.36 14.34 9.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -150.85 150.48 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.38 140.16 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -39.5 139.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.48 54.19 0.11 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.046 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.915 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 66' ' ' VAL . 25.3 tp . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.913 0.863 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.8 m -125.31 -177.43 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.788 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -144.71 125.61 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.759 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.56 149.54 17.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 mt -100.37 -24.48 14.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -145.49 -176.87 5.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.899 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.72 125.39 29.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.452 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.3 t80 -104.87 147.0 28.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.249 0.547 . . . . 0.0 112.429 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -136.45 93.83 14.14 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.041 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 4.6 Cg_exo -39.41 112.93 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.169 3.246 . . . . 0.0 113.251 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -29.6 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -84.7 170.22 13.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.02 141.77 35.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 59.98 41.6 97.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.306 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -109.52 155.65 21.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.491 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.5 tp -110.17 129.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.981 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.23 147.79 18.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.941 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -148.25 177.91 9.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 110.896 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.1 174.71 5.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.848 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -73.37 129.1 37.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.51 -10.54 58.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.393 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.43 165.61 1.47 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.1 mt-30 -124.31 147.11 48.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.528 0.68 . . . . 0.0 111.295 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.91 128.02 14.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.065 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -79.91 104.03 10.21 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 22.6 mm -58.54 112.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.317 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.727 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 27.6 mt -79.68 -46.62 16.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.573 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.4 134.83 26.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.023 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.543 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.8 OUTLIER -120.56 36.65 4.5 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.222 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.36 122.52 39.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.993 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.15 159.92 36.03 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.851 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.01 -20.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.429 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.1 m95 -113.79 115.39 27.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.45 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -96.4 139.26 32.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.249 0.547 . . . . 0.0 112.358 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.727 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.39 113.6 21.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 177.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.09 143.27 48.23 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.893 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.519 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.0 tt0 -107.27 110.8 22.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.628 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 166.34 0.06 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.82 -23.24 4.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.123 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.03 -40.34 20.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.812 0.815 . . . . 0.0 108.915 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.73 -35.93 6.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.472 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.26 -0.32 88.99 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.262 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.02 122.52 7.67 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.282 0.563 . . . . 0.0 111.01 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.7 146.0 25.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.547 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.05 41.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.3 m-85 -89.85 142.39 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.699 0.285 . . . . 0.0 110.823 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 82' ' ' PHE . 7.4 pt -135.67 146.29 56.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 112.1 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.47 118.73 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.257 2.638 . . . . 0.0 111.335 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.24 -19.19 32.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -102.89 34.17 2.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.52 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.64 -30.14 3.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.635 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 29.0 m -108.09 149.47 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.24 139.09 39.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.29 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -39.33 139.17 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.93 54.54 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.92 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 66' ' ' VAL . 24.8 tp . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.834 0.826 . . . . 0.0 111.617 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.8 m -125.94 -176.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.991 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.87 126.87 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.576 179.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 152.16 41.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.111 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.87 13.73 11.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.865 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.53 141.67 3.0 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.735 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.61 124.48 19.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.297 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -103.94 146.78 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.2 mt-10 -137.06 94.15 12.8 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.852 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.0 Cg_exo -36.61 125.63 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.336 3.358 . . . . 0.0 113.364 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -123.32 -41.53 2.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.684 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.0 159.67 26.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.26 137.05 52.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.31 36.37 78.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -104.74 154.84 19.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.103 0.477 . . . . 0.0 111.124 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.2 tp -110.59 130.85 55.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.082 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.99 143.9 16.88 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.313 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -146.99 176.91 9.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -109.36 173.67 6.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -71.89 128.75 36.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.04 -12.92 56.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.42 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.508 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.46 165.42 0.8 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.7 mt-30 -123.04 147.38 46.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.532 0.682 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.39 128.02 14.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.147 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -79.87 103.23 9.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 28.6 mm -58.5 111.9 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.035 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 22.5 mt -79.37 -46.69 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.679 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 152.49 40.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.412 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.496 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -137.12 36.78 2.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.895 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.61 131.23 34.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.155 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.75 164.78 16.23 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -47.64 -21.0 0.31 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.681 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.3 m95 -110.6 116.95 32.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.496 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.9 m0 -99.26 144.81 27.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.102 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.687 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -90.01 115.36 27.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.43 143.18 49.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.119 0.485 . . . . 0.0 111.636 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.505 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.4 111.12 22.86 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.606 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 167.43 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.45 -23.67 4.06 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.08 -40.56 19.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.918 0.866 . . . . 0.0 108.91 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.24 -35.57 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.41 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.74 -1.6 85.68 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 113.221 -1.809 . . . . 0.0 113.252 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -49.7 122.49 6.48 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.256 0.551 . . . . 0.0 111.13 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.0 145.19 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.544 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.02 177.93 42.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.26 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -86.21 153.8 21.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.663 0.268 . . . . 0.0 110.459 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 111' ' ' ILE . 5.0 pt -149.12 143.78 17.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 112.1 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.9 Cg_endo -52.32 111.74 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.265 2.643 . . . . 0.0 111.286 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.5 -23.08 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -102.5 32.27 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.308 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.97 -15.14 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.124 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 19.8 m -124.86 151.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.47 142.9 41.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.572 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -39.6 138.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 54.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.087 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.871 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 66' ' ' VAL . 23.2 tp . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 121.854 0.835 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.39 -177.4 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.841 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.19 123.55 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.86 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.9 153.3 17.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.804 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.02 8.59 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.47 143.02 5.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.702 -179.113 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.68 123.95 16.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.279 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.01 146.63 28.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -137.92 94.28 11.51 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.89 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 3.9 Cg_exo -35.91 128.72 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.357 3.371 . . . . 0.0 113.356 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -44.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.651 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.423 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.6 m-70 -80.01 149.1 30.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.17 130.74 48.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.58 29.3 53.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.855 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.437 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.9 m-20 -97.3 157.99 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.06 0.457 . . . . 0.0 111.023 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.5 OUTLIER -114.24 129.64 56.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.904 179.564 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.5 142.1 15.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.441 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -147.53 176.82 9.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.962 0.41 . . . . 0.0 110.511 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -107.34 172.51 6.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -72.53 129.57 38.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.69 -12.37 56.76 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.403 -177.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.82 165.77 0.85 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.9 mt-30 -122.38 146.24 47.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.556 0.693 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.61 128.2 15.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 ttt-85 -79.94 103.86 10.12 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 26.9 mm -58.23 112.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.116 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.7 mt -79.47 -46.84 16.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.777 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.82 136.29 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.634 178.331 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -123.23 35.89 4.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.44 122.44 39.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.869 179.165 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.07 160.3 35.94 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.757 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.5 tt0 -49.84 -19.99 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 66.8 m95 -114.1 109.68 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.295 . . . . 0.0 110.794 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.3 m0 -91.48 137.41 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.122 0.487 . . . . 0.0 112.059 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.28 115.98 22.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.159 178.122 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.08 144.12 48.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.887 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.532 ' HB2' HD13 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.32 110.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.583 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.91 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.162 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 mp -125.76 -23.89 3.92 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.999 -178.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.99 -40.71 19.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.952 0.882 . . . . 0.0 108.933 178.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -35.6 6.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.549 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.24 -2.03 85.64 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.199 -1.819 . . . . 0.0 113.173 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -49.44 123.45 7.62 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.167 0.508 . . . . 0.0 111.104 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.88 147.68 22.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.725 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.46 177.87 41.49 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -86.32 144.56 27.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.651 0.263 . . . . 0.0 110.56 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 111' ' ' ILE . 4.6 pt -139.12 142.72 34.0 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.335 0.588 . . . . 0.0 112.135 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.5 Cg_endo -52.42 113.98 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.212 2.608 . . . . 0.0 111.385 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -22.72 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.022 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' CD1' ' A' ' 113' ' ' PHE . 7.9 p-10 -101.95 32.88 3.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.705 0.288 . . . . 0.0 111.115 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -120.33 -23.91 6.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.004 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 28.4 m -114.9 147.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -177.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.15 139.7 46.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.57 140.72 0.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.944 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.06 50.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.104 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 66' ' ' VAL . 29.1 tp . . . . . 0 N--CA 1.447 -0.624 0 CA-C-O 122.025 0.917 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -125.17 -177.17 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.576 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.3 124.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.816 179.15 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.55 147.95 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.457 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 mt -100.26 -24.96 14.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -143.46 -177.15 5.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 179.47 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.67 124.92 29.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.2 t80 -103.94 146.94 27.95 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -137.63 94.23 11.94 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.6 Cg_exo -37.08 127.28 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.303 3.335 . . . . 0.0 113.354 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -41.54 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.607 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.403 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m170 -80.01 156.72 27.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.46 140.75 58.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 38.57 95.51 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.39 156.0 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 111.139 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -111.3 131.41 55.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.23 147.79 18.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.179 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -150.69 179.05 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.009 0.433 . . . . 0.0 110.786 -179.745 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.76 177.92 4.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.762 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -75.38 134.79 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.68 -7.31 41.8 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.473 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -60.2 165.77 3.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 2.1 mt-30 -123.71 146.29 48.38 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.511 0.672 . . . . 0.0 111.157 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.5 128.22 15.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.143 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -79.83 104.28 10.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 29.6 mm -60.38 112.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.294 -178.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.59 -47.76 14.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.751 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.15 136.27 33.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.793 178.305 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.542 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -124.19 36.49 4.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.352 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.79 40.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.996 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.64 159.88 35.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.726 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.1 tt0 -49.19 -20.57 0.62 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.35 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.509 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.3 m95 -113.2 114.6 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.9 m0 -96.42 139.44 32.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.58 113.19 21.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.987 177.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.76 144.04 47.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.092 0.472 . . . . 0.0 111.697 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.516 ' HB2' HD13 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.03 110.65 21.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.613 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.52 167.72 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.067 -179.475 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.64 -23.32 4.07 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.003 -178.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.82 -40.89 19.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.968 0.89 . . . . 0.0 108.932 178.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.97 -36.04 6.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.342 179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.45 0.68 89.47 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.348 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.68 122.45 8.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.236 0.541 . . . . 0.0 110.978 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.85 143.77 26.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.493 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.59 177.02 43.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.272 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.98 143.34 27.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.666 0.269 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.428 HG23 ' CE1' ' A' ' 82' ' ' PHE . 7.5 pt -137.53 145.14 47.9 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.387 0.613 . . . . 0.0 112.125 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.02 116.46 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.21 2.606 . . . . 0.0 111.189 178.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.39 -20.01 10.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -101.98 33.94 2.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 111.154 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.35 -30.43 4.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.618 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 29.8 m -109.44 147.32 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.37 139.87 44.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.143 178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.39 140.15 0.48 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.92 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.41 51.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.583 HD11 ' O ' ' A' ' 66' ' ' VAL . 19.0 tp . . . . . 0 N--CA 1.446 -0.639 0 CA-C-O 121.784 0.802 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.583 ' O ' HD11 ' A' ' 65' ' ' LEU . 3.0 m -126.57 -178.41 2.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.229 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -142.36 124.55 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.616 179.434 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.66 151.07 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.039 -179.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.88 13.19 12.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 141.81 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.629 -179.185 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.21 124.48 19.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.452 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.2 t80 -104.1 146.64 28.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -136.77 94.38 13.11 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.963 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.1 Cg_exo -36.4 132.93 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 124.332 3.355 . . . . 0.0 113.41 -179.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -42.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.91 157.55 26.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.43 133.66 49.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 35.32 55.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.373 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.422 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -103.96 155.56 18.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -112.21 132.26 55.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.924 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.14 143.2 16.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.588 ' HB3' HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.17 176.41 9.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.987 0.422 . . . . 0.0 110.782 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -109.27 173.47 6.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.957 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -72.22 127.71 33.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 -13.58 58.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.309 -177.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.495 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.32 165.64 0.72 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.442 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.1 mt-30 -123.05 147.63 46.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.405 0.621 . . . . 0.0 111.057 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.97 127.52 13.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.176 -179.88 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -79.86 103.66 9.91 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 mm -59.13 111.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.223 -178.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.723 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 19.9 mt -79.5 -47.15 16.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.544 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 155.1 45.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.431 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.464 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -140.63 37.51 1.83 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.811 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 131.48 34.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.216 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.86 167.08 10.47 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.046 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -47.14 -20.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.071 -0.564 . . . . 0.0 111.685 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m95 -108.86 118.45 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 110.911 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.4 m0 -101.82 139.87 36.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.157 0.504 . . . . 0.0 111.944 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -85.51 114.73 22.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.358 178.303 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.29 143.52 49.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.49 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.11 111.12 22.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.609 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.01 167.17 0.06 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.99 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.15 -23.55 4.18 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.032 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.21 -41.4 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.883 0.849 . . . . 0.0 108.894 178.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.91 -35.51 6.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.456 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.15 -0.76 86.99 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.221 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -50.6 121.91 6.46 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.32 0.581 . . . . 0.0 111.053 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -88.7 145.75 25.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.549 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.15 177.89 41.99 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.309 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.47 151.9 23.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.647 0.26 . . . . 0.0 110.449 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 111' ' ' ILE . 7.6 pt -147.88 143.01 17.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 112.191 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.521 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.3 Cg_endo -52.01 110.16 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.098 2.532 . . . . 0.0 111.161 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.08 -25.77 2.28 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 7.2 p30 -96.99 29.16 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.722 0.296 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.489 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.12 18.96 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.984 -179.289 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.3 m -154.1 150.65 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.4 139.03 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.615 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -39.49 138.84 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 112.008 -178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.47 54.31 0.11 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.027 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.924 179.984 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 66' ' ' VAL . 24.7 tp . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.936 0.874 . . . . 0.0 111.958 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.83 -177.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.657 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.95 125.76 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.78 179.157 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.47 151.78 40.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.001 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.03 14.78 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.712 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -169.32 142.28 2.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 -179.227 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.02 124.73 20.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.6 t80 -104.75 146.47 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.98 94.6 12.58 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.054 178.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -37.09 128.71 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.43 3.42 . . . . 0.0 113.379 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -126.75 -42.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.97 158.42 26.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.707 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.38 142.32 57.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.33 42.22 99.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -110.57 155.38 22.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.127 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.4 tp -111.0 133.0 53.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.054 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -98.54 143.94 16.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.453 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.93 175.97 10.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.407 . . . . 0.0 110.822 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -109.02 175.93 5.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.699 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -72.86 132.22 43.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.76 -10.06 48.25 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.67 -177.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.8 165.83 1.61 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.438 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.1 mt-30 -123.24 146.0 48.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.545 0.688 . . . . 0.0 111.148 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.24 128.3 15.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -79.93 103.51 9.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 23.2 mm -59.81 111.31 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.061 -178.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.692 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 22.8 mt -79.62 -48.16 14.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.722 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 136.85 35.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.803 178.276 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.4 35.89 4.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 111.334 -178.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.62 122.53 39.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.823 179.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.02 159.25 35.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.671 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.3 -20.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.442 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.7 m95 -113.19 110.63 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.8 m0 -92.48 138.36 31.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.235 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.692 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -84.73 113.37 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.138 178.147 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.62 143.05 47.89 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.054 0.454 . . . . 0.0 111.659 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.497 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.48 110.52 22.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.605 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 168.0 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.185 -179.54 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.89 -23.62 3.93 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.055 -179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.71 -41.01 19.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.968 0.89 . . . . 0.0 108.876 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.67 -35.97 6.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.314 179.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.26 0.62 89.25 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.362 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.56 121.98 7.29 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.991 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.36 143.4 27.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.561 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 177.16 43.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.239 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -85.2 153.93 22.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.604 0.24 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.6 pt -149.62 143.29 16.64 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.372 0.606 . . . . 0.0 112.125 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.7 Cg_endo -51.08 110.16 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 111.191 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.28 -26.29 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -99.08 30.81 3.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 111.232 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.486 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -122.58 17.67 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.953 -179.581 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -154.16 150.67 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.48 139.56 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.51 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -39.56 139.33 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.42 54.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 66' ' ' VAL . 27.5 tp . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.901 0.857 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -124.61 -177.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.033 -1.439 . . . . 0.0 111.949 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.83 123.98 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.748 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.92 153.74 16.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.914 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.91 6.92 10.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.885 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.16 143.29 6.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 -179.163 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.22 124.27 17.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.9 t80 -104.96 146.39 29.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.5 mt-10 -138.05 94.69 11.08 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.811 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.0 Cg_exo -36.66 129.87 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.316 3.344 . . . . 0.0 113.365 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.9 t -128.3 -42.02 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.99 158.67 26.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.8 139.2 57.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.37 40.6 96.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.67 155.43 20.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.027 0.442 . . . . 0.0 111.11 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.45 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.2 tp -111.29 133.29 53.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.042 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.6 145.79 17.97 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.441 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -150.55 177.71 9.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.47 175.58 5.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.708 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -73.89 131.68 41.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.09 -10.8 51.88 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.355 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.5 165.59 1.52 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.433 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.8 mt-30 -122.55 146.55 47.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.6 0.714 . . . . 0.0 111.197 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.55 127.81 14.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -79.95 103.2 9.68 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 28.5 mm -59.69 111.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.264 -178.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.725 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.3 mt -79.63 -47.04 16.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.47 178.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.46 155.63 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.309 178.127 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -141.47 37.39 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.09 131.96 34.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.301 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.44 166.5 15.57 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.992 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.4 tt0 -47.76 -20.75 0.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.7 m95 -110.22 118.21 35.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.462 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.3 m0 -100.63 143.63 30.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.121 0.486 . . . . 0.0 112.033 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.725 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.26 114.85 25.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.482 178.464 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.61 143.8 49.11 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.962 0.41 . . . . 0.0 111.697 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.492 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.5 tt0 -109.09 110.99 22.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.598 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.19 -179.453 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.27 -23.25 4.2 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.663 -0.415 . . . . 0.0 112.025 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.18 -41.7 18.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.976 0.893 . . . . 0.0 108.943 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.13 -36.04 6.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.334 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 0.06 88.72 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 113.176 -1.829 . . . . 0.0 113.423 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.16 122.57 7.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.276 0.56 . . . . 0.0 111.08 179.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.78 146.01 25.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.616 -178.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.99 177.77 41.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.54 155.53 21.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 82' ' ' PHE . 5.5 pt -150.03 144.36 17.54 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.344 0.592 . . . . 0.0 112.205 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 8.9 Cg_endo -53.45 112.17 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.209 2.606 . . . . 0.0 111.251 178.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -54.74 -21.11 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 6.2 p-10 -101.6 30.72 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.25 -26.33 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -113.22 149.6 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.55 140.67 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.23 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 140.47 0.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.908 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.26 50.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 . . . . . 0 CA--C 1.516 -0.342 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 66' ' ' VAL . 28.6 tp -82.25 142.52 32.05 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.937 0.875 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -124.86 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.78 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.24 126.7 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.668 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.99 151.73 42.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.992 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.9 13.33 12.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.862 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.585 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.93 141.1 2.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.661 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.65 124.08 17.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.308 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.0 t80 -103.27 145.46 29.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -135.73 94.3 15.03 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.91 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.21 126.22 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.327 3.351 . . . . 0.0 113.327 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -124.01 -41.83 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.631 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.407 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -79.98 159.09 26.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.704 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 141.67 56.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.923 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 63.88 39.11 97.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.613 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.12 155.49 19.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.059 0.456 . . . . 0.0 111.141 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 3.5 tp -111.15 129.91 55.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.53 142.19 15.92 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.57 176.2 9.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.993 0.425 . . . . 0.0 110.711 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.73 171.59 7.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -70.98 128.58 36.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.29 -13.4 55.2 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.427 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.87 165.61 0.61 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.428 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.5 mt-30 -123.21 146.48 47.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.67 0.748 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.44 128.55 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.177 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -79.89 103.59 9.88 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 26.2 mm -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.17 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.688 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.2 mt -79.53 -47.76 15.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.722 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.5 135.48 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.807 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.8 pt20 -121.94 35.92 4.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.369 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.65 122.23 38.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.92 158.54 34.61 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.691 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.3 tt0 -48.55 -21.51 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.457 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.483 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.1 m95 -112.46 109.69 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.717 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -91.38 139.34 30.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.199 0.524 . . . . 0.0 112.184 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.72 114.35 22.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.239 177.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.85 144.68 47.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 0.0 111.785 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.528 ' HB2' HD13 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.87 110.7 21.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.599 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.35 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.186 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.88 -23.66 3.93 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.007 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -40.21 20.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.959 0.885 . . . . 0.0 108.914 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -35.78 6.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.411 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.83 -0.18 88.65 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 113.285 -1.78 . . . . 0.0 113.384 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.12 122.8 8.17 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.236 0.541 . . . . 0.0 111.003 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.95 144.2 26.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.47 177.59 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.199 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -86.18 152.38 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.661 0.267 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 6.2 pt -148.14 143.49 17.65 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 112.086 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.483 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.4 Cg_endo -52.64 108.34 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.152 2.568 . . . . 0.0 111.281 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -50.64 -24.9 3.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.4 p30 -98.97 30.36 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.451 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -118.0 -24.41 7.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.01 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.7 m -115.46 150.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 142.58 44.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.487 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -39.67 139.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.35 54.44 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.003 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 66' ' ' VAL . 26.6 tp -83.15 142.28 31.34 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.86 0.838 . . . . 0.0 111.709 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -125.28 -176.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.856 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.97 126.66 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.62 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.67 152.23 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.01 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.48 14.2 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.884 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.578 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 140.76 2.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.672 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.87 124.13 17.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.244 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.551 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 13.1 t80 -103.78 146.19 28.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -137.15 94.31 12.55 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.914 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 6.0 Cg_exo -37.65 120.45 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.259 3.306 . . . . 0.0 113.426 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -118.79 -36.79 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.413 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.7 m80 -81.35 172.68 13.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.624 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -80.07 142.82 34.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.28 38.08 94.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.438 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.73 155.55 18.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 111.211 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.458 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -111.42 128.58 56.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.082 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.08 144.71 17.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.354 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -147.82 176.22 10.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.989 0.423 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -107.15 173.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.729 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -72.58 129.08 37.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.86 -11.0 58.59 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.512 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.47 165.56 1.08 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.417 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 3.3 mt-30 -122.77 146.6 47.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.552 0.691 . . . . 0.0 111.212 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.99 128.07 14.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.204 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -79.85 103.52 9.8 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 29.1 mm -57.77 112.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.223 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.1 mt -79.41 -46.87 16.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.704 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.32 135.69 27.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.626 178.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.3 pt20 -122.26 35.69 4.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.076 0.465 . . . . 0.0 111.239 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 122.66 38.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.876 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.19 158.65 34.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.613 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.8 tt0 -49.38 -20.84 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.435 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.17 107.78 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.9 m0 -89.34 140.41 29.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 112.201 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.7 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.82 115.73 24.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.191 178.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.43 144.14 48.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.937 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.528 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.6 110.93 22.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.576 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.98 167.81 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.123 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.79 -24.04 3.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.914 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -83.15 -40.47 19.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.913 0.863 . . . . 0.0 108.942 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.84 -35.47 6.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.502 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.77 -2.89 85.29 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.035 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -48.8 124.75 8.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.98 151.05 20.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.716 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 167.61 176.91 38.68 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.61 142.69 28.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.69 0.281 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.45 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.0 pt -136.76 144.57 47.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.62 . . . . 0.0 112.176 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 9.0 Cg_endo -53.62 109.77 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.195 2.597 . . . . 0.0 111.29 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.54 -23.85 7.09 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.814 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.1 p-10 -99.12 30.87 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.99 -22.73 6.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.043 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.5 m -117.23 150.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.43 142.36 43.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.39 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -39.59 139.09 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.01 53.98 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.075 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' VAL . 29.8 tp -84.79 141.73 30.29 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.982 0.896 . . . . 0.0 112.096 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.527 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.5 m -125.48 -177.28 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 113.826 -1.533 . . . . 0.0 111.779 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.28 126.1 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.636 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.84 151.93 41.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.091 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.17 14.38 12.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.94 141.12 2.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.14 124.6 19.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.325 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.6 t80 -103.92 146.09 29.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.89 94.44 12.86 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.963 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 4.6 Cg_exo -36.34 132.43 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.336 3.358 . . . . 0.0 113.381 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 t -130.53 -43.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.741 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.417 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.8 m80 -79.96 149.09 30.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 129.76 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.044 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.82 28.78 49.75 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.624 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 3.2 m-20 -96.98 158.47 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER -116.2 132.73 56.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.831 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.33 141.87 15.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.626 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.566 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -144.8 176.8 9.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.471 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.09 170.5 8.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.055 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -69.71 126.63 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.72 -15.65 50.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.323 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.486 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.17 166.21 0.26 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.6 mt-30 -123.34 145.81 48.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.5 0.667 . . . . 0.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.26 127.69 15.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.258 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -79.74 103.41 9.62 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 23.0 mm -58.25 111.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.119 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.726 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.7 mt -79.34 -46.68 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.554 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.24 154.89 44.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -140.25 36.7 1.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 0.0 111.863 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.33 131.28 34.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.93 166.81 18.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.027 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.04 -20.36 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.662 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 71.2 m95 -110.18 116.85 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.469 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.0 m0 -99.74 140.5 33.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.084 0.469 . . . . 0.0 111.994 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.726 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.81 116.76 25.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.54 178.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -123.2 144.6 49.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.031 0.443 . . . . 0.0 111.722 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.493 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.65 111.24 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.597 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.52 167.09 0.07 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.871 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.62 -23.41 4.39 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.426 -0.51 . . . . 0.0 112.105 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.84 -41.15 17.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 0.0 108.989 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.12 -35.57 6.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.427 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.63 -1.74 84.98 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.239 -1.801 . . . . 0.0 113.218 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -49.37 123.37 7.41 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.177 0.513 . . . . 0.0 111.15 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.79 149.5 21.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.607 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 168.46 177.02 39.22 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.313 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.35 143.42 28.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.658 0.266 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.4 pt -137.84 142.14 35.25 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 0.0 112.126 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.26 112.06 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.264 2.643 . . . . 0.0 111.242 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -49.84 -24.87 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.3 p-10 -100.52 31.42 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.492 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.39 17.07 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.946 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.8 m -154.23 150.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.23 140.75 37.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.548 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -39.53 138.91 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.25 54.38 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.89 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 66' ' ' VAL . 26.2 tp -81.96 142.25 32.58 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.951 0.881 . . . . 0.0 111.838 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.5 m -124.04 -176.64 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.894 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.48 128.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.749 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.62 150.55 48.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.641 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.98 -6.22 15.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.482 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -153.52 172.89 16.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.676 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.05 123.99 27.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.513 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.58 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 20.4 t80 -101.51 145.96 28.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.289 0.566 . . . . 0.0 112.331 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.24 15.15 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.038 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.22 129.36 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.368 3.379 . . . . 0.0 113.293 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -125.76 -40.7 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.791 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -79.94 174.99 11.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.695 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.21 144.9 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.97 37.29 84.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.634 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -98.47 156.2 16.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.168 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -115.2 125.23 53.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.54 141.35 15.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.108 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -141.19 175.62 9.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -107.05 172.7 6.68 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.813 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.18 127.92 34.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.63 59.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.355 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.74 165.59 1.15 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.409 ' HG2' HG13 ' A' ' 67' ' ' ILE . 3.0 mt-30 -123.9 146.71 48.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.521 0.677 . . . . 0.0 111.202 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.12 128.47 15.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -80.03 103.31 9.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.5 mm -59.36 111.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.216 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.72 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.5 mt -79.55 -47.25 15.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.813 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.43 136.37 29.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.739 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -124.19 35.92 4.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.473 . . . . 0.0 111.32 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 122.41 38.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.959 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.58 160.91 36.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.798 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.0 tt0 -48.79 -20.96 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.501 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.25 117.19 31.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.7 m0 -98.82 137.57 37.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.13 0.49 . . . . 0.0 112.169 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.72 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.92 112.68 20.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.061 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -118.96 143.28 47.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.514 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.93 110.53 21.87 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.618 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.08 167.17 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.104 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.45 -23.7 4.06 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.099 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.73 -40.49 20.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.909 0.861 . . . . 0.0 108.936 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.37 -35.57 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.408 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.46 -0.0 88.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.299 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.24 121.63 6.51 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.261 0.553 . . . . 0.0 111.058 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.93 142.55 27.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.601 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 177.09 -179.94 47.75 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.249 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.34 139.8 30.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.695 0.284 . . . . 0.0 110.97 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 6.0 pt -134.26 144.18 50.16 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.421 0.629 . . . . 0.0 111.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.4 Cg_endo -53.11 119.18 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.218 2.612 . . . . 0.0 111.265 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.69 -20.97 16.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -105.18 35.4 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.244 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -120.96 -17.49 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 14.8 m -126.88 152.33 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.62 143.27 43.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.388 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -39.59 139.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.19 54.51 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.046 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.864 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 66' ' ' VAL . 25.4 tp -44.0 142.86 1.26 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.877 0.846 . . . . 0.0 112.091 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.9 m -126.72 -176.89 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.894 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.63 125.94 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.629 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB1' ' CD2' ' A' ' 82' ' ' PHE . . . -57.67 146.85 29.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.466 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 mt -97.98 -24.54 15.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.418 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -145.87 -177.37 5.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.965 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.31 125.22 29.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.214 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -103.64 145.39 30.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.34 94.13 15.9 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.046 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -37.14 133.58 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.304 3.336 . . . . 0.0 113.432 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.46 -43.57 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.0 150.57 30.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.722 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -62.31 136.16 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 74.39 29.96 61.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.6 m-20 -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 0.0 111.024 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.498 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.1 tp -116.34 123.99 48.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.899 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -90.3 143.12 16.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.137 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p90 -143.93 178.19 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -108.3 172.98 6.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.89 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -72.71 128.77 36.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 -10.73 59.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.286 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.33 165.5 1.44 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.411 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.3 mt-30 -123.69 147.33 47.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.465 0.65 . . . . 0.0 111.111 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.48 127.67 14.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.951 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -79.84 101.37 8.48 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.418 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 37.0 mm -55.4 112.11 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.079 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.2 mt -79.4 -46.5 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.578 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -145.71 148.36 32.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.344 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.513 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -132.1 37.14 3.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.23 131.78 34.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.91 164.57 20.75 Favored Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.979 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -48.43 -20.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.59 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.507 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.0 m95 -111.1 119.47 39.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.513 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.0 m0 -101.53 142.26 33.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.109 0.481 . . . . 0.0 112.21 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.7 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.99 114.74 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.2 178.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.62 143.31 48.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 111.814 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.521 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.37 110.83 22.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.604 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.51 166.66 0.05 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.101 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 mp -125.04 -23.95 4.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.055 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.95 -39.98 20.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.841 . . . . 0.0 109.046 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.4 -35.47 6.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.554 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.56 -1.23 88.27 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.154 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 123.16 7.96 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 146.65 23.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.734 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.09 179.44 43.77 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.111 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.2 m-85 -90.39 139.83 30.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.789 0.328 . . . . 0.0 110.737 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.432 HG23 ' CE1' ' A' ' 82' ' ' PHE . 7.5 pt -133.69 144.48 52.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.5 116.77 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.263 2.642 . . . . 0.0 111.182 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.31 -19.9 16.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 5.9 p-10 -101.99 33.75 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.069 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.82 -30.33 4.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.651 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 27.4 m -111.13 148.61 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.69 142.21 45.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.408 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -39.36 137.98 0.71 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.08 54.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.061 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 66' ' ' VAL . 27.2 tp -79.79 142.43 35.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.988 0.899 . . . . 0.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.544 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.8 m -125.08 -176.64 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.594 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.69 125.13 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.733 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.94 29.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.928 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.81 10.68 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -167.43 142.85 4.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.653 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.5 124.82 20.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.384 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -104.62 146.8 28.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.419 0.628 . . . . 0.0 112.658 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -138.11 94.53 11.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.954 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.4 Cg_exo -36.83 127.56 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.304 3.336 . . . . 0.0 113.33 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.37 -40.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.403 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m80 -79.85 170.83 15.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.768 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.99 137.2 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.76 38.57 94.57 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.607 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -104.17 154.45 19.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 4.9 tp -110.48 133.01 53.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.089 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.1 143.74 16.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.402 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.593 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.78 176.7 9.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.79 172.96 6.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.863 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.93 128.84 37.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.85 -15.02 50.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.327 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.16 165.75 0.47 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 67' ' ' ILE . 0.9 OUTLIER -123.58 145.98 48.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.58 0.705 . . . . 0.0 111.29 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.31 128.36 15.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.149 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -79.84 103.77 9.97 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 23.2 mm -58.92 111.47 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.148 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.694 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 24.5 mt -79.56 -47.4 15.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.821 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.73 137.79 33.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.861 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.547 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -125.29 35.71 4.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.61 122.55 38.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.936 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.84 159.09 35.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.724 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.483 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.4 tt0 -48.49 -20.92 0.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.42 -0.39 . . . . 0.0 111.476 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.6 m95 -112.59 111.98 23.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.679 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -93.97 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.694 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.75 114.85 24.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.194 178.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.43 143.04 48.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.048 0.451 . . . . 0.0 111.774 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.1 tt0 -107.93 110.88 22.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.61 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.42 167.64 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.95 -24.06 3.84 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.968 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.44 -40.64 20.9 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.906 0.86 . . . . 0.0 108.919 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.22 -35.3 6.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.29 -1.23 86.0 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -50.53 121.86 6.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 0.0 111.082 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.47 145.13 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.619 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.66 176.63 42.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.78 151.78 24.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.609 0.242 . . . . 0.0 110.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 111' ' ' ILE . 5.7 pt -148.08 143.11 17.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.292 0.568 . . . . 0.0 112.148 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.493 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.7 Cg_endo -51.8 112.59 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.235 2.623 . . . . 0.0 111.339 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.47 -23.7 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 14.1 p30 -101.83 32.45 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.74 -17.06 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.7 m -121.61 150.42 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.24 140.77 41.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.477 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -39.46 139.48 0.56 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.84 53.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.966 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD11 ' O ' ' A' ' 66' ' ' VAL . 26.5 tp -82.36 142.51 31.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.904 0.859 . . . . 0.0 111.822 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -125.23 -176.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.884 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.7 124.92 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.61 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.84 152.96 21.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.03 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -121.4 8.9 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.916 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.596 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -166.32 143.36 5.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.24 123.74 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.332 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.575 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -103.03 146.94 27.59 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -138.2 94.53 10.99 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.847 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.4 Cg_exo -36.27 131.69 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.45 3.434 . . . . 0.0 113.299 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -130.1 -43.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 13.1 m-70 -79.96 157.31 26.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.33 128.45 36.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.64 47.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.657 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.3 m-20 -96.27 156.9 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.109 0.48 . . . . 0.0 110.991 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.4 tp -114.69 130.13 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.38 141.67 15.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.391 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -146.57 176.89 9.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -108.83 172.03 7.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.003 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -71.56 127.23 31.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.5 -15.32 55.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.286 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.522 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.41 165.53 0.36 Allowed 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.7 mt-30 -122.68 146.7 47.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.567 0.699 . . . . 0.0 111.216 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.77 127.97 14.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -79.93 103.07 9.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 25.0 mm -58.67 113.48 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.141 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.716 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 39.2 mt -79.51 -46.37 17.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.748 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -145.2 134.56 23.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.911 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.9 OUTLIER -119.77 36.05 4.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.77 122.24 37.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.925 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.39 159.53 35.61 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.696 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.85 -20.81 0.54 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.479 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 68.4 m95 -113.03 110.95 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.539 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -92.66 136.86 32.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 114.84 21.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.239 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.87 143.74 47.76 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.073 0.463 . . . . 0.0 111.745 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.96 110.58 21.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.59 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.41 168.4 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.223 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.12 -23.55 3.88 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.015 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.86 -40.4 20.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.868 0.842 . . . . 0.0 108.923 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -35.8 6.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.471 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.1 -0.62 88.48 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.271 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.45 123.17 8.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.231 0.539 . . . . 0.0 111.097 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -90.01 144.54 25.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.562 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.52 178.64 44.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.372 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -87.52 146.53 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.618 0.247 . . . . 0.0 110.643 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 111' ' ' ILE . 4.9 pt -142.25 142.07 23.05 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.0 112.125 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.1 Cg_endo -51.94 112.24 0.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.193 2.595 . . . . 0.0 111.385 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.64 -23.76 7.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p-10 -100.57 31.6 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.467 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.09 -25.63 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.1 m -114.32 149.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 141.81 44.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.478 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -39.58 138.94 0.64 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.61 54.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.083 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.975 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 CA--C 1.517 -0.303 0 CA-C-O 120.64 0.257 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 66' ' ' VAL . 22.9 tp -82.39 141.84 32.47 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.745 0.783 . . . . 0.0 111.464 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' O ' HD13 ' A' ' 65' ' ' LEU . 2.7 m -125.24 -177.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.105 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.51 126.03 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.608 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.82 152.03 37.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.132 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.05 12.69 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.26 142.73 3.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.585 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 124.19 18.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.389 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.4 t80 -104.07 146.18 29.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.69 94.38 13.26 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.927 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.5 Cg_exo -37.04 122.14 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.313 3.342 . . . . 0.0 113.336 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -41.16 2.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.508 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.406 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m-70 -80.51 159.05 25.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.21 143.48 56.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.17 41.65 99.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.593 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.59 155.61 21.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.162 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.6 tp -111.41 131.56 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.75 144.59 17.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.401 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.75 176.66 9.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -109.42 172.35 6.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.802 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -71.31 127.33 32.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.3 -14.34 57.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.347 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.9 165.61 0.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.429 ' HG2' HG13 ' A' ' 67' ' ' ILE . 3.3 mt-30 -123.2 147.49 46.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.668 . . . . 0.0 111.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.31 127.96 14.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.102 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -79.82 103.46 9.74 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 28.1 mm -59.07 111.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.202 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.707 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.6 mt -79.34 -47.02 16.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.505 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.97 154.24 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.336 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -139.47 36.71 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.842 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.56 131.26 34.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.235 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.75 15.93 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.108 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -47.46 -21.19 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.084 -0.558 . . . . 0.0 111.625 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.49 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m95 -109.99 118.1 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.471 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.7 m0 -100.4 143.18 30.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 112.021 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.707 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.22 114.71 25.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.468 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.9 142.98 49.18 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.051 0.453 . . . . 0.0 111.77 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.497 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.23 111.08 22.87 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.57 167.43 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.114 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.43 -23.52 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.056 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -41.06 19.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.919 0.866 . . . . 0.0 108.881 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.13 -35.66 6.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.419 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.98 -1.45 86.62 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.329 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -49.77 122.06 6.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.289 0.566 . . . . 0.0 111.07 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.44 145.03 26.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.665 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.62 42.24 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.6 m-85 -86.36 155.39 20.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.614 0.245 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.437 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 4.5 pt -150.11 144.25 17.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.609 . . . . 0.0 112.157 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.5 Cg_endo -52.88 111.15 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.226 2.617 . . . . 0.0 111.25 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.03 -22.97 6.55 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.6 p-10 -101.04 30.97 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.37 -19.75 8.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.985 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.2 m -119.7 150.63 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.81 141.34 42.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.325 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.65 140.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.8 50.89 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.897 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 66' ' ' VAL . 29.1 tp -82.22 142.19 32.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.063 0.935 . . . . 0.0 112.077 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -124.7 -176.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.546 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 126.46 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.687 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 147.97 25.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.401 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 mt -100.43 -23.07 14.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -145.54 -176.72 5.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.888 0.375 . . . . 0.0 110.776 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.25 125.26 30.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.9 t80 -104.66 146.57 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 mt-10 -136.41 94.13 13.97 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.024 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 6.0 Cg_exo -37.72 120.02 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.327 3.352 . . . . 0.0 113.366 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -117.07 -34.75 4.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.539 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -84.12 169.72 14.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -79.0 143.43 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.91 35.95 92.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.354 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -104.29 155.75 18.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 111.202 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.477 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.9 tp -111.85 127.45 55.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.136 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.77 144.2 16.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.03 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.543 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.9 OUTLIER -145.21 179.21 7.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.924 0.392 . . . . 0.0 110.949 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.89 175.41 5.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.956 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 131.22 41.28 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.34 -9.1 56.39 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.331 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.63 165.6 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.407 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 2.6 mt-30 -124.58 146.07 49.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 111.258 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.15 128.04 15.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.272 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -79.67 104.27 10.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 25.3 mm -59.57 112.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.388 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.681 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.8 mt -79.44 -47.43 15.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.475 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 154.27 43.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.413 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.491 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -138.61 38.02 2.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 111.888 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 131.27 34.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.283 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.8 166.42 9.7 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.12 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -46.77 -21.55 0.21 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.52 . . . . 0.0 111.655 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 80.3 m95 -108.52 121.01 44.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.491 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.97 143.14 33.27 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.681 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.39 113.94 24.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.228 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.9 145.64 47.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.136 0.493 . . . . 0.0 111.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.537 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.84 110.88 22.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.599 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.86 167.75 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.043 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.63 -23.49 4.04 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.073 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -83.12 -39.91 20.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.863 0.84 . . . . 0.0 109.015 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.21 -35.8 5.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.428 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.76 -0.34 88.37 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.286 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.03 122.62 7.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.225 0.536 . . . . 0.0 111.098 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.81 146.03 25.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.51 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.0 177.33 42.2 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.69 140.38 29.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.659 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 8.6 pt -134.78 145.34 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 112.161 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.9 Cg_endo -56.06 114.04 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.164 2.576 . . . . 0.0 111.156 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -21.64 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.426 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.5 p30 -98.81 31.63 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.851 0.357 . . . . 0.0 111.041 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.51 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -120.99 -27.13 5.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.632 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 23.0 m -112.9 148.74 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.3 141.35 41.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.374 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -39.4 138.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.56 54.41 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.029 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.923 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 66' ' ' VAL . 27.9 tp -83.54 142.03 31.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.985 0.898 . . . . 0.0 111.991 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -124.19 -177.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.672 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.09 125.33 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.753 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . . . -57.12 147.24 25.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.508 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.14 -24.4 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -146.39 -177.17 5.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.991 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 125.47 29.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.305 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -104.05 145.72 29.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.43 94.1 15.78 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.996 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.4 Cg_exo -36.92 124.46 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.387 3.392 . . . . 0.0 113.365 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -40.44 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.74 157.19 22.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.87 147.3 53.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.09 33.87 85.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.599 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -101.55 156.86 17.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.178 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 1.3 tp -114.36 125.04 53.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.095 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.92 142.64 16.14 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.176 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.1 p90 -143.06 178.35 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.922 0.391 . . . . 0.0 110.939 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -108.32 174.89 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.838 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.27 130.04 38.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.25 -8.76 60.06 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.382 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.75 165.4 2.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.6 mt-30 -124.31 146.12 49.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.651 0.738 . . . . 0.0 111.142 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.78 128.23 15.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -79.99 104.21 10.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 24.9 mm -59.5 112.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.34 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.684 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 21.9 mt -79.54 -46.94 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.388 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.85 155.02 43.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.347 178.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.488 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -139.74 37.56 2.0 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.836 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.08 131.01 34.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.358 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.84 167.14 14.47 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.086 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.5 tt0 -47.29 -21.29 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.605 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.7 m95 -109.25 121.67 45.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.488 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.4 m0 -104.29 142.65 34.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.043 0.449 . . . . 0.0 112.144 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.684 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.8 113.97 23.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.334 178.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.9 145.28 47.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 111.817 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.526 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.88 111.02 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.596 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.69 167.7 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.064 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.42 -23.61 4.08 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.084 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.99 -40.87 19.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.943 0.878 . . . . 0.0 109.013 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.12 -36.07 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.43 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.14 -0.27 88.91 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.288 -1.778 . . . . 0.0 113.257 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 123.3 8.96 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.229 0.538 . . . . 0.0 111.018 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 145.95 24.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.582 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.15 178.62 43.27 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -90.3 140.81 29.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 110.622 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.7 pt -134.74 145.31 54.29 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.347 0.594 . . . . 0.0 112.152 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 11.0 Cg_endo -55.89 115.36 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.238 2.626 . . . . 0.0 111.157 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.83 -19.72 12.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 13.9 p30 -101.22 32.5 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.509 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.18 -30.45 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.536 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 31.1 m -109.67 149.27 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.13 139.88 41.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.364 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -39.38 138.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.32 54.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD11 ' O ' ' A' ' 66' ' ' VAL . 27.3 tp -83.76 141.94 31.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.937 0.875 . . . . 0.0 112.017 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.539 ' O ' HD11 ' A' ' 65' ' ' LEU . 2.6 m -125.58 -177.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.746 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.55 126.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.601 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.07 151.53 39.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.212 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.08 13.67 12.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.757 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.87 141.35 2.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.736 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.35 124.27 18.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.408 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.8 t80 -103.73 146.26 28.87 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.3 94.32 14.0 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.01 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.4 Cg_exo -36.77 123.93 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.382 3.388 . . . . 0.0 113.292 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -122.34 -39.35 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.804 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.402 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.9 m80 -79.93 174.39 11.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.89 141.99 35.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.22 40.24 97.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -105.15 154.53 20.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.147 0.499 . . . . 0.0 111.189 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -110.64 131.75 54.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.907 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.59 16.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.369 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.3 175.97 9.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.802 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.1 173.22 6.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -71.65 128.45 35.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.95 -13.92 54.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.407 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.489 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.02 165.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.3 mt-30 -123.52 146.52 48.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.59 128.43 15.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.25 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -79.92 103.62 9.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 25.9 mm -59.57 111.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.232 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.702 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.8 mt -79.65 -47.93 14.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.786 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.74 136.99 34.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.849 178.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.534 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.0 pt20 -124.84 35.88 4.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.107 0.479 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.4 122.44 39.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.92 159.69 35.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.672 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.29 -21.29 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.351 -0.425 . . . . 0.0 111.538 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.1 m95 -111.75 113.3 25.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.534 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -95.59 136.46 35.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.069 0.461 . . . . 0.0 112.156 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.702 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 113.24 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.104 177.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.29 142.99 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 111.675 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.51 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.36 110.7 22.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.611 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 167.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.165 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.82 -23.71 3.94 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.968 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -82.7 -40.69 20.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.868 0.842 . . . . 0.0 108.859 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 -35.74 6.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.395 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 -0.85 87.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.293 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -50.21 121.94 6.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.82 143.35 26.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.579 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.99 177.51 44.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.341 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.64 149.18 25.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.68 0.276 . . . . 0.0 110.614 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 111' ' ' ILE . 7.1 pt -145.31 143.15 19.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.355 0.598 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.8 Cg_endo -51.68 109.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.45 -26.12 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -98.69 30.37 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 0.0 111.205 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.79 10.93 10.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.987 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.9 m -147.53 151.01 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.86 140.49 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.592 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -39.47 139.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 53.95 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.077 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.923 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 66' ' ' VAL . 24.8 tp -43.89 142.52 1.31 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.848 0.832 . . . . 0.0 112.103 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.545 ' O ' HD11 ' A' ' 65' ' ' LEU . 2.9 m -127.08 -176.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.968 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.24 124.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.01 152.05 20.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.786 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.22 7.48 10.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.983 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.14 143.88 6.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.14 124.13 17.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.318 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.56 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.96 146.96 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -138.59 94.51 10.46 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.886 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.95 131.38 0.33 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.359 3.372 . . . . 0.0 113.44 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -130.01 -43.48 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.711 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.426 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.5 m-70 -79.84 156.38 27.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.35 130.59 43.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.017 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.81 55.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.65 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -97.1 157.23 16.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 110.973 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -114.19 131.15 56.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.967 179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.31 142.31 16.01 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.489 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.56 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -148.13 177.13 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -108.12 176.48 5.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.702 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -74.24 134.36 42.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.39 -8.78 38.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.566 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.7 165.65 2.18 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.433 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.2 mt-30 -122.07 146.76 46.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.676 . . . . 0.0 111.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.95 127.44 14.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.931 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -79.63 101.43 8.34 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.523 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 36.8 mm -55.43 111.76 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.038 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.712 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 33.8 mt -79.45 -46.0 18.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.675 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.79 135.95 26.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.735 178.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.542 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -122.31 35.96 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.073 0.463 . . . . 0.0 111.437 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.35 122.49 39.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.834 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.17 159.51 35.32 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.756 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -49.73 -20.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.312 -0.444 . . . . 0.0 111.476 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.486 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 65.2 m95 -113.95 108.3 16.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.676 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -90.3 138.27 31.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.083 0.468 . . . . 0.0 112.08 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.712 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.55 116.6 23.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.09 178.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.64 142.65 49.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.794 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.514 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.17 110.76 22.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.583 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.7 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 -179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.56 -23.9 3.98 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.953 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.9 -40.22 20.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 108.986 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.28 -35.75 5.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.63 -1.29 88.26 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.175 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.78 123.16 7.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.251 0.548 . . . . 0.0 111.114 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.28 146.92 23.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.686 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.64 177.36 41.27 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.211 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.43 143.83 28.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.641 0.257 . . . . 0.0 110.475 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.4 pt -138.17 142.31 35.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.307 0.575 . . . . 0.0 112.205 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.7 Cg_endo -52.41 113.17 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.222 2.614 . . . . 0.0 111.312 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.85 -23.09 6.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -101.28 32.68 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 111.08 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.487 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.37 -17.71 7.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 30.5 m -121.27 149.04 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.68 140.91 44.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.594 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -39.52 138.76 0.65 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.67 53.78 0.12 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.946 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' VAL . 29.7 tp -82.88 142.39 31.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.966 0.888 . . . . 0.0 112.06 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -125.46 -176.64 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -145.55 126.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.723 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.64 148.3 29.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.464 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 mt -101.67 -22.81 14.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -143.36 -178.12 5.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.813 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.3 125.52 31.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.273 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.4 t80 -104.67 146.37 29.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.62 93.99 13.69 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.4 123.19 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.338 3.359 . . . . 0.0 113.34 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -39.05 2.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.84 19.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.12 143.11 41.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.07 38.97 96.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -106.07 155.21 19.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.489 . . . . 0.0 111.087 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -111.29 128.95 56.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.062 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.56 146.61 18.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.088 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -147.95 178.55 8.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.981 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.55 173.35 6.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.32 128.71 36.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 -13.24 56.16 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.288 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.12 165.63 0.96 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.405 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 2.9 mt-30 -124.71 146.79 48.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.605 0.717 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.57 128.2 15.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.983 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -79.8 103.85 9.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.3 mm -58.72 112.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.222 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 22.9 mt -79.39 -46.9 16.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.53 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 151.25 39.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.494 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.9 pt20 -135.67 37.63 2.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.37 131.26 34.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.331 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.67 15.67 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.0 tt0 -47.66 -21.53 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.106 -0.547 . . . . 0.0 111.586 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.0 m95 -109.63 120.9 43.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 110.738 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.507 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.33 143.92 32.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.102 0.477 . . . . 0.0 112.212 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -89.03 114.55 25.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.256 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.02 144.2 48.66 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.055 0.455 . . . . 0.0 111.851 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.541 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.49 111.01 22.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.613 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.75 166.96 0.05 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.042 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.36 -23.76 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.603 -0.439 . . . . 0.0 112.091 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.64 -40.09 21.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.88 0.848 . . . . 0.0 108.911 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.04 -35.9 6.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.471 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.32 -0.7 88.69 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.243 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.02 122.9 8.22 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.246 0.546 . . . . 0.0 111.067 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -88.98 146.56 24.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.588 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.74 177.49 42.13 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.191 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.48 142.51 27.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.72 0.295 . . . . 0.0 110.779 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.434 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.8 pt -136.7 144.88 48.77 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.453 0.644 . . . . 0.0 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.513 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.8 Cg_endo -55.63 116.18 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.293 2.662 . . . . 0.0 111.154 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.63 -19.6 17.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.412 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 p-10 -100.62 32.3 3.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.22 -29.57 4.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.732 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.9 m -110.21 152.13 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.39 141.17 35.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.346 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -39.42 139.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.94 54.0 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.925 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 66' ' ' VAL . 28.3 tp -83.32 141.55 31.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.019 0.914 . . . . 0.0 112.041 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.536 ' O ' HD11 ' A' ' 65' ' ' LEU . 2.7 m -125.51 -177.65 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.774 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.92 124.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.774 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.86 151.34 25.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.957 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.35 12.45 12.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.772 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.68 141.94 2.96 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.665 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.1 124.47 19.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.4 t80 -103.98 147.15 27.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.6 mt-10 -137.63 94.42 11.82 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.926 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.1 Cg_exo -36.73 126.81 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.354 3.369 . . . . 0.0 113.377 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -124.67 -40.75 2.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -79.89 171.38 15.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.42 142.65 39.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.56 40.71 98.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.376 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -106.21 155.12 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.192 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.9 tp -111.04 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.982 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.24 16.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.273 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.574 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.54 176.5 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.01 0.433 . . . . 0.0 110.736 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.39 174.34 5.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.751 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.02 129.91 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.79 -11.58 56.17 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.419 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.52 165.85 1.03 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.438 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.2 mt-30 -122.78 146.21 47.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.509 0.671 . . . . 0.0 111.163 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.6 128.06 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.385 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -79.88 103.57 9.87 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 22.3 mm -59.94 112.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.218 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.714 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.4 mt -79.52 -47.35 15.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.713 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.93 139.87 34.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.936 178.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.551 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -126.18 35.38 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 111.23 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 122.2 37.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.021 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.89 160.77 36.86 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.775 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.9 tt0 -49.63 -19.95 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.277 -0.462 . . . . 0.0 111.383 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.3 m95 -113.17 112.93 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.327 . . . . 0.0 110.573 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -94.73 136.92 34.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.108 0.48 . . . . 0.0 112.228 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.714 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.3 113.33 20.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.234 178.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.65 143.36 47.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.024 0.44 . . . . 0.0 111.678 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.84 110.78 22.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.607 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 168.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.136 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.69 -23.74 3.97 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.939 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.83 -41.05 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.009 0.909 . . . . 0.0 108.913 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.69 -35.62 6.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.04 -0.77 86.81 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.203 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -50.34 121.71 5.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.265 0.555 . . . . 0.0 111.078 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.71 143.76 26.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.525 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 178.52 44.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.71 149.02 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.704 0.288 . . . . 0.0 110.67 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 111' ' ' ILE . 5.1 pt -143.99 143.24 22.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 112.065 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.6 Cg_endo -51.3 111.5 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.175 2.584 . . . . 0.0 111.299 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.75 -25.74 1.98 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.8 p-10 -98.99 30.83 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 111.062 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.504 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -124.06 19.84 9.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.9 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.1 m -153.63 150.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.1 138.05 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.619 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -39.38 139.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.14 53.67 0.13 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.913 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 120.602 0.239 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 66' ' ' VAL . 24.5 tp -43.27 142.31 1.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.911 0.862 . . . . 0.0 112.099 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 65' ' ' LEU . 3.0 m -127.04 -176.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.176 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.47 128.06 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.622 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.83 150.71 47.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.66 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 mt -109.9 -6.94 15.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.964 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.487 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -152.19 173.44 14.97 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.598 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.34 124.47 28.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.533 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 18.7 t80 -102.69 146.7 27.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.207 0.527 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.13 15.25 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.148 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 6.2 Cg_exo -37.9 123.71 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.28 3.32 . . . . 0.0 113.223 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -40.67 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.559 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -80.37 157.18 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.17 142.99 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 63.22 39.69 98.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.545 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.22 155.31 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.21 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 7.2 tp -110.83 129.15 55.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.0 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.2 144.9 17.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.112 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.66 175.47 10.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.952 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.08 173.53 6.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.859 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -72.01 127.33 32.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.32 -11.86 59.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.354 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.53 165.52 1.11 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.422 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.1 mt-30 -123.76 147.85 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.31 127.22 13.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.95 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -79.87 102.28 9.04 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.389 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.5 mm -56.82 111.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.171 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.704 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.7 mt -79.52 -46.89 16.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.443 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.61 154.04 43.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.241 178.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.472 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.5 pt20 -139.44 37.33 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 0.0 111.819 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.3 131.2 34.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.9 166.6 17.63 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.041 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.7 tt0 -47.51 -20.91 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.608 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 77.7 m95 -110.42 120.27 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.764 0.316 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.472 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.5 m0 -102.72 142.34 34.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.151 0.501 . . . . 0.0 112.101 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.06 114.46 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.374 178.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.45 142.8 48.92 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.0 111.635 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.487 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.3 tt0 -107.57 110.97 23.0 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.622 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.82 166.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.048 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.9 -23.75 4.22 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.066 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.92 -40.56 19.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.891 0.853 . . . . 0.0 108.881 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.19 -35.61 6.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.445 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.64 -0.24 88.36 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.283 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.95 122.36 7.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.271 0.558 . . . . 0.0 110.971 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.75 145.41 25.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.541 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.37 177.4 42.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.15 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.0 m-85 -89.63 142.69 27.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.796 0.332 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.456 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 7.0 pt -135.99 145.05 50.9 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.38 0.609 . . . . 0.0 112.109 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.546 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.18 114.93 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.318 2.679 . . . . 0.0 111.125 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.94 -22.89 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 18.3 p-10 -102.56 34.92 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.339 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -122.45 -9.01 8.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.121 -179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 14.5 m -133.76 153.11 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.59 143.17 41.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.488 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -39.53 139.4 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.59 53.47 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.875 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 66' ' ' VAL . 23.3 tp -82.43 142.44 31.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.832 0.825 . . . . 0.0 111.412 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.536 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.8 m -125.91 -177.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.981 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 125.29 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.654 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.32 149.06 21.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.479 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.5 -25.41 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.737 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.427 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -144.3 -177.25 5.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.57 125.01 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 19.5 t80 -103.68 145.58 29.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.311 0.576 . . . . 0.0 112.496 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.35 94.58 15.44 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.76 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 2.6 Cg_exo -35.03 126.73 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.384 3.39 . . . . 0.0 113.359 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -121.9 -42.45 2.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.729 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.13 170.85 15.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.74 145.59 40.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.03 35.37 83.48 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.405 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.418 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.2 m-20 -97.99 156.73 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.414 . . . . 0.0 111.176 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.488 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 4.4 tp -115.63 127.53 55.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.889 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.84 142.6 16.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.118 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.2 p90 -142.04 177.52 8.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.014 0.435 . . . . 0.0 110.899 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -108.26 172.71 6.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.838 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -72.36 128.98 37.31 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.58 -10.23 59.96 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.4 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.29 165.38 2.04 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.427 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 1.9 mt-30 -123.52 147.88 46.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 111.215 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.61 127.84 13.84 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -79.81 103.63 9.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 30.4 mm -58.42 111.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.313 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.6 mt -79.55 -46.21 17.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.603 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.37 137.07 30.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.8 178.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.52 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.6 pt20 -125.73 36.15 4.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 0.0 111.34 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.29 122.81 38.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.6 161.26 37.28 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.7 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -48.47 -21.15 0.5 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.449 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.503 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.9 m95 -112.03 119.86 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.297 . . . . 0.0 110.529 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.52 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -101.8 138.21 39.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 112.223 -179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.728 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.91 114.4 22.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.954 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.88 143.12 49.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.995 0.426 . . . . 0.0 111.839 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.4 tt0 -106.61 111.16 23.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.634 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.38 165.38 0.1 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.787 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.26 -23.59 4.48 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.218 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.02 -40.41 19.98 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.881 0.848 . . . . 0.0 108.983 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -35.74 6.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.498 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.67 -1.37 88.15 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.134 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.31 122.64 7.21 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.173 0.511 . . . . 0.0 110.946 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.94 149.19 21.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.598 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.44 178.78 41.45 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.38 139.57 30.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.752 0.31 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.433 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 6.1 pt -133.46 145.68 57.48 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.421 0.629 . . . . 0.0 111.998 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.69 119.61 6.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.198 2.599 . . . . 0.0 111.398 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.4 -19.13 33.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -103.45 34.9 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.66 -30.25 3.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.661 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 31.5 m -111.43 147.73 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.48 141.01 46.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.365 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -39.47 138.24 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.8 54.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.949 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 66' ' ' VAL . 27.7 tp -80.03 142.21 35.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.03 0.919 . . . . 0.0 112.233 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.545 ' O ' HD13 ' A' ' 65' ' ' LEU . 2.7 m -124.11 -176.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.402 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.85 125.22 5.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.813 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.58 152.11 27.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.918 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.6 mt -119.63 8.46 11.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.864 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.88 142.52 5.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.63 124.46 18.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.421 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -104.14 146.6 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -137.28 94.25 12.42 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.924 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.1 Cg_exo -36.48 128.22 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 124.396 3.397 . . . . 0.0 113.346 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -126.35 -41.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.406 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.2 m-70 -79.85 156.11 27.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.66 130.49 43.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.832 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.71 33.41 42.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.457 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.32 154.6 19.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.15 0.5 . . . . 0.0 111.112 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.8 tp -110.08 131.8 54.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.71 143.91 16.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.358 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.63 176.62 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.66 171.58 7.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.879 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -70.39 126.84 30.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.42 -16.53 52.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.291 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.09 165.72 0.29 Allowed 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.8 mt-30 -123.92 145.96 48.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.629 0.728 . . . . 0.0 111.324 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.6 128.69 16.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.162 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -79.95 103.53 9.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 22.5 mm -58.98 111.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.184 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.4 mt -79.63 -47.12 15.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.685 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -141.23 137.08 32.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.798 178.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.535 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.84 36.1 4.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.09 122.37 38.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.896 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.3 159.4 35.53 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.707 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.6 tt0 -48.33 -21.22 0.49 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.498 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.0 m95 -112.51 112.4 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.741 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.535 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -94.32 139.66 30.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 112.166 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.07 114.96 23.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.03 178.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.51 142.76 49.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.991 0.424 . . . . 0.0 111.808 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.512 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.01 110.7 22.48 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.606 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.21 167.58 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.149 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.9 -23.58 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.577 -0.449 . . . . 0.0 112.013 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.88 -40.4 20.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.851 0.834 . . . . 0.0 108.9 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 -35.83 6.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.328 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.08 -0.5 88.57 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.268 -1.787 . . . . 0.0 113.297 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.91 123.23 8.74 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.22 0.533 . . . . 0.0 110.995 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.79 144.19 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.628 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.56 177.68 43.88 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.169 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.02 152.0 23.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 110.686 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.2 pt -148.02 142.96 17.05 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.264 0.554 . . . . 0.0 112.08 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.9 Cg_endo -52.67 112.32 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.171 2.58 . . . . 0.0 111.369 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.24 -23.52 9.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.819 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.1 p-10 -100.13 31.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.38 -22.78 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.957 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -115.6 151.24 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.2 140.17 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.388 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.48 140.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.31 51.4 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.993 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.956 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 CA--C 1.518 -0.256 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 66' ' ' VAL . 28.7 tp -86.37 141.84 28.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.98 0.895 . . . . 0.0 112.042 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.536 ' O ' HD13 ' A' ' 65' ' ' LEU . 2.7 m -125.94 -177.67 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.832 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.18 126.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.64 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.61 151.84 36.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -120.04 13.0 12.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.778 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.51 141.74 3.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.715 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.33 124.27 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.448 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.0 t80 -104.12 146.37 28.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.9 94.45 12.84 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.918 178.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.9 Cg_exo -37.12 125.86 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.299 3.332 . . . . 0.0 113.364 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -40.34 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -79.93 167.64 20.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.692 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.46 142.49 44.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.62 41.9 99.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.425 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.31 155.35 20.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.069 0.461 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -110.96 132.27 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.059 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.59 143.02 16.47 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.461 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.32 176.11 10.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.07 175.14 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.656 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -72.84 131.98 42.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.79 -11.23 48.14 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.488 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.18 165.79 1.28 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.432 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.2 mt-30 -123.04 146.54 47.58 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.436 0.636 . . . . 0.0 111.183 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.91 128.13 14.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.259 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -79.93 103.81 10.07 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 26.8 mm -59.81 111.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.215 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.697 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.56 -47.82 14.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.29 136.47 33.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.841 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.532 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.1 pt20 -123.95 36.03 4.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.06 0.457 . . . . 0.0 111.355 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.0 122.36 39.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.907 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.33 159.87 35.52 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.758 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 tt0 -49.77 -20.11 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.383 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.509 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.9 m95 -113.62 112.01 22.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.532 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -93.51 138.39 31.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 112.307 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.697 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.14 112.96 21.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.158 178.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.39 143.25 47.55 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 120.999 0.428 . . . . 0.0 111.692 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.505 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.52 110.81 22.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.54 167.96 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.089 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.76 -23.79 3.95 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.994 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.67 -40.98 19.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.974 0.892 . . . . 0.0 108.883 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.77 -35.66 6.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.947 -1.478 . . . . 0.0 109.407 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.01 -0.44 87.3 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.286 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -50.89 121.53 6.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.222 0.534 . . . . 0.0 111.061 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.09 143.75 26.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.556 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.16 177.52 43.39 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.79 149.72 24.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 111' ' ' ILE . 4.9 pt -144.87 143.46 20.96 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.371 0.605 . . . . 0.0 112.137 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.509 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.14 111.38 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.257 2.638 . . . . 0.0 111.315 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p30 -99.84 31.7 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.494 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.36 14.34 9.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -150.85 150.48 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.38 140.16 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -39.5 139.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.48 54.19 0.11 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.046 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.915 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 66' ' ' VAL . 25.3 tp -83.22 142.0 31.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.913 0.863 . . . . 0.0 111.794 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.8 m -125.31 -177.43 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.788 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -144.71 125.61 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.759 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.56 149.54 17.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 mt -100.37 -24.48 14.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -145.49 -176.87 5.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.899 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.72 125.39 29.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.452 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.3 t80 -104.87 147.0 28.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.249 0.547 . . . . 0.0 112.429 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -136.45 93.83 14.14 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.041 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 4.6 Cg_exo -39.41 112.93 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.169 3.246 . . . . 0.0 113.251 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -29.6 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -84.7 170.22 13.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.02 141.77 35.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 59.98 41.6 97.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.306 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -109.52 155.65 21.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.491 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.5 tp -110.17 129.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.981 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.23 147.79 18.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.941 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -148.25 177.91 9.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 110.896 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.1 174.71 5.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.848 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -73.37 129.1 37.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.51 -10.54 58.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.393 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.43 165.61 1.47 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.1 mt-30 -124.31 147.11 48.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.528 0.68 . . . . 0.0 111.295 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.91 128.02 14.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.065 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -79.91 104.03 10.21 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 22.6 mm -58.54 112.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.317 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.727 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 27.6 mt -79.68 -46.62 16.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.573 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.4 134.83 26.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.023 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.543 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.8 OUTLIER -120.56 36.65 4.5 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.222 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.36 122.52 39.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.993 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.15 159.92 36.03 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.851 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.01 -20.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.429 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.1 m95 -113.79 115.39 27.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.45 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -96.4 139.26 32.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.249 0.547 . . . . 0.0 112.358 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.727 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.39 113.6 21.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 177.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -120.09 143.27 48.23 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.893 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.519 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.0 tt0 -107.27 110.8 22.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.628 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 166.34 0.06 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.82 -23.24 4.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.123 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.03 -40.34 20.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.812 0.815 . . . . 0.0 108.915 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.73 -35.93 6.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.472 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.26 -0.32 88.99 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.262 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.02 122.52 7.67 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.282 0.563 . . . . 0.0 111.01 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.7 146.0 25.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.547 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.05 41.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.3 m-85 -89.85 142.39 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.699 0.285 . . . . 0.0 110.823 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 82' ' ' PHE . 7.4 pt -135.67 146.29 56.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 112.1 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.47 118.73 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.257 2.638 . . . . 0.0 111.335 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.24 -19.19 32.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -102.89 34.17 2.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.52 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.64 -30.14 3.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.635 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 29.0 m -108.09 149.47 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.24 139.09 39.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.29 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -39.33 139.17 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.93 54.54 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.92 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 66' ' ' VAL . 24.8 tp -81.61 142.36 32.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.834 0.826 . . . . 0.0 111.617 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.8 m -125.94 -176.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.991 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.87 126.87 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.576 179.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 152.16 41.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.111 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.87 13.73 11.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.865 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.53 141.67 3.0 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.735 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.61 124.48 19.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.297 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -103.94 146.78 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.2 mt-10 -137.06 94.15 12.8 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.852 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.0 Cg_exo -36.61 125.63 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.336 3.358 . . . . 0.0 113.364 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -123.32 -41.53 2.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.684 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.0 159.67 26.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.26 137.05 52.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.31 36.37 78.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -104.74 154.84 19.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.103 0.477 . . . . 0.0 111.124 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.2 tp -110.59 130.85 55.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.082 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.99 143.9 16.88 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.313 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -146.99 176.91 9.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -109.36 173.67 6.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -71.89 128.75 36.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.04 -12.92 56.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.42 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.508 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.46 165.42 0.8 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.7 mt-30 -123.04 147.38 46.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.532 0.682 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.39 128.02 14.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.147 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -79.87 103.23 9.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 28.6 mm -58.5 111.9 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.035 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 22.5 mt -79.37 -46.69 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.679 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 152.49 40.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.412 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.496 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -137.12 36.78 2.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.895 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.61 131.23 34.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.155 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.75 164.78 16.23 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -47.64 -21.0 0.31 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.681 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.3 m95 -110.6 116.95 32.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.496 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.9 m0 -99.26 144.81 27.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.102 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.687 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -90.01 115.36 27.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.43 143.18 49.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.119 0.485 . . . . 0.0 111.636 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.505 ' HB2' HD13 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.4 111.12 22.86 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.606 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 167.43 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.45 -23.67 4.06 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.08 -40.56 19.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.918 0.866 . . . . 0.0 108.91 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.24 -35.57 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.41 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.74 -1.6 85.68 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 113.221 -1.809 . . . . 0.0 113.252 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -49.7 122.49 6.48 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.256 0.551 . . . . 0.0 111.13 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.0 145.19 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.544 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.02 177.93 42.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.26 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -86.21 153.8 21.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.663 0.268 . . . . 0.0 110.459 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 111' ' ' ILE . 5.0 pt -149.12 143.78 17.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 112.1 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.9 Cg_endo -52.32 111.74 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.265 2.643 . . . . 0.0 111.286 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.5 -23.08 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -102.5 32.27 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.308 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.97 -15.14 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.124 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 19.8 m -124.86 151.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.47 142.9 41.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.572 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -39.6 138.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 54.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.087 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.871 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 66' ' ' VAL . 23.2 tp -81.27 141.54 34.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.854 0.835 . . . . 0.0 111.668 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.39 -177.4 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.841 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.19 123.55 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.86 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.9 153.3 17.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.804 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.02 8.59 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.47 143.02 5.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.702 -179.113 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.68 123.95 16.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.279 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.01 146.63 28.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -137.92 94.28 11.51 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.89 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 3.9 Cg_exo -35.91 128.72 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.357 3.371 . . . . 0.0 113.356 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -44.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.651 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.423 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.6 m-70 -80.01 149.1 30.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.17 130.74 48.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.58 29.3 53.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.855 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.437 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.9 m-20 -97.3 157.99 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.06 0.457 . . . . 0.0 111.023 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.5 OUTLIER -114.24 129.64 56.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.904 179.564 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.5 142.1 15.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.441 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -147.53 176.82 9.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.962 0.41 . . . . 0.0 110.511 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -107.34 172.51 6.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -72.53 129.57 38.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.69 -12.37 56.76 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.403 -177.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.82 165.77 0.85 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.9 mt-30 -122.38 146.24 47.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.556 0.693 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.61 128.2 15.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 ttt-85 -79.94 103.86 10.12 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 26.9 mm -58.23 112.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.116 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.7 mt -79.47 -46.84 16.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.777 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.82 136.29 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.634 178.331 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -123.23 35.89 4.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.44 122.44 39.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.869 179.165 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.07 160.3 35.94 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.757 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.5 tt0 -49.84 -19.99 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 66.8 m95 -114.1 109.68 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.295 . . . . 0.0 110.794 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.3 m0 -91.48 137.41 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.122 0.487 . . . . 0.0 112.059 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.28 115.98 22.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.159 178.122 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.08 144.12 48.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.887 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.532 ' HB2' HD13 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.32 110.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.583 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.91 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.162 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 mp -125.76 -23.89 3.92 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.999 -178.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.99 -40.71 19.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.952 0.882 . . . . 0.0 108.933 178.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -35.6 6.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.549 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.24 -2.03 85.64 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.199 -1.819 . . . . 0.0 113.173 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -49.44 123.45 7.62 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.167 0.508 . . . . 0.0 111.104 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.88 147.68 22.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.725 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.46 177.87 41.49 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -86.32 144.56 27.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.651 0.263 . . . . 0.0 110.56 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 111' ' ' ILE . 4.6 pt -139.12 142.72 34.0 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.335 0.588 . . . . 0.0 112.135 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.5 Cg_endo -52.42 113.98 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.212 2.608 . . . . 0.0 111.385 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -22.72 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.022 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' CD1' ' A' ' 113' ' ' PHE . 7.9 p-10 -101.95 32.88 3.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.705 0.288 . . . . 0.0 111.115 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -120.33 -23.91 6.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.004 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 28.4 m -114.9 147.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -177.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.15 139.7 46.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.57 140.72 0.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.944 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.06 50.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.104 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 66' ' ' VAL . 29.1 tp -84.19 142.27 30.44 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.025 0.917 . . . . 0.0 112.061 -178.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.7 m -125.17 -177.17 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.576 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.3 124.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.816 179.15 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.55 147.95 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.457 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 mt -100.26 -24.96 14.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -143.46 -177.15 5.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 179.47 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.67 124.92 29.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.2 t80 -103.94 146.94 27.95 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -137.63 94.23 11.94 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.6 Cg_exo -37.08 127.28 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.303 3.335 . . . . 0.0 113.354 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -41.54 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.607 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.403 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m170 -80.01 156.72 27.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.46 140.75 58.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 38.57 95.51 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.39 156.0 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 111.139 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -111.3 131.41 55.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.23 147.79 18.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.179 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -150.69 179.05 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.009 0.433 . . . . 0.0 110.786 -179.745 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.76 177.92 4.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.762 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -75.38 134.79 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.68 -7.31 41.8 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.473 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -60.2 165.77 3.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' C ' ' HG ' ' A' ' 88' ' ' LEU . 2.1 mt-30 -123.71 146.29 48.38 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.511 0.672 . . . . 0.0 111.157 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.5 128.22 15.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.143 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -79.83 104.28 10.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 29.6 mm -60.38 112.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.294 -178.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.59 -47.76 14.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.751 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.15 136.27 33.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.793 178.305 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.542 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -124.19 36.49 4.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.352 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.79 40.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.996 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.64 159.88 35.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.726 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.1 tt0 -49.19 -20.57 0.62 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.35 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.509 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.3 m95 -113.2 114.6 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.9 m0 -96.42 139.44 32.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.695 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.58 113.19 21.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.987 177.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.76 144.04 47.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.092 0.472 . . . . 0.0 111.697 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.516 ' HB2' HD13 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.03 110.65 21.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.613 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.52 167.72 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.067 -179.475 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.64 -23.32 4.07 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.003 -178.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.82 -40.89 19.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.968 0.89 . . . . 0.0 108.932 178.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.97 -36.04 6.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.342 179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.45 0.68 89.47 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.348 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.68 122.45 8.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.236 0.541 . . . . 0.0 110.978 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.85 143.77 26.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.493 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.59 177.02 43.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.272 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.98 143.34 27.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.666 0.269 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.428 HG23 ' CE1' ' A' ' 82' ' ' PHE . 7.5 pt -137.53 145.14 47.9 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.387 0.613 . . . . 0.0 112.125 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.02 116.46 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.21 2.606 . . . . 0.0 111.189 178.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.39 -20.01 10.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -101.98 33.94 2.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 111.154 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.35 -30.43 4.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.618 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 29.8 m -109.44 147.32 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.37 139.87 44.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.143 178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.39 140.15 0.48 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.92 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.41 51.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.553 0.216 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.583 HD11 ' O ' ' A' ' 66' ' ' VAL . 19.0 tp -81.95 141.38 33.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.784 0.802 . . . . 0.0 111.249 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.583 ' O ' HD11 ' A' ' 65' ' ' LEU . 3.0 m -126.57 -178.41 2.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.229 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -142.36 124.55 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.616 179.434 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.66 151.07 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.039 -179.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.88 13.19 12.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 141.81 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.629 -179.185 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.21 124.48 19.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.452 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.2 t80 -104.1 146.64 28.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -136.77 94.38 13.11 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.963 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.1 Cg_exo -36.4 132.93 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 124.332 3.355 . . . . 0.0 113.41 -179.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -42.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.91 157.55 26.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.43 133.66 49.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 35.32 55.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.373 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.422 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -103.96 155.56 18.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -112.21 132.26 55.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.924 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.14 143.2 16.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' HB3' HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.17 176.41 9.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.987 0.422 . . . . 0.0 110.782 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -109.27 173.47 6.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.957 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -72.22 127.71 33.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 -13.58 58.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.309 -177.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.495 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.32 165.64 0.72 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.442 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.1 mt-30 -123.05 147.63 46.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.405 0.621 . . . . 0.0 111.057 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -147.97 127.52 13.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.176 -179.88 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -79.86 103.66 9.91 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 mm -59.13 111.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.223 -178.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.723 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 19.9 mt -79.5 -47.15 16.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.544 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 155.1 45.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.431 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.464 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -140.63 37.51 1.83 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.811 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 131.48 34.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.216 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.86 167.08 10.47 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.046 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -47.14 -20.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.071 -0.564 . . . . 0.0 111.685 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m95 -108.86 118.45 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 110.911 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.4 m0 -101.82 139.87 36.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.157 0.504 . . . . 0.0 111.944 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -85.51 114.73 22.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.358 178.303 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.29 143.52 49.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.49 ' HB2' HD11 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.11 111.12 22.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.609 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.01 167.17 0.06 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.99 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.15 -23.55 4.18 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.032 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.21 -41.4 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.883 0.849 . . . . 0.0 108.894 178.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.91 -35.51 6.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.456 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.15 -0.76 86.99 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.221 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -50.6 121.91 6.46 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.32 0.581 . . . . 0.0 111.053 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -88.7 145.75 25.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.549 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.15 177.89 41.99 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.309 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.47 151.9 23.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.647 0.26 . . . . 0.0 110.449 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 111' ' ' ILE . 7.6 pt -147.88 143.01 17.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 112.191 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.521 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.3 Cg_endo -52.01 110.16 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.098 2.532 . . . . 0.0 111.161 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.08 -25.77 2.28 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 7.2 p30 -96.99 29.16 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.722 0.296 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.489 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.12 18.96 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.984 -179.289 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.3 m -154.1 150.65 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.4 139.03 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.615 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -39.49 138.84 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 112.008 -178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.47 54.31 0.11 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.027 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.924 179.984 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 CA--C 1.518 -0.281 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 66' ' ' VAL . 24.7 tp -80.51 141.68 34.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.936 0.874 . . . . 0.0 111.958 -178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.83 -177.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.657 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.95 125.76 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.78 179.157 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.47 151.78 40.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.001 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.03 14.78 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.712 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -169.32 142.28 2.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 -179.227 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.02 124.73 20.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.6 t80 -104.75 146.47 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.98 94.6 12.58 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.054 178.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -37.09 128.71 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.43 3.42 . . . . 0.0 113.379 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -126.75 -42.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.97 158.42 26.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.707 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.38 142.32 57.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.33 42.22 99.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -110.57 155.38 22.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.127 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.4 tp -111.0 133.0 53.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.054 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -98.54 143.94 16.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.453 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.93 175.97 10.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.407 . . . . 0.0 110.822 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -109.02 175.93 5.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.699 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -72.86 132.22 43.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.76 -10.06 48.25 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.67 -177.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.8 165.83 1.61 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.438 ' HG2' HG13 ' A' ' 67' ' ' ILE . 2.1 mt-30 -123.24 146.0 48.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.545 0.688 . . . . 0.0 111.148 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.24 128.3 15.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -79.93 103.51 9.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 23.2 mm -59.81 111.31 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.061 -178.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.692 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 22.8 mt -79.62 -48.16 14.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.722 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 136.85 35.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.803 178.276 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.54 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.4 35.89 4.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 111.334 -178.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.62 122.53 39.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.823 179.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.02 159.25 35.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.671 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.3 -20.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.442 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.7 m95 -113.19 110.63 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.8 m0 -92.48 138.36 31.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.235 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.692 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -84.73 113.37 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.138 178.147 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.62 143.05 47.89 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.054 0.454 . . . . 0.0 111.659 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.497 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.48 110.52 22.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.605 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 168.0 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.185 -179.54 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.89 -23.62 3.93 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.055 -179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.71 -41.01 19.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.968 0.89 . . . . 0.0 108.876 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.67 -35.97 6.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.314 179.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.26 0.62 89.25 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.362 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.56 121.98 7.29 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.991 179.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.36 143.4 27.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.561 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 177.16 43.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.239 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -85.2 153.93 22.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.604 0.24 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 111' ' ' ILE . 6.6 pt -149.62 143.29 16.64 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.372 0.606 . . . . 0.0 112.125 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.7 Cg_endo -51.08 110.16 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 111.191 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.28 -26.29 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -99.08 30.81 3.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 111.232 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.486 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -122.58 17.67 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.953 -179.581 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -154.16 150.67 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.48 139.56 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.51 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -39.56 139.33 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.42 54.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 66' ' ' VAL . 27.5 tp -81.82 142.03 32.93 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.901 0.857 . . . . 0.0 111.766 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 2.6 m -124.61 -177.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.033 -1.439 . . . . 0.0 111.949 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.83 123.98 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.748 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.92 153.74 16.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.914 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.91 6.92 10.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.885 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.16 143.29 6.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 -179.163 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.22 124.27 17.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.9 t80 -104.96 146.39 29.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.5 mt-10 -138.05 94.69 11.08 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.811 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 73' ' ' GLU . 5.0 Cg_exo -36.66 129.87 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.316 3.344 . . . . 0.0 113.365 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.9 t -128.3 -42.02 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.99 158.67 26.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.8 139.2 57.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.37 40.6 96.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.67 155.43 20.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.027 0.442 . . . . 0.0 111.11 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.45 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.2 tp -111.29 133.29 53.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.042 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.6 145.79 17.97 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.441 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -150.55 177.71 9.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.47 175.58 5.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.708 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -73.89 131.68 41.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.09 -10.8 51.88 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.355 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.5 165.59 1.52 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.433 ' HG2' HG13 ' A' ' 67' ' ' ILE . 1.8 mt-30 -122.55 146.55 47.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.6 0.714 . . . . 0.0 111.197 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -146.55 127.81 14.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -79.95 103.2 9.68 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 28.5 mm -59.69 111.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.264 -178.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.725 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.3 mt -79.63 -47.04 16.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.47 178.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.46 155.63 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.309 178.127 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -141.47 37.39 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.09 131.96 34.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.301 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.44 166.5 15.57 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.992 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.4 tt0 -47.76 -20.75 0.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.7 m95 -110.22 118.21 35.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.462 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.3 m0 -100.63 143.63 30.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.121 0.486 . . . . 0.0 112.033 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.725 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.26 114.85 25.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.482 178.464 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . . . -121.61 143.8 49.11 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.962 0.41 . . . . 0.0 111.697 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.492 ' HB2' HD12 ' A' ' 91' ' ' LEU . 13.5 tt0 -109.09 110.99 22.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.598 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.19 -179.453 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mp -125.27 -23.25 4.2 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.663 -0.415 . . . . 0.0 112.025 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.18 -41.7 18.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.976 0.893 . . . . 0.0 108.943 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.13 -36.04 6.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.334 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 0.06 88.72 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 113.176 -1.829 . . . . 0.0 113.423 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.16 122.57 7.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.276 0.56 . . . . 0.0 111.08 179.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.78 146.01 25.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.616 -178.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.99 177.77 41.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.54 155.53 21.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 82' ' ' PHE . 5.5 pt -150.03 144.36 17.54 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.344 0.592 . . . . 0.0 112.205 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 8.9 Cg_endo -53.45 112.17 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.209 2.606 . . . . 0.0 111.251 178.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -54.74 -21.11 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 6.2 p-10 -101.6 30.72 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.25 -26.33 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -113.22 149.6 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.55 140.67 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.23 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 140.47 0.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.908 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.26 50.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.754 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.6 tp . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.937 0.875 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.86 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.78 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.24 126.7 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.668 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.99 151.73 42.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.992 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.9 13.33 12.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.862 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.585 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.93 141.1 2.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.661 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.65 124.08 17.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.308 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.0 t80 -103.27 145.46 29.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -135.73 94.3 15.03 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.91 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.21 126.22 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.327 3.351 . . . . 0.0 113.327 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -124.01 -41.83 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.631 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -79.98 159.09 26.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.704 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 141.67 56.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.923 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 39.11 97.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.613 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.12 155.49 19.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.059 0.456 . . . . 0.0 111.141 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD21 HD22 ' A' ' 88' ' ' LEU . 3.5 tp -111.15 129.91 55.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.53 142.19 15.92 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.57 176.2 9.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.993 0.425 . . . . 0.0 110.711 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.73 171.59 7.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -70.98 128.58 36.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.29 -13.4 55.2 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.427 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.87 165.61 0.61 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.5 mt-30 -123.21 146.48 47.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.67 0.748 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.711 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.44 128.55 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.177 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.533 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -79.89 103.59 9.88 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 66' ' ' VAL . 26.2 mm -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.17 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.733 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.2 mt -79.53 -47.76 15.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.722 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.5 135.48 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.807 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.562 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.8 pt20 -121.94 35.92 4.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.369 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.65 122.23 38.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.92 158.54 34.61 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.691 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.3 tt0 -48.55 -21.51 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.457 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.488 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.1 m95 -112.46 109.69 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.717 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.562 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -91.38 139.34 30.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.199 0.524 . . . . 0.0 112.184 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.72 114.35 22.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.239 177.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.85 144.68 47.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 0.0 111.785 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.733 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.87 110.7 21.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.35 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.186 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.88 -23.66 3.93 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.007 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -40.21 20.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.959 0.885 . . . . 0.0 108.914 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -35.78 6.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.411 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.83 -0.18 88.65 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 113.285 -1.78 . . . . 0.0 113.384 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.49 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.12 122.8 8.17 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.236 0.541 . . . . 0.0 111.003 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.95 144.2 26.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.47 177.59 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.199 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.18 152.38 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.661 0.267 . . . . 0.0 110.55 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.711 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.14 143.49 17.65 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 112.086 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.4 Cg_endo -52.64 108.34 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.152 2.568 . . . . 0.0 111.281 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -50.64 -24.9 3.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.4 p30 -98.97 30.36 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -118.0 -24.41 7.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.01 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.683 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -115.46 150.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 142.58 44.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.487 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.6 mmtt -39.67 139.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.35 54.44 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.003 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.6 tp . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.86 0.838 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.28 -176.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.856 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.97 126.66 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.62 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.67 152.23 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.01 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.48 14.2 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.884 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.578 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 140.76 2.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.672 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.87 124.13 17.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.244 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.551 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 13.1 t80 -103.78 146.19 28.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -137.15 94.31 12.55 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.914 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.65 120.45 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.259 3.306 . . . . 0.0 113.426 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -118.79 -36.79 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.7 m80 -81.35 172.68 13.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.624 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -80.07 142.82 34.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.28 38.08 94.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.438 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.73 155.55 18.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 111.211 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.829 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -111.42 128.58 56.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.082 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.08 144.71 17.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.354 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.82 176.22 10.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.989 0.423 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -107.15 173.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.729 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -72.58 129.08 37.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.86 -11.0 58.59 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.512 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.47 165.56 1.08 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.557 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -122.77 146.6 47.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.552 0.691 . . . . 0.0 111.212 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.829 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.99 128.07 14.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.204 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.0 ttt180 -79.85 103.52 9.8 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 66' ' ' VAL . 29.1 mm -57.77 112.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.223 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.1 mt -79.41 -46.87 16.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.704 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.32 135.69 27.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.626 178.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.3 pt20 -122.26 35.69 4.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.076 0.465 . . . . 0.0 111.239 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 122.66 38.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.876 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.19 158.65 34.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.613 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.8 tt0 -49.38 -20.84 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.435 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.17 107.78 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.9 m0 -89.34 140.41 29.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 112.201 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.82 115.73 24.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.191 178.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 144.14 48.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.937 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.793 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.6 110.93 22.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.592 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.98 167.81 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.123 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.54 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.79 -24.04 3.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.914 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -83.15 -40.47 19.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.913 0.863 . . . . 0.0 108.942 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.84 -35.47 6.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.502 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.77 -2.89 85.29 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.035 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.9 mp0 -48.8 124.75 8.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.98 151.05 20.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.716 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 167.61 176.91 38.68 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.61 142.69 28.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.69 0.281 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -136.76 144.57 47.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.62 . . . . 0.0 112.176 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 9.0 Cg_endo -53.62 109.77 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.195 2.597 . . . . 0.0 111.29 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.54 -23.85 7.09 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.814 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.1 p-10 -99.12 30.87 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.99 -22.73 6.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.043 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 88' ' ' LEU . 16.5 m -117.23 150.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.43 142.36 43.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.39 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 66' ' ' VAL . 7.2 mmtp -39.59 139.09 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.01 53.98 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.075 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.8 tp . . . . . 0 N--CA 1.445 -0.697 0 CA-C-O 121.982 0.896 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -125.48 -177.28 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 113.826 -1.533 . . . . 0.0 111.779 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.28 126.1 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.636 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.84 151.93 41.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.091 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.17 14.38 12.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.94 141.12 2.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.14 124.6 19.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.325 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.6 t80 -103.92 146.09 29.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.89 94.44 12.86 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.963 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -36.34 132.43 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.336 3.358 . . . . 0.0 113.381 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 t -130.53 -43.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.741 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.438 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.8 m80 -79.96 149.09 30.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 129.76 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.044 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.82 28.78 49.75 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.624 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 3.2 m-20 -96.98 158.47 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.2 132.73 56.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.831 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.33 141.87 15.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.626 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -144.8 176.8 9.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.471 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.09 170.5 8.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.055 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -69.71 126.63 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.72 -15.65 50.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.323 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.17 166.21 0.26 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -123.34 145.81 48.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.5 0.667 . . . . 0.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.26 127.69 15.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.258 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.6 ttt180 -79.74 103.41 9.62 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.779 HD11 HG21 ' A' ' 66' ' ' VAL . 23.0 mm -58.25 111.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.119 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.837 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.34 -46.68 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.554 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.24 154.89 44.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -140.25 36.7 1.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 0.0 111.863 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.33 131.28 34.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.93 166.81 18.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.027 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.04 -20.36 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.662 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 71.2 m95 -110.18 116.85 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.0 m0 -99.74 140.5 33.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.084 0.469 . . . . 0.0 111.994 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.81 116.76 25.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.54 178.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -123.2 144.6 49.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.031 0.443 . . . . 0.0 111.722 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.837 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.65 111.24 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.615 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.52 167.09 0.07 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.871 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -124.62 -23.41 4.39 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.426 -0.51 . . . . 0.0 112.105 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.84 -41.15 17.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 0.0 108.989 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.12 -35.57 6.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.427 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.63 -1.74 84.98 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.239 -1.801 . . . . 0.0 113.218 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.37 123.37 7.41 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.177 0.513 . . . . 0.0 111.15 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.79 149.5 21.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.607 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 168.46 177.02 39.22 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.313 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.35 143.42 28.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.658 0.266 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -137.84 142.14 35.25 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 0.0 112.126 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.512 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.9 Cg_endo -51.26 112.06 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.264 2.643 . . . . 0.0 111.242 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -49.84 -24.87 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.3 p-10 -100.52 31.42 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.39 17.07 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.946 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.8 m -154.23 150.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.23 140.75 37.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.548 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.53 138.91 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.25 54.38 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.89 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.2 tp . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.951 0.881 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.838 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -124.04 -176.64 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.894 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.48 128.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.749 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -65.62 150.55 48.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.641 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.98 -6.22 15.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 p-80 -153.52 172.89 16.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.676 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.05 123.99 27.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.513 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.58 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 20.4 t80 -101.51 145.96 28.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.289 0.566 . . . . 0.0 112.331 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.24 15.15 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.038 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.22 129.36 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.368 3.379 . . . . 0.0 113.293 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -125.76 -40.7 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.791 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.3 m-70 -79.94 174.99 11.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.695 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.21 144.9 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.97 37.29 84.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.634 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -98.47 156.2 16.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.168 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.3 tp -115.2 125.23 53.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.54 141.35 15.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.108 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.62 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -141.19 175.62 9.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -107.05 172.7 6.68 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.813 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.18 127.92 34.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.63 59.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.355 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.74 165.59 1.15 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.0 mt-30 -123.9 146.71 48.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.521 0.677 . . . . 0.0 111.202 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.73 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.12 128.47 15.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -80.03 103.31 9.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 66' ' ' VAL . 27.5 mm -59.36 111.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.216 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.741 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.5 mt -79.55 -47.25 15.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.813 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.43 136.37 29.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.739 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.563 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -124.19 35.92 4.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.473 . . . . 0.0 111.32 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 122.41 38.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.959 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.58 160.91 36.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.798 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.0 tt0 -48.79 -20.96 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.501 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.25 117.19 31.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.563 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.7 m0 -98.82 137.57 37.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.13 0.49 . . . . 0.0 112.169 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.92 112.68 20.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.061 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -118.96 143.28 47.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.93 110.53 21.87 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.08 167.17 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.104 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.45 -23.7 4.06 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.099 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.73 -40.49 20.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.909 0.861 . . . . 0.0 108.936 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.505 ' HB ' HE22 ' A' ' 107' ' ' GLN . 0.9 OUTLIER -109.37 -35.57 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.408 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.46 -0.0 88.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.299 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.548 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.5 mp0 -51.24 121.63 6.51 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.261 0.553 . . . . 0.0 111.058 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.93 142.55 27.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.601 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 177.09 -179.94 47.75 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.249 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.34 139.8 30.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.695 0.284 . . . . 0.0 110.97 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.722 HD13 HD13 ' A' ' 88' ' ' LEU . 6.0 pt -134.26 144.18 50.16 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.421 0.629 . . . . 0.0 111.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.4 Cg_endo -53.11 119.18 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.218 2.612 . . . . 0.0 111.265 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.69 -20.97 16.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -105.18 35.4 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.244 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -120.96 -17.49 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 88' ' ' LEU . 14.8 m -126.88 152.33 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.62 143.27 43.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.388 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.59 139.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.19 54.51 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.046 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.864 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.4 tp . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 121.877 0.846 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -126.72 -176.89 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.894 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.63 125.94 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.629 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.67 146.85 29.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.466 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 mt -97.98 -24.54 15.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.418 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -145.87 -177.37 5.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.965 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.31 125.22 29.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.214 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -103.64 145.39 30.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.34 94.13 15.9 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.046 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.14 133.58 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.304 3.336 . . . . 0.0 113.432 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.46 -43.57 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.41 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 8.3 m80 -80.0 150.57 30.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.722 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -62.31 136.16 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.96 61.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.6 m-20 -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 0.0 111.024 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.761 HD21 HD22 ' A' ' 88' ' ' LEU . 1.1 tp -116.34 123.99 48.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.899 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -90.3 143.12 16.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.137 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p90 -143.93 178.19 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -108.3 172.98 6.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.89 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -72.71 128.77 36.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 -10.73 59.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.286 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.33 165.5 1.44 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.545 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.69 147.33 47.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.465 0.65 . . . . 0.0 111.111 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.772 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.48 127.67 14.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.951 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.542 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.7 ttt180 -79.84 101.37 8.48 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.418 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 66' ' ' VAL . 37.0 mm -55.4 112.11 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.079 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.838 HD21 ' CB ' ' A' ' 101' ' ' GLN . 25.2 mt -79.4 -46.5 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.578 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -145.71 148.36 32.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.344 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -132.1 37.14 3.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.23 131.78 34.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.91 164.57 20.75 Favored Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.979 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -48.43 -20.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.59 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.0 m95 -111.1 119.47 39.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.523 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.0 m0 -101.53 142.26 33.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.109 0.481 . . . . 0.0 112.21 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.99 114.74 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.2 178.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.62 143.31 48.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 111.814 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.838 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.37 110.83 22.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.621 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.51 166.66 0.05 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.101 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.04 -23.95 4.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.055 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.95 -39.98 20.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.841 . . . . 0.0 109.046 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.4 -35.47 6.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.554 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.56 -1.23 88.27 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.154 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.682 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.28 123.16 7.96 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 146.65 23.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.734 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.09 179.44 43.77 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.111 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -90.39 139.83 30.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.789 0.328 . . . . 0.0 110.737 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.737 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -133.69 144.48 52.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.517 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.5 116.77 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.263 2.642 . . . . 0.0 111.182 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.488 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.31 -19.9 16.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 5.9 p-10 -101.99 33.75 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.069 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.82 -30.33 4.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.651 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 88' ' ' LEU . 27.4 m -111.13 148.61 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.69 142.21 45.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.408 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.9 mmtp -39.36 137.98 0.71 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.08 54.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.061 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.768 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.2 tp . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.988 0.899 . . . . 0.0 112.109 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.82 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.08 -176.64 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.594 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.69 125.13 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.733 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.51 150.94 29.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.928 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.81 10.68 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -167.43 142.85 4.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.653 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.5 124.82 20.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.384 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -104.62 146.8 28.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.419 0.628 . . . . 0.0 112.658 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -138.11 94.53 11.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.954 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.83 127.56 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.304 3.336 . . . . 0.0 113.33 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.37 -40.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m80 -79.85 170.83 15.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.768 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.99 137.2 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.76 38.57 94.57 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.607 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -104.17 154.45 19.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 88' ' ' LEU . 4.9 tp -110.48 133.01 53.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.089 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.1 143.74 16.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.402 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.606 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.78 176.7 9.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.79 172.96 6.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.863 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.93 128.84 37.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.85 -15.02 50.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.327 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.16 165.75 0.47 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -123.58 145.98 48.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.58 0.705 . . . . 0.0 111.29 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.31 128.36 15.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.149 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.0 ttt180 -79.84 103.77 9.97 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.82 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -58.92 111.47 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.148 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 101' ' ' GLN . 24.5 mt -79.56 -47.4 15.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.821 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.73 137.79 33.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.861 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -125.29 35.71 4.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.61 122.55 38.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.936 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.84 159.09 35.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.724 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.483 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.4 tt0 -48.49 -20.92 0.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.42 -0.39 . . . . 0.0 111.476 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.6 m95 -112.59 111.98 23.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.679 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -93.97 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.75 114.85 24.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.194 178.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.43 143.04 48.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.048 0.451 . . . . 0.0 111.774 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -107.93 110.88 22.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.42 167.64 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.95 -24.06 3.84 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.968 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.44 -40.64 20.9 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.906 0.86 . . . . 0.0 108.919 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.22 -35.3 6.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.29 -1.23 86.0 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.53 121.86 6.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 0.0 111.082 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.47 145.13 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.619 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.66 176.63 42.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.402 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -84.78 151.78 24.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.609 0.242 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.684 HD13 HD13 ' A' ' 88' ' ' LEU . 5.7 pt -148.08 143.11 17.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.292 0.568 . . . . 0.0 112.148 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.7 Cg_endo -51.8 112.59 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.235 2.623 . . . . 0.0 111.339 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.47 -23.7 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 14.1 p30 -101.83 32.45 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.74 -17.06 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -121.61 150.42 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.24 140.77 41.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.477 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.5 mmtp -39.46 139.48 0.56 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.84 53.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.966 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.5 tp . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.904 0.859 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.23 -176.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.884 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.7 124.92 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.61 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -59.84 152.96 21.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.03 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -121.4 8.9 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.916 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.596 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -166.32 143.36 5.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.24 123.74 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.332 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.575 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -103.03 146.94 27.59 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -138.2 94.53 10.99 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.847 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.4 Cg_exo -36.27 131.69 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.45 3.434 . . . . 0.0 113.299 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -130.1 -43.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.439 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 13.1 m-70 -79.96 157.31 26.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.33 128.45 36.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.64 47.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.657 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.3 m-20 -96.27 156.9 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.109 0.48 . . . . 0.0 110.991 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.735 HD21 HD22 ' A' ' 88' ' ' LEU . 1.4 tp -114.69 130.13 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.38 141.67 15.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.391 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -146.57 176.89 9.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -108.83 172.03 7.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.003 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -71.56 127.23 31.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.5 -15.32 55.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.286 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.41 165.53 0.36 Allowed 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.556 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.7 mt-30 -122.68 146.7 47.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.567 0.699 . . . . 0.0 111.216 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.746 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.77 127.97 14.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.8 ttt180 -79.93 103.07 9.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 66' ' ' VAL . 25.0 mm -58.67 113.48 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.141 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.736 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 39.2 mt -79.51 -46.37 17.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.748 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -145.2 134.56 23.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.911 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.9 pt20 -119.77 36.05 4.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.77 122.24 37.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.925 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.39 159.53 35.61 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.696 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.85 -20.81 0.54 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 68.4 m95 -113.03 110.95 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.561 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -92.66 136.86 32.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.736 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 114.84 21.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.239 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.87 143.74 47.76 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.073 0.463 . . . . 0.0 111.745 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.658 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.96 110.58 21.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.41 168.4 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.223 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -126.12 -23.55 3.88 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.015 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.86 -40.4 20.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.868 0.842 . . . . 0.0 108.923 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -35.8 6.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.471 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.1 -0.62 88.48 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.271 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.45 123.17 8.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.231 0.539 . . . . 0.0 111.097 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -90.01 144.54 25.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.562 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.52 178.64 44.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.372 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -87.52 146.53 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.618 0.247 . . . . 0.0 110.643 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -142.25 142.07 23.05 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.0 112.125 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.548 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.1 Cg_endo -51.94 112.24 0.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.193 2.595 . . . . 0.0 111.385 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.64 -23.76 7.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p-10 -100.57 31.6 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.09 -25.63 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 88' ' ' LEU . 17.1 m -114.32 149.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 141.81 44.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.478 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.495 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.4 mmtt -39.58 138.94 0.64 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.61 54.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.083 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.975 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 22.9 tp . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.745 0.783 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.24 -177.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.105 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.51 126.03 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.608 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.82 152.03 37.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.132 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.05 12.69 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.26 142.73 3.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.585 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 124.19 18.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.389 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.4 t80 -104.07 146.18 29.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.69 94.38 13.26 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.927 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.5 Cg_exo -37.04 122.14 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.313 3.342 . . . . 0.0 113.336 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -41.16 2.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.508 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m-70 -80.51 159.05 25.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.21 143.48 56.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.17 41.65 99.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.593 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.59 155.61 21.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.162 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.506 HD21 HD22 ' A' ' 88' ' ' LEU . 6.6 tp -111.41 131.56 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.75 144.59 17.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.401 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.75 176.66 9.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -109.42 172.35 6.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.802 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -71.31 127.33 32.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.3 -14.34 57.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.347 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.9 165.61 0.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -123.2 147.49 46.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.668 . . . . 0.0 111.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -147.31 127.96 14.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.102 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.522 ' N ' HD11 ' A' ' 103' ' ' LEU . 33.1 ttt180 -79.82 103.46 9.74 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 66' ' ' VAL . 28.1 mm -59.07 111.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.202 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.6 mt -79.34 -47.02 16.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.505 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.97 154.24 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.336 178.137 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -139.47 36.71 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.842 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.56 131.26 34.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.235 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.75 15.93 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.108 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -47.46 -21.19 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.084 -0.558 . . . . 0.0 111.625 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m95 -109.99 118.1 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.7 m0 -100.4 143.18 30.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 112.021 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.725 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.22 114.71 25.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.468 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.9 142.98 49.18 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.051 0.453 . . . . 0.0 111.77 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.779 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.23 111.08 22.87 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.624 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.57 167.43 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.114 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.43 -23.52 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.056 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -41.06 19.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.919 0.866 . . . . 0.0 108.881 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.13 -35.66 6.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.419 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.98 -1.45 86.62 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.329 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.459 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.2 mp0 -49.77 122.06 6.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.289 0.566 . . . . 0.0 111.07 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.44 145.03 26.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.665 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.62 42.24 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.36 155.39 20.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.614 0.245 . . . . 0.0 110.442 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 4.5 pt -150.11 144.25 17.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.609 . . . . 0.0 112.157 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.493 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.5 Cg_endo -52.88 111.15 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.226 2.617 . . . . 0.0 111.25 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.03 -22.97 6.55 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.6 p-10 -101.04 30.97 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.454 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.37 -19.75 8.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.985 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.641 HG11 HD12 ' A' ' 88' ' ' LEU . 16.2 m -119.7 150.63 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.81 141.34 42.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.325 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.65 140.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.8 50.89 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.897 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.063 0.935 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.7 -176.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.546 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 126.46 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.687 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.66 147.97 25.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.401 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 mt -100.43 -23.07 14.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -145.54 -176.72 5.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.888 0.375 . . . . 0.0 110.776 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.25 125.26 30.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.9 t80 -104.66 146.57 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 mt-10 -136.41 94.13 13.97 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.024 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.72 120.02 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.327 3.352 . . . . 0.0 113.366 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -117.07 -34.75 4.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.539 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 5.6 m80 -84.12 169.72 14.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.798 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -79.0 143.43 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.91 35.95 92.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.354 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -104.29 155.75 18.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 111.202 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 88' ' ' LEU . 1.9 tp -111.85 127.45 55.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.136 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.77 144.2 16.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.03 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.543 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.9 OUTLIER -145.21 179.21 7.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.924 0.392 . . . . 0.0 110.949 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.89 175.41 5.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.956 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 131.22 41.28 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.34 -9.1 56.39 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.331 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.63 165.6 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.6 mt-30 -124.58 146.07 49.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 111.258 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.804 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.15 128.04 15.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.272 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.1 ttt180 -79.67 104.27 10.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.827 HD11 HG21 ' A' ' 66' ' ' VAL . 25.3 mm -59.57 112.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.388 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.808 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.8 mt -79.44 -47.43 15.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.475 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 154.27 43.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.413 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -138.61 38.02 2.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 111.888 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 131.27 34.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.283 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.8 166.42 9.7 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.12 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -46.77 -21.55 0.21 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.52 . . . . 0.0 111.655 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 80.3 m95 -108.52 121.01 44.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.506 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.97 143.14 33.27 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.39 113.94 24.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.228 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.64 47.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.136 0.493 . . . . 0.0 111.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.808 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.84 110.88 22.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.618 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.86 167.75 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.043 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.63 -23.49 4.04 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.073 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -83.12 -39.91 20.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.863 0.84 . . . . 0.0 109.015 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.21 -35.8 5.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.428 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.76 -0.34 88.37 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.286 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.595 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.03 122.62 7.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.225 0.536 . . . . 0.0 111.098 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.81 146.03 25.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.51 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.0 177.33 42.2 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.69 140.38 29.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.659 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 88' ' ' LEU . 8.6 pt -134.78 145.34 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 112.161 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.9 Cg_endo -56.06 114.04 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.164 2.576 . . . . 0.0 111.156 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -21.64 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.426 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.5 p30 -98.81 31.63 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.851 0.357 . . . . 0.0 111.041 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -120.99 -27.13 5.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.632 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 88' ' ' LEU . 23.0 m -112.9 148.74 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.3 141.35 41.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.374 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' HG12 ' A' ' 66' ' ' VAL . 13.7 mmtp -39.4 138.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.56 54.41 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.029 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.923 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.9 tp . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 121.985 0.898 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.858 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.19 -177.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.672 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.09 125.33 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.753 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.12 147.24 25.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.508 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.14 -24.4 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.419 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -146.39 -177.17 5.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.991 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 125.47 29.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.305 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -104.05 145.72 29.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.43 94.1 15.78 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.996 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.92 124.46 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.387 3.392 . . . . 0.0 113.365 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -40.44 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -83.74 157.19 22.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.87 147.3 53.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.09 33.87 85.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.599 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -101.55 156.86 17.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.178 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.703 HD21 HD22 ' A' ' 88' ' ' LEU . 1.3 tp -114.36 125.04 53.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.095 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.92 142.64 16.14 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.176 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.1 p90 -143.06 178.35 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.922 0.391 . . . . 0.0 110.939 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -108.32 174.89 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.838 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.27 130.04 38.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.25 -8.76 60.06 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.382 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.75 165.4 2.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.612 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -124.31 146.12 49.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.651 0.738 . . . . 0.0 111.142 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.78 128.23 15.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 103' ' ' LEU . 29.7 ttt180 -79.99 104.21 10.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.858 HD11 HG21 ' A' ' 66' ' ' VAL . 24.9 mm -59.5 112.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.34 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 101' ' ' GLN . 21.9 mt -79.54 -46.94 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.388 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.85 155.02 43.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.347 178.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.3 pt20 -139.74 37.56 2.0 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.836 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.08 131.01 34.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.358 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.84 167.14 14.47 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.086 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.5 tt0 -47.29 -21.29 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.605 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.7 m95 -109.25 121.67 45.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.4 m0 -104.29 142.65 34.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.043 0.449 . . . . 0.0 112.144 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.8 113.97 23.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.334 178.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.28 47.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 111.817 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.8 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.88 111.02 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.614 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.69 167.7 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.064 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.42 -23.61 4.08 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.084 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.99 -40.87 19.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.943 0.878 . . . . 0.0 109.013 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.12 -36.07 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.43 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.14 -0.27 88.91 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.288 -1.778 . . . . 0.0 113.257 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.681 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.98 123.3 8.96 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.229 0.538 . . . . 0.0 111.018 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 145.95 24.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.582 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.15 178.62 43.27 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -90.3 140.81 29.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 110.622 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 88' ' ' LEU . 7.7 pt -134.74 145.31 54.29 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.347 0.594 . . . . 0.0 112.152 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 11.0 Cg_endo -55.89 115.36 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.238 2.626 . . . . 0.0 111.157 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.83 -19.72 12.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 13.9 p30 -101.22 32.5 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.516 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.18 -30.45 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.536 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 88' ' ' LEU . 31.1 m -109.67 149.27 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.13 139.88 41.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.364 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.58 ' HD3' HG12 ' A' ' 66' ' ' VAL . 41.7 mmtm -39.38 138.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.32 54.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.3 tp . . . . . 0 N--CA 1.447 -0.622 0 CA-C-O 121.937 0.875 . . . . 0.0 112.017 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.774 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.58 -177.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.746 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.55 126.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.601 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.07 151.53 39.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.212 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.08 13.67 12.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.757 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.87 141.35 2.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.736 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.35 124.27 18.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.408 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.8 t80 -103.73 146.26 28.87 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.3 94.32 14.0 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.01 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.77 123.93 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.382 3.388 . . . . 0.0 113.292 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -122.34 -39.35 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.804 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.9 m80 -79.93 174.39 11.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.89 141.99 35.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.22 40.24 97.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -105.15 154.53 20.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.147 0.499 . . . . 0.0 111.189 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.509 HD21 HD22 ' A' ' 88' ' ' LEU . 5.7 tp -110.64 131.75 54.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.907 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.59 16.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.369 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.622 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.3 175.97 9.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.802 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.1 173.22 6.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -71.65 128.45 35.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.95 -13.92 54.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.407 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.02 165.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.595 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.52 146.52 48.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.59 128.43 15.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.25 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.92 103.62 9.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 66' ' ' VAL . 25.9 mm -59.57 111.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.232 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.724 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.8 mt -79.65 -47.93 14.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.786 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.74 136.99 34.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.849 178.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.0 pt20 -124.84 35.88 4.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.107 0.479 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.4 122.44 39.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.92 159.69 35.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.672 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.29 -21.29 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.351 -0.425 . . . . 0.0 111.538 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.1 m95 -111.75 113.3 25.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -95.59 136.46 35.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.069 0.461 . . . . 0.0 112.156 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.724 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 113.24 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.104 177.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.29 142.99 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 111.675 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.71 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.36 110.7 22.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.628 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 167.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.165 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.82 -23.71 3.94 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.968 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -82.7 -40.69 20.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.868 0.842 . . . . 0.0 108.859 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 -35.74 6.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.395 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 -0.85 87.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.293 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.21 121.94 6.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.82 143.35 26.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.579 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.99 177.51 44.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.341 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.64 149.18 25.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.68 0.276 . . . . 0.0 110.614 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.736 HD13 HD13 ' A' ' 88' ' ' LEU . 7.1 pt -145.31 143.15 19.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.355 0.598 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.8 Cg_endo -51.68 109.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.45 -26.12 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -98.69 30.37 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 0.0 111.205 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.493 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.79 10.93 10.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.987 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.9 m -147.53 151.01 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.86 140.49 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.592 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.516 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.8 mmtp -39.47 139.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 53.95 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.077 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.923 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.848 0.832 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -127.08 -176.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.968 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.24 124.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.01 152.05 20.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.786 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.22 7.48 10.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.983 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.14 143.88 6.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.14 124.13 17.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.318 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.56 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.96 146.96 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -138.59 94.51 10.46 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.886 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.95 131.38 0.33 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.359 3.372 . . . . 0.0 113.44 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -130.01 -43.48 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.711 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.5 m-70 -79.84 156.38 27.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.35 130.59 43.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.017 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.81 55.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.65 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.4 m-20 -97.1 157.23 16.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 110.973 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -114.19 131.15 56.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.967 179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.31 142.31 16.01 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.489 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -148.13 177.13 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -108.12 176.48 5.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.702 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -74.24 134.36 42.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.39 -8.78 38.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.566 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.7 165.65 2.18 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.07 146.76 46.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.676 . . . . 0.0 111.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.792 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.95 127.44 14.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.931 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.4 ttt180 -79.63 101.43 8.34 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.796 HD11 HG21 ' A' ' 66' ' ' VAL . 36.8 mm -55.43 111.76 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.038 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 33.8 mt -79.45 -46.0 18.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.675 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.79 135.95 26.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.735 178.337 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -122.31 35.96 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.073 0.463 . . . . 0.0 111.437 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.35 122.49 39.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.834 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.17 159.51 35.32 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.756 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -49.73 -20.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.312 -0.444 . . . . 0.0 111.476 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 65.2 m95 -113.95 108.3 16.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.676 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -90.3 138.27 31.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.083 0.468 . . . . 0.0 112.08 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.735 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.55 116.6 23.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.09 178.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.64 142.65 49.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.794 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.722 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.17 110.76 22.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.602 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.7 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 -179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.56 -23.9 3.98 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.953 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.9 -40.22 20.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 108.986 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.28 -35.75 5.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.63 -1.29 88.26 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.175 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.713 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -49.78 123.16 7.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.251 0.548 . . . . 0.0 111.114 179.017 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.28 146.92 23.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.686 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.64 177.36 41.27 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.211 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.43 143.83 28.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.641 0.257 . . . . 0.0 110.475 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.655 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -138.17 142.31 35.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.307 0.575 . . . . 0.0 112.205 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.529 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.7 Cg_endo -52.41 113.17 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.222 2.614 . . . . 0.0 111.312 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.85 -23.09 6.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -101.28 32.68 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 111.08 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.37 -17.71 7.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 66' ' ' VAL . 30.5 m -121.27 149.04 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.68 140.91 44.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.594 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' HD3' HG12 ' A' ' 66' ' ' VAL . 71.3 mmtt -39.52 138.76 0.65 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.67 53.78 0.12 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.946 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.7 tp . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.966 0.888 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.821 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.46 -176.64 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -145.55 126.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.723 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.64 148.3 29.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.464 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 mt -101.67 -22.81 14.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -143.36 -178.12 5.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.813 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.3 125.52 31.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.273 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.4 t80 -104.67 146.37 29.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.62 93.99 13.69 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.4 123.19 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.338 3.359 . . . . 0.0 113.34 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -39.05 2.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.413 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -80.0 167.84 19.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.12 143.11 41.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.07 38.97 96.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -106.07 155.21 19.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.489 . . . . 0.0 111.087 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.578 HD21 HD22 ' A' ' 88' ' ' LEU . 6.3 tp -111.29 128.95 56.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.062 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.56 146.61 18.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.088 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -147.95 178.55 8.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.981 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.55 173.35 6.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.32 128.71 36.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 -13.24 56.16 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.288 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.12 165.63 0.96 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.9 mt-30 -124.71 146.79 48.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.605 0.717 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.57 128.2 15.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.983 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.523 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.8 103.85 9.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.821 HD11 HG21 ' A' ' 66' ' ' VAL . 27.3 mm -58.72 112.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.222 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.819 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.9 mt -79.39 -46.9 16.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.53 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 151.25 39.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.494 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.9 pt20 -135.67 37.63 2.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.37 131.26 34.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.331 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.67 15.67 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.0 tt0 -47.66 -21.53 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.106 -0.547 . . . . 0.0 111.586 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.0 m95 -109.63 120.9 43.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 110.738 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.518 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.33 143.92 32.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.102 0.477 . . . . 0.0 112.212 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -89.03 114.55 25.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.256 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.02 144.2 48.66 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.055 0.455 . . . . 0.0 111.851 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.819 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.49 111.01 22.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.63 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.75 166.96 0.05 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.042 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.36 -23.76 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.603 -0.439 . . . . 0.0 112.091 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.64 -40.09 21.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.88 0.848 . . . . 0.0 108.911 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.495 ' HB ' HE22 ' A' ' 107' ' ' GLN . 0.9 OUTLIER -110.04 -35.9 6.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.471 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.32 -0.7 88.69 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.243 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.495 HE22 ' HB ' ' A' ' 105' ' ' THR . 2.5 mp0 -51.02 122.9 8.22 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.246 0.546 . . . . 0.0 111.067 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -88.98 146.56 24.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.588 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.74 177.49 42.13 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.191 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.48 142.51 27.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.72 0.295 . . . . 0.0 110.779 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 88' ' ' LEU . 7.8 pt -136.7 144.88 48.77 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.453 0.644 . . . . 0.0 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.8 Cg_endo -55.63 116.18 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.293 2.662 . . . . 0.0 111.154 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.63 -19.6 17.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.412 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 p-10 -100.62 32.3 3.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.514 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.22 -29.57 4.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.732 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.708 HG11 HD12 ' A' ' 88' ' ' LEU . 18.9 m -110.21 152.13 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.39 141.17 35.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.346 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HD3' HG12 ' A' ' 66' ' ' VAL . 31.1 mmtp -39.42 139.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.94 54.0 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.925 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.3 tp . . . . . 0 N--CA 1.446 -0.653 0 CA-C-O 122.019 0.914 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.752 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -125.51 -177.65 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.774 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.92 124.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.774 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.86 151.34 25.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.957 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.35 12.45 12.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.772 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.68 141.94 2.96 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.665 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.1 124.47 19.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.4 t80 -103.98 147.15 27.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.6 mt-10 -137.63 94.42 11.82 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.926 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.73 126.81 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.354 3.369 . . . . 0.0 113.377 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -124.67 -40.75 2.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m-70 -79.89 171.38 15.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.42 142.65 39.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.56 40.71 98.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.376 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -106.21 155.12 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.192 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.9 tp -111.04 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.982 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.24 16.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.273 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.54 176.5 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.01 0.433 . . . . 0.0 110.736 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.39 174.34 5.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.751 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.02 129.91 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.79 -11.58 56.17 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.419 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.52 165.85 1.03 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.559 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.78 146.21 47.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.509 0.671 . . . . 0.0 111.163 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.6 128.06 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.385 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.51 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.8 ttt180 -79.88 103.57 9.87 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 66' ' ' VAL . 22.3 mm -59.94 112.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.218 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.737 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.4 mt -79.52 -47.35 15.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.713 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.93 139.87 34.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.936 178.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.2 pt20 -126.18 35.38 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 111.23 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 122.2 37.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.021 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.89 160.77 36.86 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.775 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.9 tt0 -49.63 -19.95 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.277 -0.462 . . . . 0.0 111.383 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.3 m95 -113.17 112.93 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.327 . . . . 0.0 110.573 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -94.73 136.92 34.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.108 0.48 . . . . 0.0 112.228 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.3 113.33 20.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.234 178.132 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.65 143.36 47.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.024 0.44 . . . . 0.0 111.678 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.675 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.84 110.78 22.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 168.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.136 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.51 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.69 -23.74 3.97 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.939 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.83 -41.05 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.009 0.909 . . . . 0.0 108.913 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.69 -35.62 6.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.04 -0.77 86.81 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.203 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.486 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.34 121.71 5.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.265 0.555 . . . . 0.0 111.078 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.71 143.76 26.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.525 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 178.52 44.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.71 149.02 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.704 0.288 . . . . 0.0 110.67 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.665 HD13 HD13 ' A' ' 88' ' ' LEU . 5.1 pt -143.99 143.24 22.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 112.065 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.6 Cg_endo -51.3 111.5 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.175 2.584 . . . . 0.0 111.299 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.75 -25.74 1.98 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 113' ' ' PHE . 8.8 p-10 -98.99 30.83 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 111.062 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.51 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -124.06 19.84 9.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.9 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.1 m -153.63 150.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.1 138.05 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.619 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD3' HG12 ' A' ' 66' ' ' VAL . 60.7 mmtt -39.38 139.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.14 53.67 0.13 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.913 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.5 tp . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.911 0.862 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -127.04 -176.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.176 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.47 128.06 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.622 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -64.83 150.71 47.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.66 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 mt -109.9 -6.94 15.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.964 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.673 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -152.19 173.44 14.97 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.598 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.34 124.47 28.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.533 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 18.7 t80 -102.69 146.7 27.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.207 0.527 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.13 15.25 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.148 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.2 Cg_exo -37.9 123.71 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.28 3.32 . . . . 0.0 113.223 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -40.67 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.559 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.3 m80 -80.37 157.18 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.17 142.99 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.22 39.69 98.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.545 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.22 155.31 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.21 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 88' ' ' LEU . 7.2 tp -110.83 129.15 55.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.0 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.2 144.9 17.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.112 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.653 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.66 175.47 10.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.952 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.08 173.53 6.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.859 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -72.01 127.33 32.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.32 -11.86 59.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.354 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.53 165.52 1.11 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.76 147.85 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.31 127.22 13.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.95 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 40.0 ttt-85 -79.87 102.28 9.04 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.389 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.701 HD11 ' CG2' ' A' ' 66' ' ' VAL . 31.5 mm -56.82 111.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.171 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.84 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.52 -46.89 16.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.443 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.61 154.04 43.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.241 178.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.5 pt20 -139.44 37.33 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 0.0 111.819 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.3 131.2 34.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.9 166.6 17.63 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.041 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -47.51 -20.91 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.608 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 77.7 m95 -110.42 120.27 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.764 0.316 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.5 m0 -102.72 142.34 34.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.151 0.501 . . . . 0.0 112.101 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.06 114.46 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.374 178.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.45 142.8 48.92 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.0 111.635 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.84 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -107.57 110.97 23.0 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.639 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.82 166.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.048 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.9 -23.75 4.22 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.066 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.92 -40.56 19.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.891 0.853 . . . . 0.0 108.881 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.19 -35.61 6.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.445 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.64 -0.24 88.36 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.283 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.447 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.95 122.36 7.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.271 0.558 . . . . 0.0 110.971 179.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.75 145.41 25.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.541 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.37 177.4 42.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.15 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.63 142.69 27.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.796 0.332 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.725 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -135.99 145.05 50.9 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.38 0.609 . . . . 0.0 112.109 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.18 114.93 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.318 2.679 . . . . 0.0 111.125 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.94 -22.89 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 18.3 p-10 -102.56 34.92 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.339 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.673 ' CZ ' ' CD2' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -122.45 -9.01 8.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.121 -179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 66' ' ' VAL . 14.5 m -133.76 153.11 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.59 143.17 41.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.488 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.3 mmtt -39.53 139.4 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.59 53.47 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.875 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.3 tp . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.832 0.825 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.819 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.91 -177.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.981 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 125.29 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.654 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.32 149.06 21.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.5 -25.41 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.737 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.427 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -144.3 -177.25 5.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.57 125.01 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 19.5 t80 -103.68 145.58 29.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.311 0.576 . . . . 0.0 112.496 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.35 94.58 15.44 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.76 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 2.6 Cg_exo -35.03 126.73 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.384 3.39 . . . . 0.0 113.359 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -121.9 -42.45 2.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.729 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.13 170.85 15.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.74 145.59 40.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.03 35.37 83.48 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.405 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.418 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.2 m-20 -97.99 156.73 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.414 . . . . 0.0 111.176 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 107' ' ' GLN . 4.4 tp -115.63 127.53 55.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.889 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.84 142.6 16.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.118 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 p90 -142.04 177.52 8.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.014 0.435 . . . . 0.0 110.899 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -108.26 172.71 6.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.838 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -72.36 128.98 37.31 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.58 -10.23 59.96 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.4 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.29 165.38 2.04 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.56 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -123.52 147.88 46.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 111.215 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.718 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.61 127.84 13.84 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.3 ttt180 -79.81 103.63 9.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.819 HD11 HG21 ' A' ' 66' ' ' VAL . 30.4 mm -58.42 111.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.313 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.752 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.6 mt -79.55 -46.21 17.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.603 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.37 137.07 30.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.8 178.317 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.6 pt20 -125.73 36.15 4.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 0.0 111.34 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.29 122.81 38.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.6 161.26 37.28 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.7 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -48.47 -21.15 0.5 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.449 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.9 m95 -112.03 119.86 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.297 . . . . 0.0 110.529 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.541 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -101.8 138.21 39.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 112.223 -179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.752 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.91 114.4 22.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.954 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.88 143.12 49.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.995 0.426 . . . . 0.0 111.839 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.717 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -106.61 111.16 23.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.38 165.38 0.1 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.787 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.26 -23.59 4.48 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.218 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.02 -40.41 19.98 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.881 0.848 . . . . 0.0 108.983 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.48 ' HB ' HE22 ' A' ' 107' ' ' GLN . 0.9 OUTLIER -109.46 -35.74 6.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.498 179.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.67 -1.37 88.15 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.134 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.533 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.5 mp0 -50.31 122.64 7.21 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.173 0.511 . . . . 0.0 110.946 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.94 149.19 21.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.598 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.44 178.78 41.45 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.38 139.57 30.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.752 0.31 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 88' ' ' LEU . 6.1 pt -133.46 145.68 57.48 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.421 0.629 . . . . 0.0 111.998 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.69 119.61 6.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.198 2.599 . . . . 0.0 111.398 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.4 -19.13 33.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -103.45 34.9 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.66 -30.25 3.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.661 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 88' ' ' LEU . 31.5 m -111.43 147.73 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.48 141.01 46.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.365 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.503 ' HD3' HG12 ' A' ' 66' ' ' VAL . 42.4 mmtm -39.47 138.24 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.8 54.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.949 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.753 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.7 tp . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 122.03 0.919 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.11 -176.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.402 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.85 125.22 5.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.813 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.58 152.11 27.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.918 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.6 mt -119.63 8.46 11.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.864 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.88 142.52 5.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.63 124.46 18.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.421 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -104.14 146.6 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -137.28 94.25 12.42 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.924 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.48 128.22 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 124.396 3.397 . . . . 0.0 113.346 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -126.35 -41.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.2 m-70 -79.85 156.11 27.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.66 130.49 43.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.832 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.71 33.41 42.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.457 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.32 154.6 19.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.15 0.5 . . . . 0.0 111.112 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 88' ' ' LEU . 5.8 tp -110.08 131.8 54.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.71 143.91 16.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.358 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.607 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.63 176.62 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.66 171.58 7.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.879 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -70.39 126.84 30.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.42 -16.53 52.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.291 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.09 165.72 0.29 Allowed 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.68 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -123.92 145.96 48.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.629 0.728 . . . . 0.0 111.324 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.726 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.6 128.69 16.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.162 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.527 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.2 ttt180 -79.95 103.53 9.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.843 HD11 HG21 ' A' ' 66' ' ' VAL . 22.5 mm -58.98 111.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.184 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.717 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.4 mt -79.63 -47.12 15.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.685 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -141.23 137.08 32.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.798 178.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.84 36.1 4.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.09 122.37 38.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.896 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.3 159.4 35.53 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.707 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.6 tt0 -48.33 -21.22 0.49 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.498 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.5 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.0 m95 -112.51 112.4 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.741 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -94.32 139.66 30.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 112.166 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.07 114.96 23.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.03 178.087 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.51 142.76 49.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.991 0.424 . . . . 0.0 111.808 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.699 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.01 110.7 22.48 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.21 167.58 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.149 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.9 -23.58 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.577 -0.449 . . . . 0.0 112.013 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.88 -40.4 20.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.851 0.834 . . . . 0.0 108.9 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 -35.83 6.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.328 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.08 -0.5 88.57 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.268 -1.787 . . . . 0.0 113.297 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.405 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.91 123.23 8.74 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.22 0.533 . . . . 0.0 110.995 179.077 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.79 144.19 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.628 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.56 177.68 43.88 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.169 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -86.02 152.0 23.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 110.686 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.02 142.96 17.05 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.264 0.554 . . . . 0.0 112.08 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.502 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.9 Cg_endo -52.67 112.32 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.171 2.58 . . . . 0.0 111.369 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.24 -23.52 9.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.819 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.1 p-10 -100.13 31.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.38 -22.78 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.957 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.665 HG11 HD12 ' A' ' 88' ' ' LEU . 18.2 m -115.6 151.24 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.2 140.17 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.388 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.48 140.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.31 51.4 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.993 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.7 tp . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 121.98 0.895 . . . . 0.0 112.042 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.94 -177.67 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.832 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.18 126.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.64 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.61 151.84 36.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -120.04 13.0 12.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.778 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.51 141.74 3.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.715 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.33 124.27 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.448 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.0 t80 -104.12 146.37 28.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.9 94.45 12.84 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.918 178.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.12 125.86 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.299 3.332 . . . . 0.0 113.364 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -40.34 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.0 m80 -79.93 167.64 20.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.46 142.49 44.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.62 41.9 99.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.425 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.31 155.35 20.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.069 0.461 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -110.96 132.27 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.059 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.59 143.02 16.47 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.461 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.608 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.32 176.11 10.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.07 175.14 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.656 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -72.84 131.98 42.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.79 -11.23 48.14 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.488 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.18 165.79 1.28 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.2 mt-30 -123.04 146.54 47.58 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.436 0.636 . . . . 0.0 111.183 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.13 14.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.259 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.93 103.81 10.07 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 66' ' ' VAL . 26.8 mm -59.81 111.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.215 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.56 -47.82 14.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.29 136.47 33.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.841 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.1 pt20 -123.95 36.03 4.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.06 0.457 . . . . 0.0 111.355 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.0 122.36 39.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.907 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.33 159.87 35.52 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.758 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 tt0 -49.77 -20.11 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.383 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.9 m95 -113.62 112.01 22.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -93.51 138.39 31.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 112.307 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.719 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.14 112.96 21.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.158 178.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.39 143.25 47.55 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 120.999 0.428 . . . . 0.0 111.692 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.704 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.52 110.81 22.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.626 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.54 167.96 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.089 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.76 -23.79 3.95 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.994 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.67 -40.98 19.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.974 0.892 . . . . 0.0 108.883 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.77 -35.66 6.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.947 -1.478 . . . . 0.0 109.407 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.01 -0.44 87.3 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.286 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.464 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.89 121.53 6.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.222 0.534 . . . . 0.0 111.061 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.09 143.75 26.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.556 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.16 177.52 43.39 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.79 149.72 24.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.661 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -144.87 143.46 20.96 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.371 0.605 . . . . 0.0 112.137 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.14 111.38 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.257 2.638 . . . . 0.0 111.315 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p30 -99.84 31.7 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.36 14.34 9.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -150.85 150.48 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.38 140.16 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HD3' HG12 ' A' ' 66' ' ' VAL . 44.2 mmtt -39.5 139.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.48 54.19 0.11 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.046 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.915 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.3 tp . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.913 0.863 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.822 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.31 -177.43 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.788 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -144.71 125.61 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.759 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -56.56 149.54 17.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 mt -100.37 -24.48 14.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -145.49 -176.87 5.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.899 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.72 125.39 29.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.452 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.3 t80 -104.87 147.0 28.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.249 0.547 . . . . 0.0 112.429 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -136.45 93.83 14.14 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.041 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -39.41 112.93 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.169 3.246 . . . . 0.0 113.251 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -29.6 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -84.7 170.22 13.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.02 141.77 35.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 59.98 41.6 97.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.306 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -109.52 155.65 21.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 88' ' ' LEU . 6.5 tp -110.17 129.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.981 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.23 147.79 18.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.941 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -148.25 177.91 9.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 110.896 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.1 174.71 5.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.848 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -73.37 129.1 37.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.51 -10.54 58.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.393 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.43 165.61 1.47 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.609 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -124.31 147.11 48.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.528 0.68 . . . . 0.0 111.295 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.758 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.02 14.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.065 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.8 ttt180 -79.91 104.03 10.21 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.822 HD11 HG21 ' A' ' 66' ' ' VAL . 22.6 mm -58.54 112.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.317 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 27.6 mt -79.68 -46.62 16.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.573 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.4 134.83 26.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.023 178.158 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -120.56 36.65 4.5 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.222 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.36 122.52 39.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.993 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.15 159.92 36.03 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.851 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.01 -20.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.429 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.1 m95 -113.79 115.39 27.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.45 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -96.4 139.26 32.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.249 0.547 . . . . 0.0 112.358 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.39 113.6 21.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 177.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.09 143.27 48.23 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.893 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -107.27 110.8 22.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.645 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 166.34 0.06 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -124.82 -23.24 4.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.123 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.03 -40.34 20.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.812 0.815 . . . . 0.0 108.915 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.73 -35.93 6.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.472 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.26 -0.32 88.99 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.262 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.02 122.52 7.67 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.282 0.563 . . . . 0.0 111.01 179.067 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.7 146.0 25.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.547 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.05 41.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.3 m-85 -89.85 142.39 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.699 0.285 . . . . 0.0 110.823 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.758 HD13 HD13 ' A' ' 88' ' ' LEU . 7.4 pt -135.67 146.29 56.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 112.1 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.47 118.73 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.257 2.638 . . . . 0.0 111.335 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.24 -19.19 32.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -102.89 34.17 2.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.64 -30.14 3.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.635 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 88' ' ' LEU . 29.0 m -108.09 149.47 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.24 139.09 39.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.29 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.0 mmtt -39.33 139.17 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.93 54.54 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.92 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.834 0.826 . . . . 0.0 111.617 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.94 -176.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.991 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.87 126.87 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.576 179.115 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.05 152.16 41.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.111 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.87 13.73 11.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.865 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.53 141.67 3.0 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.735 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.61 124.48 19.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.297 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -103.94 146.78 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.2 mt-10 -137.06 94.15 12.8 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.852 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.61 125.63 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.336 3.358 . . . . 0.0 113.364 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -123.32 -41.53 2.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.684 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.405 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -80.0 159.67 26.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.26 137.05 52.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.31 36.37 78.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -104.74 154.84 19.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.103 0.477 . . . . 0.0 111.124 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 88' ' ' LEU . 6.2 tp -110.59 130.85 55.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.082 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.99 143.9 16.88 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.313 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.593 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -146.99 176.91 9.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -109.36 173.67 6.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -71.89 128.75 36.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.04 -12.92 56.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.42 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.46 165.42 0.8 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.7 mt-30 -123.04 147.38 46.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.532 0.682 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.39 128.02 14.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.147 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 27.9 ttt180 -79.87 103.23 9.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.791 HD11 HG21 ' A' ' 66' ' ' VAL . 28.6 mm -58.5 111.9 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.035 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.5 mt -79.37 -46.69 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.679 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 152.49 40.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.412 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -137.12 36.78 2.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.895 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.61 131.23 34.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.155 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.75 164.78 16.23 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -47.64 -21.0 0.31 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.681 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.3 m95 -110.6 116.95 32.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.507 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.9 m0 -99.26 144.81 27.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.102 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -90.01 115.36 27.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 143.18 49.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.119 0.485 . . . . 0.0 111.636 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.797 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.4 111.12 22.86 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.622 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 167.43 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.45 -23.67 4.06 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.08 -40.56 19.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.918 0.866 . . . . 0.0 108.91 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.24 -35.57 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.41 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.74 -1.6 85.68 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 113.221 -1.809 . . . . 0.0 113.252 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -49.7 122.49 6.48 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.256 0.551 . . . . 0.0 111.13 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.0 145.19 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.544 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.02 177.93 42.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.26 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -86.21 153.8 21.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.663 0.268 . . . . 0.0 110.459 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 88' ' ' LEU . 5.0 pt -149.12 143.78 17.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 112.1 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.9 Cg_endo -52.32 111.74 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.265 2.643 . . . . 0.0 111.286 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.5 -23.08 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -102.5 32.27 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.308 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.97 -15.14 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.124 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG21 HG21 ' A' ' 66' ' ' VAL . 19.8 m -124.86 151.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.47 142.9 41.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.572 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 6.6 mmtp -39.6 138.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 54.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.087 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.871 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.2 tp . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 121.854 0.835 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.837 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.39 -177.4 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.841 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.19 123.55 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.86 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.9 153.3 17.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.804 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.02 8.59 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.47 143.02 5.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.702 -179.113 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.68 123.95 16.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.279 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HH ' ' HD3' ' A' ' 112' ' ' PRO . 12.7 t80 -103.01 146.63 28.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -137.92 94.28 11.51 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.89 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.91 128.72 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.357 3.371 . . . . 0.0 113.356 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -44.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.651 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.6 m-70 -80.01 149.1 30.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.17 130.74 48.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.58 29.3 53.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.855 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 2.9 m-20 -97.3 157.99 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.06 0.457 . . . . 0.0 111.023 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -114.24 129.64 56.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.904 179.564 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.5 142.1 15.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.441 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -147.53 176.82 9.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.962 0.41 . . . . 0.0 110.511 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -107.34 172.51 6.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -72.53 129.57 38.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.69 -12.37 56.76 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.403 -177.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.82 165.77 0.85 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -122.38 146.24 47.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.556 0.693 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.61 128.2 15.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.532 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.9 ttt-85 -79.94 103.86 10.12 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 66' ' ' VAL . 26.9 mm -58.23 112.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.116 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.762 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.7 mt -79.47 -46.84 16.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.777 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.82 136.29 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.634 178.331 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -123.23 35.89 4.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.44 122.44 39.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.869 179.165 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.07 160.3 35.94 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.757 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.5 tt0 -49.84 -19.99 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.476 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 66.8 m95 -114.1 109.68 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.295 . . . . 0.0 110.794 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.3 m0 -91.48 137.41 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.122 0.487 . . . . 0.0 112.059 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.28 115.98 22.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.159 178.122 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.08 144.12 48.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.887 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.762 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.32 110.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.6 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.91 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.162 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.76 -23.89 3.92 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.999 -178.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.99 -40.71 19.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.952 0.882 . . . . 0.0 108.933 178.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -35.6 6.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.549 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.24 -2.03 85.64 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.199 -1.819 . . . . 0.0 113.173 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.702 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.44 123.45 7.62 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.167 0.508 . . . . 0.0 111.104 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.88 147.68 22.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.725 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.46 177.87 41.49 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -86.32 144.56 27.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.651 0.263 . . . . 0.0 110.56 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 88' ' ' LEU . 4.6 pt -139.12 142.72 34.0 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.335 0.588 . . . . 0.0 112.135 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.5 Cg_endo -52.42 113.98 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.212 2.608 . . . . 0.0 111.385 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -22.72 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.022 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' CD1' ' A' ' 113' ' ' PHE . 7.9 p-10 -101.95 32.88 3.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.705 0.288 . . . . 0.0 111.115 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -120.33 -23.91 6.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.004 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.668 HG21 HG21 ' A' ' 66' ' ' VAL . 28.4 m -114.9 147.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -177.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.15 139.7 46.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.57 140.72 0.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.944 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.06 50.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.104 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp . . . . . 0 N--CA 1.447 -0.624 0 CA-C-O 122.025 0.917 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.17 -177.17 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.576 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.3 124.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.816 179.15 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -55.55 147.95 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.457 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 mt -100.26 -24.96 14.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -143.46 -177.15 5.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 179.47 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.67 124.92 29.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.2 t80 -103.94 146.94 27.95 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -137.63 94.23 11.94 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.6 Cg_exo -37.08 127.28 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.303 3.335 . . . . 0.0 113.354 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -41.54 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.607 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m170 -80.01 156.72 27.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.46 140.75 58.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 38.57 95.51 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.39 156.0 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 111.139 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -111.3 131.41 55.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.23 147.79 18.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.179 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -150.69 179.05 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.009 0.433 . . . . 0.0 110.786 -179.745 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.76 177.92 4.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.762 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -75.38 134.79 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.68 -7.31 41.8 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.473 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -60.2 165.77 3.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.974 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.58 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.71 146.29 48.38 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.511 0.672 . . . . 0.0 111.157 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.5 128.22 15.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.143 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.83 104.28 10.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.802 HD11 HG21 ' A' ' 66' ' ' VAL . 29.6 mm -60.38 112.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.294 -178.062 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.718 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.59 -47.76 14.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.751 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.15 136.27 33.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.793 178.305 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -124.19 36.49 4.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.352 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.79 40.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.996 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.64 159.88 35.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.726 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.1 tt0 -49.19 -20.57 0.62 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.35 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.3 m95 -113.2 114.6 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.9 m0 -96.42 139.44 32.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.58 113.19 21.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.987 177.985 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.76 144.04 47.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.092 0.472 . . . . 0.0 111.697 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.684 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.03 110.65 21.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.632 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.52 167.72 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.067 -179.475 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.4 mp -125.64 -23.32 4.07 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.003 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.82 -40.89 19.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.968 0.89 . . . . 0.0 108.932 178.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.97 -36.04 6.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.342 179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.45 0.68 89.47 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.348 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.451 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.68 122.45 8.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.236 0.541 . . . . 0.0 110.978 179.037 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.85 143.77 26.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.493 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.59 177.02 43.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.272 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.98 143.34 27.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.666 0.269 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.728 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -137.53 145.14 47.9 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.387 0.613 . . . . 0.0 112.125 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.02 116.46 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.21 2.606 . . . . 0.0 111.189 178.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.39 -20.01 10.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -101.98 33.94 2.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 111.154 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.35 -30.43 4.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.618 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 88' ' ' LEU . 29.8 m -109.44 147.32 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.37 139.87 44.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.143 178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.39 140.15 0.48 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.92 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.41 51.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 66' ' ' VAL . 19.0 tp . . . . . 0 N--CA 1.446 -0.639 0 CA-C-O 121.784 0.802 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -126.57 -178.41 2.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.229 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -142.36 124.55 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.616 179.434 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -60.66 151.07 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.039 -179.003 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.88 13.19 12.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 141.81 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.629 -179.185 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.21 124.48 19.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.452 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.2 t80 -104.1 146.64 28.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -136.77 94.38 13.11 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.963 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.4 132.93 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 124.332 3.355 . . . . 0.0 113.41 -179.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -42.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -79.91 157.55 26.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 179.882 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.43 133.66 49.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 35.32 55.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.373 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.422 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -103.96 155.56 18.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 107' ' ' GLN . 5.7 tp -112.21 132.26 55.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.924 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.14 143.2 16.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.17 176.41 9.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.987 0.422 . . . . 0.0 110.782 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -109.27 173.47 6.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.957 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -72.22 127.71 33.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 -13.58 58.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.309 -177.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.32 165.64 0.72 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.915 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.05 147.63 46.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.405 0.621 . . . . 0.0 111.057 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.97 127.52 13.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.176 -179.88 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.515 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.2 ttt180 -79.86 103.66 9.91 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.659 HD11 HG21 ' A' ' 66' ' ' VAL . 27.1 mm -59.13 111.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.223 -178.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' A' ' 101' ' ' GLN . 19.9 mt -79.5 -47.15 16.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.544 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 155.1 45.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.431 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.478 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -140.63 37.51 1.83 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.811 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 131.48 34.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.216 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.86 167.08 10.47 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.046 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -47.14 -20.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.071 -0.564 . . . . 0.0 111.685 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m95 -108.86 118.45 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 110.911 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.4 m0 -101.82 139.87 36.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.157 0.504 . . . . 0.0 111.944 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -85.51 114.73 22.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.358 178.303 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.29 143.52 49.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.791 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.11 111.12 22.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.627 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.01 167.17 0.06 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.99 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.515 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.15 -23.55 4.18 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.032 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.21 -41.4 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.883 0.849 . . . . 0.0 108.894 178.294 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.91 -35.51 6.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.456 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.15 -0.76 86.99 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.221 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.47 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.6 121.91 6.46 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.32 0.581 . . . . 0.0 111.053 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -88.7 145.75 25.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.549 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.15 177.89 41.99 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.309 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.47 151.9 23.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.647 0.26 . . . . 0.0 110.449 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 88' ' ' LEU . 7.6 pt -147.88 143.01 17.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 112.191 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.3 Cg_endo -52.01 110.16 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.098 2.532 . . . . 0.0 111.161 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.08 -25.77 2.28 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 7.2 p30 -96.99 29.16 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.722 0.296 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.12 18.96 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.984 -179.289 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.3 m -154.1 150.65 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.4 139.03 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.615 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HD3' HG12 ' A' ' 66' ' ' VAL . 35.3 mmtm -39.49 138.84 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 112.008 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.47 54.31 0.11 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.027 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.924 179.984 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.7 tp . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.936 0.874 . . . . 0.0 111.958 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.83 -177.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.657 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.95 125.76 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.78 179.157 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.47 151.78 40.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.03 14.78 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.712 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -169.32 142.28 2.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 -179.227 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.02 124.73 20.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.6 t80 -104.75 146.47 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.98 94.6 12.58 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.054 178.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.09 128.71 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.43 3.42 . . . . 0.0 113.379 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -126.75 -42.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 5.3 m170 -79.97 158.42 26.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.707 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.38 142.32 57.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.33 42.22 99.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -110.57 155.38 22.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.127 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.4 tp -111.0 133.0 53.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.054 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -98.54 143.94 16.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.453 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.93 175.97 10.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.407 . . . . 0.0 110.822 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -109.02 175.93 5.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.699 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -72.86 132.22 43.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.76 -10.06 48.25 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.67 -177.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.8 165.83 1.61 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.899 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.621 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.24 146.0 48.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.545 0.688 . . . . 0.0 111.148 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.696 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.24 128.3 15.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.7 ttt180 -79.93 103.51 9.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -59.81 111.31 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.061 -178.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.8 mt -79.62 -48.16 14.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.722 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 136.85 35.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.803 178.276 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.564 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.4 35.89 4.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 111.334 -178.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.62 122.53 39.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.823 179.192 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.02 159.25 35.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.671 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.3 -20.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.442 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.7 m95 -113.19 110.63 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.8 m0 -92.48 138.36 31.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.235 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -84.73 113.37 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.138 178.147 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.62 143.05 47.89 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.054 0.454 . . . . 0.0 111.659 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.719 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.48 110.52 22.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 168.0 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.185 -179.54 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.89 -23.62 3.93 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.055 -179.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.71 -41.01 19.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.968 0.89 . . . . 0.0 108.876 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.67 -35.97 6.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.314 179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.26 0.62 89.25 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.362 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.56 121.98 7.29 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.991 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.36 143.4 27.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.561 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 177.16 43.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.239 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -85.2 153.93 22.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.604 0.24 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.696 HD13 HD13 ' A' ' 88' ' ' LEU . 6.6 pt -149.62 143.29 16.64 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.372 0.606 . . . . 0.0 112.125 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.523 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.7 Cg_endo -51.08 110.16 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 111.191 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.28 -26.29 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -99.08 30.81 3.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 111.232 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.5 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -122.58 17.67 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.953 -179.581 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -154.16 150.67 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.48 139.56 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.51 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.584 ' HD3' HG12 ' A' ' 66' ' ' VAL . 38.9 mmtm -39.56 139.33 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.42 54.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.5 tp . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.901 0.857 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.61 -177.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.033 -1.439 . . . . 0.0 111.949 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.83 123.98 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.748 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.92 153.74 16.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.914 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.91 6.92 10.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.885 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.16 143.29 6.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 -179.163 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.22 124.27 17.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.9 t80 -104.96 146.39 29.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.5 mt-10 -138.05 94.69 11.08 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.811 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.66 129.87 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.316 3.344 . . . . 0.0 113.365 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.9 t -128.3 -42.02 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.7 m-70 -79.99 158.67 26.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.8 139.2 57.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.37 40.6 96.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.67 155.43 20.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.027 0.442 . . . . 0.0 111.11 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.2 tp -111.29 133.29 53.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.042 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.6 145.79 17.97 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.441 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -150.55 177.71 9.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.47 175.58 5.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.708 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -73.89 131.68 41.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.09 -10.8 51.88 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.355 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.5 165.59 1.52 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -122.55 146.55 47.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.6 0.714 . . . . 0.0 111.197 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.753 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.55 127.81 14.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.504 ' N ' HD11 ' A' ' 103' ' ' LEU . 37.2 ttt180 -79.95 103.2 9.68 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.829 HD11 HG21 ' A' ' 66' ' ' VAL . 28.5 mm -59.69 111.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.264 -178.05 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.3 mt -79.63 -47.04 16.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.47 178.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.46 155.63 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.309 178.127 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -141.47 37.39 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.09 131.96 34.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.301 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.44 166.5 15.57 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.992 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.4 tt0 -47.76 -20.75 0.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.499 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.7 m95 -110.22 118.21 35.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.477 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.3 m0 -100.63 143.63 30.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.121 0.486 . . . . 0.0 112.033 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.26 114.85 25.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.482 178.464 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.555 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.61 143.8 49.11 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.962 0.41 . . . . 0.0 111.697 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.738 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.5 tt0 -109.09 110.99 22.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.19 -179.453 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.27 -23.25 4.2 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.663 -0.415 . . . . 0.0 112.025 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.18 -41.7 18.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.976 0.893 . . . . 0.0 108.943 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.13 -36.04 6.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.334 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 0.06 88.72 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 113.176 -1.829 . . . . 0.0 113.423 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.471 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.16 122.57 7.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.276 0.56 . . . . 0.0 111.08 179.071 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.78 146.01 25.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.616 -178.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.99 177.77 41.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.54 155.53 21.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.658 HD13 HD13 ' A' ' 88' ' ' LEU . 5.5 pt -150.03 144.36 17.54 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.344 0.592 . . . . 0.0 112.205 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.499 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.9 Cg_endo -53.45 112.17 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.209 2.606 . . . . 0.0 111.251 178.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -54.74 -21.11 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.91 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 6.2 p-10 -101.6 30.72 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.25 -26.33 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 88' ' ' LEU . 17.2 m -113.22 149.6 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.55 140.67 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.23 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 140.47 0.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.908 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.26 50.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 . . . . . 0 CA--C 1.516 -0.342 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.754 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.6 tp -82.25 142.52 32.05 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.937 0.875 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.86 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.78 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.24 126.7 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.668 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.99 151.73 42.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.992 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.9 13.33 12.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.862 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.585 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.93 141.1 2.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.661 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.65 124.08 17.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.308 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.0 t80 -103.27 145.46 29.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -135.73 94.3 15.03 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.91 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.21 126.22 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.327 3.351 . . . . 0.0 113.327 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -124.01 -41.83 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.631 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -79.98 159.09 26.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.704 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 141.67 56.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.923 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 39.11 97.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.613 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.12 155.49 19.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.059 0.456 . . . . 0.0 111.141 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD21 HD22 ' A' ' 88' ' ' LEU . 3.5 tp -111.15 129.91 55.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.53 142.19 15.92 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.57 176.2 9.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.993 0.425 . . . . 0.0 110.711 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.73 171.59 7.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -70.98 128.58 36.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.29 -13.4 55.2 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.427 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.87 165.61 0.61 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.5 mt-30 -123.21 146.48 47.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.67 0.748 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.711 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.44 128.55 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.177 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -79.89 103.59 9.88 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 66' ' ' VAL . 26.2 mm -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.17 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.733 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.2 mt -79.53 -47.76 15.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.722 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.5 135.48 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.807 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.562 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.8 pt20 -121.94 35.92 4.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.369 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.65 122.23 38.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.92 158.54 34.61 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.691 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.3 tt0 -48.55 -21.51 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.457 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.488 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.1 m95 -112.46 109.69 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.717 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.562 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -91.38 139.34 30.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.199 0.524 . . . . 0.0 112.184 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.72 114.35 22.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.239 177.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.85 144.68 47.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 0.0 111.785 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.733 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.87 110.7 21.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.35 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.186 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.88 -23.66 3.93 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.007 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -40.21 20.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.959 0.885 . . . . 0.0 108.914 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -35.78 6.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.411 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.83 -0.18 88.65 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 113.285 -1.78 . . . . 0.0 113.384 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.49 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.12 122.8 8.17 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.236 0.541 . . . . 0.0 111.003 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.95 144.2 26.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.47 177.59 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.199 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.18 152.38 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.661 0.267 . . . . 0.0 110.55 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.711 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.14 143.49 17.65 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 112.086 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.4 Cg_endo -52.64 108.34 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.152 2.568 . . . . 0.0 111.281 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -50.64 -24.9 3.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.4 p30 -98.97 30.36 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -118.0 -24.41 7.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.01 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.683 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -115.46 150.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 142.58 44.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.487 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.6 mmtt -39.67 139.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.35 54.44 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.003 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.6 tp -83.15 142.28 31.34 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.86 0.838 . . . . 0.0 111.709 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.28 -176.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.856 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.97 126.66 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.62 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.67 152.23 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.01 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.48 14.2 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.884 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.578 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 140.76 2.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.672 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.87 124.13 17.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.244 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.551 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 13.1 t80 -103.78 146.19 28.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -137.15 94.31 12.55 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.914 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.65 120.45 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.259 3.306 . . . . 0.0 113.426 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -118.79 -36.79 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.7 m80 -81.35 172.68 13.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.624 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -80.07 142.82 34.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.28 38.08 94.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.438 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.73 155.55 18.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 111.211 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.829 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -111.42 128.58 56.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.082 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.08 144.71 17.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.354 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.82 176.22 10.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.989 0.423 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -107.15 173.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.729 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -72.58 129.08 37.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.86 -11.0 58.59 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.512 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.47 165.56 1.08 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.557 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -122.77 146.6 47.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.552 0.691 . . . . 0.0 111.212 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.829 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.99 128.07 14.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.204 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.0 ttt180 -79.85 103.52 9.8 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 66' ' ' VAL . 29.1 mm -57.77 112.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.223 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.1 mt -79.41 -46.87 16.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.704 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.32 135.69 27.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.626 178.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.3 pt20 -122.26 35.69 4.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.076 0.465 . . . . 0.0 111.239 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 122.66 38.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.876 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.19 158.65 34.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.613 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.8 tt0 -49.38 -20.84 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.435 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.17 107.78 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.9 m0 -89.34 140.41 29.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 112.201 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.82 115.73 24.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.191 178.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 144.14 48.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.937 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.793 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.6 110.93 22.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.592 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.98 167.81 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.123 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.54 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.79 -24.04 3.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.914 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -83.15 -40.47 19.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.913 0.863 . . . . 0.0 108.942 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.84 -35.47 6.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.502 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.77 -2.89 85.29 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.035 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.9 mp0 -48.8 124.75 8.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.98 151.05 20.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.716 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 167.61 176.91 38.68 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.61 142.69 28.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.69 0.281 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -136.76 144.57 47.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.62 . . . . 0.0 112.176 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 9.0 Cg_endo -53.62 109.77 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.195 2.597 . . . . 0.0 111.29 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.54 -23.85 7.09 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.814 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.1 p-10 -99.12 30.87 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.99 -22.73 6.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.043 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 88' ' ' LEU . 16.5 m -117.23 150.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.43 142.36 43.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.39 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 66' ' ' VAL . 7.2 mmtp -39.59 139.09 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.01 53.98 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.075 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.8 tp -84.79 141.73 30.29 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.982 0.896 . . . . 0.0 112.096 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -125.48 -177.28 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 113.826 -1.533 . . . . 0.0 111.779 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.28 126.1 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.636 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.84 151.93 41.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.091 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.17 14.38 12.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.94 141.12 2.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.14 124.6 19.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.325 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.6 t80 -103.92 146.09 29.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.89 94.44 12.86 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.963 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -36.34 132.43 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.336 3.358 . . . . 0.0 113.381 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 t -130.53 -43.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.741 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.438 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.8 m80 -79.96 149.09 30.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 129.76 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.044 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.82 28.78 49.75 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.624 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 3.2 m-20 -96.98 158.47 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.2 132.73 56.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.831 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.33 141.87 15.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.626 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -144.8 176.8 9.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.471 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.09 170.5 8.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.055 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -69.71 126.63 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.72 -15.65 50.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.323 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.17 166.21 0.26 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -123.34 145.81 48.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.5 0.667 . . . . 0.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.26 127.69 15.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.258 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.6 ttt180 -79.74 103.41 9.62 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.779 HD11 HG21 ' A' ' 66' ' ' VAL . 23.0 mm -58.25 111.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.119 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.837 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.34 -46.68 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.554 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.24 154.89 44.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -140.25 36.7 1.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 0.0 111.863 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.33 131.28 34.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.93 166.81 18.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.027 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.04 -20.36 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.662 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 71.2 m95 -110.18 116.85 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.0 m0 -99.74 140.5 33.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.084 0.469 . . . . 0.0 111.994 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.81 116.76 25.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.54 178.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -123.2 144.6 49.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.031 0.443 . . . . 0.0 111.722 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.837 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.65 111.24 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.615 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.52 167.09 0.07 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.871 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -124.62 -23.41 4.39 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.426 -0.51 . . . . 0.0 112.105 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.84 -41.15 17.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 0.0 108.989 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.12 -35.57 6.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.427 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.63 -1.74 84.98 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.239 -1.801 . . . . 0.0 113.218 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.37 123.37 7.41 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.177 0.513 . . . . 0.0 111.15 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.79 149.5 21.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.607 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 168.46 177.02 39.22 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.313 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.35 143.42 28.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.658 0.266 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -137.84 142.14 35.25 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 0.0 112.126 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.512 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.9 Cg_endo -51.26 112.06 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.264 2.643 . . . . 0.0 111.242 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -49.84 -24.87 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.3 p-10 -100.52 31.42 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.39 17.07 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.946 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.8 m -154.23 150.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.23 140.75 37.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.548 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.53 138.91 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.25 54.38 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.89 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.2 tp -81.96 142.25 32.58 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.951 0.881 . . . . 0.0 111.838 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.838 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -124.04 -176.64 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.894 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.48 128.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.749 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -65.62 150.55 48.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.641 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.98 -6.22 15.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 p-80 -153.52 172.89 16.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.676 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.05 123.99 27.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.513 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.58 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 20.4 t80 -101.51 145.96 28.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.289 0.566 . . . . 0.0 112.331 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.24 15.15 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.038 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.22 129.36 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.368 3.379 . . . . 0.0 113.293 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -125.76 -40.7 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.791 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.3 m-70 -79.94 174.99 11.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.695 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.21 144.9 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.97 37.29 84.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.634 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -98.47 156.2 16.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.168 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.3 tp -115.2 125.23 53.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.54 141.35 15.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.108 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.62 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -141.19 175.62 9.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -107.05 172.7 6.68 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.813 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.18 127.92 34.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.63 59.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.355 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.74 165.59 1.15 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.0 mt-30 -123.9 146.71 48.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.521 0.677 . . . . 0.0 111.202 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.73 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.12 128.47 15.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -80.03 103.31 9.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 66' ' ' VAL . 27.5 mm -59.36 111.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.216 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.741 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.5 mt -79.55 -47.25 15.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.813 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.43 136.37 29.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.739 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.563 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -124.19 35.92 4.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.473 . . . . 0.0 111.32 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 122.41 38.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.959 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.58 160.91 36.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.798 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.0 tt0 -48.79 -20.96 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.501 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.25 117.19 31.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.563 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.7 m0 -98.82 137.57 37.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.13 0.49 . . . . 0.0 112.169 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.92 112.68 20.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.061 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -118.96 143.28 47.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.93 110.53 21.87 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.08 167.17 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.104 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.45 -23.7 4.06 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.099 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.73 -40.49 20.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.909 0.861 . . . . 0.0 108.936 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.505 ' HB ' HE22 ' A' ' 107' ' ' GLN . 0.9 OUTLIER -109.37 -35.57 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.408 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.46 -0.0 88.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.299 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.548 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.5 mp0 -51.24 121.63 6.51 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.261 0.553 . . . . 0.0 111.058 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.93 142.55 27.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.601 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 177.09 -179.94 47.75 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.249 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.34 139.8 30.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.695 0.284 . . . . 0.0 110.97 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.722 HD13 HD13 ' A' ' 88' ' ' LEU . 6.0 pt -134.26 144.18 50.16 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.421 0.629 . . . . 0.0 111.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.4 Cg_endo -53.11 119.18 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.218 2.612 . . . . 0.0 111.265 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.69 -20.97 16.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -105.18 35.4 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.244 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -120.96 -17.49 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 88' ' ' LEU . 14.8 m -126.88 152.33 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.62 143.27 43.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.388 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.59 139.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.19 54.51 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.046 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.864 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.4 tp -44.0 142.86 1.26 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.877 0.846 . . . . 0.0 112.091 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -126.72 -176.89 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.894 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.63 125.94 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.629 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.67 146.85 29.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.466 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 mt -97.98 -24.54 15.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.418 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -145.87 -177.37 5.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.965 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.31 125.22 29.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.214 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -103.64 145.39 30.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.34 94.13 15.9 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.046 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.14 133.58 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.304 3.336 . . . . 0.0 113.432 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.46 -43.57 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.41 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 8.3 m80 -80.0 150.57 30.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.722 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -62.31 136.16 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.96 61.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.6 m-20 -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 0.0 111.024 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.761 HD21 HD22 ' A' ' 88' ' ' LEU . 1.1 tp -116.34 123.99 48.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.899 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -90.3 143.12 16.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.137 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p90 -143.93 178.19 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -108.3 172.98 6.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.89 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -72.71 128.77 36.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 -10.73 59.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.286 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.33 165.5 1.44 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.545 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.69 147.33 47.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.465 0.65 . . . . 0.0 111.111 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.772 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.48 127.67 14.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.951 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.542 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.7 ttt180 -79.84 101.37 8.48 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.418 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 66' ' ' VAL . 37.0 mm -55.4 112.11 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.079 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.838 HD21 ' CB ' ' A' ' 101' ' ' GLN . 25.2 mt -79.4 -46.5 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.578 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -145.71 148.36 32.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.344 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -132.1 37.14 3.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.23 131.78 34.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.91 164.57 20.75 Favored Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.979 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -48.43 -20.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.59 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.0 m95 -111.1 119.47 39.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.523 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.0 m0 -101.53 142.26 33.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.109 0.481 . . . . 0.0 112.21 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.99 114.74 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.2 178.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.62 143.31 48.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 111.814 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.838 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.37 110.83 22.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.621 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.51 166.66 0.05 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.101 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.04 -23.95 4.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.055 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.95 -39.98 20.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.841 . . . . 0.0 109.046 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.4 -35.47 6.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.554 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.56 -1.23 88.27 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.154 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.682 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.28 123.16 7.96 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 146.65 23.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.734 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.09 179.44 43.77 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.111 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -90.39 139.83 30.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.789 0.328 . . . . 0.0 110.737 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.737 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -133.69 144.48 52.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.517 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.5 116.77 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.263 2.642 . . . . 0.0 111.182 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.488 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.31 -19.9 16.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 5.9 p-10 -101.99 33.75 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.069 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.82 -30.33 4.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.651 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 88' ' ' LEU . 27.4 m -111.13 148.61 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.69 142.21 45.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.408 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.9 mmtp -39.36 137.98 0.71 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.08 54.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.061 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.768 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.2 tp -79.79 142.43 35.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.988 0.899 . . . . 0.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.82 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.08 -176.64 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.594 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.69 125.13 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.733 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.51 150.94 29.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.928 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.81 10.68 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -167.43 142.85 4.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.653 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.5 124.82 20.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.384 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -104.62 146.8 28.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.419 0.628 . . . . 0.0 112.658 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -138.11 94.53 11.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.954 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.83 127.56 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.304 3.336 . . . . 0.0 113.33 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.37 -40.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m80 -79.85 170.83 15.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.768 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.99 137.2 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.76 38.57 94.57 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.607 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -104.17 154.45 19.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 88' ' ' LEU . 4.9 tp -110.48 133.01 53.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.089 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.1 143.74 16.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.402 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.606 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.78 176.7 9.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.79 172.96 6.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.863 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.93 128.84 37.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.85 -15.02 50.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.327 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.16 165.75 0.47 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -123.58 145.98 48.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.58 0.705 . . . . 0.0 111.29 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.31 128.36 15.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.149 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.0 ttt180 -79.84 103.77 9.97 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.82 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -58.92 111.47 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.148 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 101' ' ' GLN . 24.5 mt -79.56 -47.4 15.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.821 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.73 137.79 33.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.861 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -125.29 35.71 4.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.61 122.55 38.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.936 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.84 159.09 35.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.724 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.483 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.4 tt0 -48.49 -20.92 0.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.42 -0.39 . . . . 0.0 111.476 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.6 m95 -112.59 111.98 23.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.679 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -93.97 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.75 114.85 24.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.194 178.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.43 143.04 48.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.048 0.451 . . . . 0.0 111.774 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -107.93 110.88 22.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.42 167.64 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.95 -24.06 3.84 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.968 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.44 -40.64 20.9 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.906 0.86 . . . . 0.0 108.919 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.22 -35.3 6.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.29 -1.23 86.0 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.53 121.86 6.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 0.0 111.082 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.47 145.13 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.619 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.66 176.63 42.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.402 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -84.78 151.78 24.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.609 0.242 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.684 HD13 HD13 ' A' ' 88' ' ' LEU . 5.7 pt -148.08 143.11 17.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.292 0.568 . . . . 0.0 112.148 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.7 Cg_endo -51.8 112.59 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.235 2.623 . . . . 0.0 111.339 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.47 -23.7 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 14.1 p30 -101.83 32.45 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.74 -17.06 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -121.61 150.42 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.24 140.77 41.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.477 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.5 mmtp -39.46 139.48 0.56 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.84 53.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.966 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.5 tp -82.36 142.51 31.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.904 0.859 . . . . 0.0 111.822 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.23 -176.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.884 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.7 124.92 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.61 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -59.84 152.96 21.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.03 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -121.4 8.9 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.916 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.596 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -166.32 143.36 5.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.24 123.74 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.332 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.575 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -103.03 146.94 27.59 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -138.2 94.53 10.99 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.847 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.4 Cg_exo -36.27 131.69 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.45 3.434 . . . . 0.0 113.299 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -130.1 -43.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.439 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 13.1 m-70 -79.96 157.31 26.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.33 128.45 36.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.64 47.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.657 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.3 m-20 -96.27 156.9 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.109 0.48 . . . . 0.0 110.991 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.735 HD21 HD22 ' A' ' 88' ' ' LEU . 1.4 tp -114.69 130.13 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.38 141.67 15.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.391 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -146.57 176.89 9.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -108.83 172.03 7.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.003 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -71.56 127.23 31.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.5 -15.32 55.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.286 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.41 165.53 0.36 Allowed 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.556 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.7 mt-30 -122.68 146.7 47.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.567 0.699 . . . . 0.0 111.216 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.746 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.77 127.97 14.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.8 ttt180 -79.93 103.07 9.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 66' ' ' VAL . 25.0 mm -58.67 113.48 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.141 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.736 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 39.2 mt -79.51 -46.37 17.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.748 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -145.2 134.56 23.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.911 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.9 pt20 -119.77 36.05 4.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.77 122.24 37.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.925 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.39 159.53 35.61 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.696 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.85 -20.81 0.54 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 68.4 m95 -113.03 110.95 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.561 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -92.66 136.86 32.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.736 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 114.84 21.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.239 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.87 143.74 47.76 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.073 0.463 . . . . 0.0 111.745 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.658 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.96 110.58 21.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.41 168.4 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.223 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -126.12 -23.55 3.88 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.015 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.86 -40.4 20.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.868 0.842 . . . . 0.0 108.923 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -35.8 6.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.471 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.1 -0.62 88.48 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.271 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.45 123.17 8.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.231 0.539 . . . . 0.0 111.097 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -90.01 144.54 25.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.562 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.52 178.64 44.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.372 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -87.52 146.53 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.618 0.247 . . . . 0.0 110.643 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -142.25 142.07 23.05 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.0 112.125 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.548 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.1 Cg_endo -51.94 112.24 0.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.193 2.595 . . . . 0.0 111.385 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.64 -23.76 7.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p-10 -100.57 31.6 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.09 -25.63 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 88' ' ' LEU . 17.1 m -114.32 149.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 141.81 44.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.478 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.495 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.4 mmtt -39.58 138.94 0.64 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.61 54.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.083 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.975 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 CA--C 1.517 -0.303 0 CA-C-O 120.64 0.257 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 22.9 tp -82.39 141.84 32.47 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.745 0.783 . . . . 0.0 111.464 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.24 -177.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.105 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.51 126.03 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.608 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.82 152.03 37.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.132 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.05 12.69 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.26 142.73 3.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.585 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 124.19 18.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.389 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.4 t80 -104.07 146.18 29.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.69 94.38 13.26 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.927 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.5 Cg_exo -37.04 122.14 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.313 3.342 . . . . 0.0 113.336 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -41.16 2.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.508 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m-70 -80.51 159.05 25.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.21 143.48 56.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.17 41.65 99.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.593 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.59 155.61 21.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.162 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.506 HD21 HD22 ' A' ' 88' ' ' LEU . 6.6 tp -111.41 131.56 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.75 144.59 17.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.401 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.75 176.66 9.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -109.42 172.35 6.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.802 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -71.31 127.33 32.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.3 -14.34 57.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.347 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.9 165.61 0.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -123.2 147.49 46.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.668 . . . . 0.0 111.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -147.31 127.96 14.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.102 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' N ' HD11 ' A' ' 103' ' ' LEU . 33.1 ttt180 -79.82 103.46 9.74 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 66' ' ' VAL . 28.1 mm -59.07 111.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.202 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.6 mt -79.34 -47.02 16.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.505 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.97 154.24 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.336 178.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -139.47 36.71 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.842 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.56 131.26 34.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.235 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.75 15.93 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.108 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -47.46 -21.19 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.084 -0.558 . . . . 0.0 111.625 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m95 -109.99 118.1 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.7 m0 -100.4 143.18 30.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 112.021 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.725 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.22 114.71 25.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.468 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.9 142.98 49.18 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.051 0.453 . . . . 0.0 111.77 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.779 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.23 111.08 22.87 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.624 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.57 167.43 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.114 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.43 -23.52 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.056 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -41.06 19.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.919 0.866 . . . . 0.0 108.881 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.13 -35.66 6.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.419 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.98 -1.45 86.62 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.329 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.459 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.2 mp0 -49.77 122.06 6.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.289 0.566 . . . . 0.0 111.07 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.44 145.03 26.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.665 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.62 42.24 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.36 155.39 20.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.614 0.245 . . . . 0.0 110.442 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 4.5 pt -150.11 144.25 17.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.609 . . . . 0.0 112.157 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.493 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.5 Cg_endo -52.88 111.15 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.226 2.617 . . . . 0.0 111.25 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.03 -22.97 6.55 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.6 p-10 -101.04 30.97 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.454 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.37 -19.75 8.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.985 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.641 HG11 HD12 ' A' ' 88' ' ' LEU . 16.2 m -119.7 150.63 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.81 141.34 42.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.325 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.65 140.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.8 50.89 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.897 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp -82.22 142.19 32.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.063 0.935 . . . . 0.0 112.077 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.7 -176.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.546 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 126.46 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.687 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.66 147.97 25.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.401 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 mt -100.43 -23.07 14.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -145.54 -176.72 5.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.888 0.375 . . . . 0.0 110.776 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.25 125.26 30.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.9 t80 -104.66 146.57 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 mt-10 -136.41 94.13 13.97 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.024 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.72 120.02 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.327 3.352 . . . . 0.0 113.366 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -117.07 -34.75 4.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.539 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 5.6 m80 -84.12 169.72 14.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.798 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -79.0 143.43 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.91 35.95 92.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.354 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -104.29 155.75 18.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 111.202 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 88' ' ' LEU . 1.9 tp -111.85 127.45 55.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.136 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.77 144.2 16.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.03 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.543 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.9 OUTLIER -145.21 179.21 7.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.924 0.392 . . . . 0.0 110.949 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.89 175.41 5.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.956 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 131.22 41.28 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.34 -9.1 56.39 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.331 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.63 165.6 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.6 mt-30 -124.58 146.07 49.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 111.258 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.804 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.15 128.04 15.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.272 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.1 ttt180 -79.67 104.27 10.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.827 HD11 HG21 ' A' ' 66' ' ' VAL . 25.3 mm -59.57 112.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.388 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.808 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.8 mt -79.44 -47.43 15.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.475 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 154.27 43.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.413 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -138.61 38.02 2.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 111.888 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 131.27 34.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.283 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.8 166.42 9.7 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.12 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -46.77 -21.55 0.21 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.52 . . . . 0.0 111.655 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 80.3 m95 -108.52 121.01 44.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.506 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.97 143.14 33.27 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.39 113.94 24.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.228 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.64 47.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.136 0.493 . . . . 0.0 111.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.808 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.84 110.88 22.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.618 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.86 167.75 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.043 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.63 -23.49 4.04 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.073 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -83.12 -39.91 20.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.863 0.84 . . . . 0.0 109.015 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.21 -35.8 5.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.428 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.76 -0.34 88.37 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.286 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.595 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.03 122.62 7.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.225 0.536 . . . . 0.0 111.098 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.81 146.03 25.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.51 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.0 177.33 42.2 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.69 140.38 29.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.659 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 88' ' ' LEU . 8.6 pt -134.78 145.34 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 112.161 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.9 Cg_endo -56.06 114.04 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.164 2.576 . . . . 0.0 111.156 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -21.64 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.426 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.5 p30 -98.81 31.63 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.851 0.357 . . . . 0.0 111.041 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -120.99 -27.13 5.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.632 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 88' ' ' LEU . 23.0 m -112.9 148.74 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.3 141.35 41.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.374 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' HG12 ' A' ' 66' ' ' VAL . 13.7 mmtp -39.4 138.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.56 54.41 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.029 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.923 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.9 tp -83.54 142.03 31.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.985 0.898 . . . . 0.0 111.991 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.858 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.19 -177.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.672 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.09 125.33 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.753 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.12 147.24 25.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.508 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.14 -24.4 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -146.39 -177.17 5.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.991 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 125.47 29.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.305 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -104.05 145.72 29.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.43 94.1 15.78 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.996 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.92 124.46 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.387 3.392 . . . . 0.0 113.365 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -40.44 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -83.74 157.19 22.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.87 147.3 53.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.09 33.87 85.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.599 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -101.55 156.86 17.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.178 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.703 HD21 HD22 ' A' ' 88' ' ' LEU . 1.3 tp -114.36 125.04 53.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.095 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.92 142.64 16.14 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.176 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.1 p90 -143.06 178.35 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.922 0.391 . . . . 0.0 110.939 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -108.32 174.89 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.838 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.27 130.04 38.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.25 -8.76 60.06 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.382 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.75 165.4 2.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.612 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -124.31 146.12 49.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.651 0.738 . . . . 0.0 111.142 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.78 128.23 15.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 103' ' ' LEU . 29.7 ttt180 -79.99 104.21 10.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.858 HD11 HG21 ' A' ' 66' ' ' VAL . 24.9 mm -59.5 112.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.34 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 101' ' ' GLN . 21.9 mt -79.54 -46.94 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.388 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.85 155.02 43.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.347 178.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.3 pt20 -139.74 37.56 2.0 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.836 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.08 131.01 34.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.358 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.84 167.14 14.47 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.086 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.5 tt0 -47.29 -21.29 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.605 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.7 m95 -109.25 121.67 45.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.4 m0 -104.29 142.65 34.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.043 0.449 . . . . 0.0 112.144 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.8 113.97 23.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.334 178.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.28 47.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 111.817 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.8 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.88 111.02 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.614 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.69 167.7 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.064 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.42 -23.61 4.08 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.084 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.99 -40.87 19.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.943 0.878 . . . . 0.0 109.013 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.12 -36.07 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.43 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.14 -0.27 88.91 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.288 -1.778 . . . . 0.0 113.257 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.681 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.98 123.3 8.96 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.229 0.538 . . . . 0.0 111.018 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 145.95 24.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.582 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.15 178.62 43.27 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -90.3 140.81 29.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 110.622 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 88' ' ' LEU . 7.7 pt -134.74 145.31 54.29 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.347 0.594 . . . . 0.0 112.152 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 11.0 Cg_endo -55.89 115.36 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.238 2.626 . . . . 0.0 111.157 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.83 -19.72 12.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 13.9 p30 -101.22 32.5 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.516 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.18 -30.45 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.536 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 88' ' ' LEU . 31.1 m -109.67 149.27 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.13 139.88 41.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.364 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.58 ' HD3' HG12 ' A' ' 66' ' ' VAL . 41.7 mmtm -39.38 138.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.32 54.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.3 tp -83.76 141.94 31.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.937 0.875 . . . . 0.0 112.017 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.774 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.58 -177.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.746 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.55 126.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.601 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.07 151.53 39.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.212 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.08 13.67 12.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.757 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.87 141.35 2.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.736 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.35 124.27 18.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.408 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.8 t80 -103.73 146.26 28.87 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.3 94.32 14.0 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.01 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.77 123.93 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.382 3.388 . . . . 0.0 113.292 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -122.34 -39.35 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.804 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.9 m80 -79.93 174.39 11.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.89 141.99 35.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.22 40.24 97.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -105.15 154.53 20.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.147 0.499 . . . . 0.0 111.189 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.509 HD21 HD22 ' A' ' 88' ' ' LEU . 5.7 tp -110.64 131.75 54.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.907 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.59 16.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.369 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.622 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.3 175.97 9.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.802 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.1 173.22 6.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -71.65 128.45 35.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.95 -13.92 54.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.407 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.02 165.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.595 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.52 146.52 48.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.59 128.43 15.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.25 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.92 103.62 9.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 66' ' ' VAL . 25.9 mm -59.57 111.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.232 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.724 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.8 mt -79.65 -47.93 14.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.786 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.74 136.99 34.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.849 178.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.0 pt20 -124.84 35.88 4.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.107 0.479 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.4 122.44 39.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.92 159.69 35.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.672 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.29 -21.29 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.351 -0.425 . . . . 0.0 111.538 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.1 m95 -111.75 113.3 25.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -95.59 136.46 35.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.069 0.461 . . . . 0.0 112.156 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.724 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 113.24 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.104 177.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.29 142.99 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 111.675 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.71 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.36 110.7 22.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.628 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 167.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.165 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.82 -23.71 3.94 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.968 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -82.7 -40.69 20.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.868 0.842 . . . . 0.0 108.859 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 -35.74 6.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.395 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 -0.85 87.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.293 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.21 121.94 6.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.82 143.35 26.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.579 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.99 177.51 44.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.341 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.64 149.18 25.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.68 0.276 . . . . 0.0 110.614 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.736 HD13 HD13 ' A' ' 88' ' ' LEU . 7.1 pt -145.31 143.15 19.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.355 0.598 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.8 Cg_endo -51.68 109.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.45 -26.12 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -98.69 30.37 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 0.0 111.205 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.493 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.79 10.93 10.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.987 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.9 m -147.53 151.01 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.86 140.49 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.592 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.516 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.8 mmtp -39.47 139.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 53.95 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.077 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.923 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp -43.89 142.52 1.31 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.848 0.832 . . . . 0.0 112.103 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -127.08 -176.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.968 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.24 124.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.01 152.05 20.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.786 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.22 7.48 10.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.983 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.14 143.88 6.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.14 124.13 17.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.318 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.56 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.96 146.96 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -138.59 94.51 10.46 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.886 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.95 131.38 0.33 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.359 3.372 . . . . 0.0 113.44 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -130.01 -43.48 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.711 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.5 m-70 -79.84 156.38 27.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.35 130.59 43.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.017 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.81 55.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.65 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.4 m-20 -97.1 157.23 16.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 110.973 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -114.19 131.15 56.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.967 179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.31 142.31 16.01 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.489 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -148.13 177.13 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -108.12 176.48 5.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.702 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -74.24 134.36 42.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.39 -8.78 38.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.566 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.7 165.65 2.18 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.07 146.76 46.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.676 . . . . 0.0 111.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.792 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.95 127.44 14.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.931 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.4 ttt180 -79.63 101.43 8.34 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.796 HD11 HG21 ' A' ' 66' ' ' VAL . 36.8 mm -55.43 111.76 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.038 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 33.8 mt -79.45 -46.0 18.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.675 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.79 135.95 26.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.735 178.337 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -122.31 35.96 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.073 0.463 . . . . 0.0 111.437 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.35 122.49 39.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.834 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.17 159.51 35.32 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.756 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -49.73 -20.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.312 -0.444 . . . . 0.0 111.476 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 65.2 m95 -113.95 108.3 16.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.676 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -90.3 138.27 31.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.083 0.468 . . . . 0.0 112.08 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.735 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.55 116.6 23.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.09 178.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.64 142.65 49.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.794 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.722 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.17 110.76 22.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.602 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.7 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 -179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.56 -23.9 3.98 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.953 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.9 -40.22 20.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 108.986 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.28 -35.75 5.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.63 -1.29 88.26 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.175 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.713 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -49.78 123.16 7.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.251 0.548 . . . . 0.0 111.114 179.017 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.28 146.92 23.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.686 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.64 177.36 41.27 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.211 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.43 143.83 28.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.641 0.257 . . . . 0.0 110.475 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.655 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -138.17 142.31 35.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.307 0.575 . . . . 0.0 112.205 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.529 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.7 Cg_endo -52.41 113.17 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.222 2.614 . . . . 0.0 111.312 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.85 -23.09 6.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -101.28 32.68 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 111.08 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.37 -17.71 7.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 66' ' ' VAL . 30.5 m -121.27 149.04 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.68 140.91 44.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.594 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' HD3' HG12 ' A' ' 66' ' ' VAL . 71.3 mmtt -39.52 138.76 0.65 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.67 53.78 0.12 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.946 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.7 tp -82.88 142.39 31.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.966 0.888 . . . . 0.0 112.06 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.821 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.46 -176.64 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -145.55 126.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.723 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.64 148.3 29.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.464 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 mt -101.67 -22.81 14.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -143.36 -178.12 5.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.813 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.3 125.52 31.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.273 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.4 t80 -104.67 146.37 29.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.62 93.99 13.69 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.4 123.19 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.338 3.359 . . . . 0.0 113.34 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -39.05 2.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.413 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -80.0 167.84 19.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.12 143.11 41.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.07 38.97 96.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -106.07 155.21 19.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.489 . . . . 0.0 111.087 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.578 HD21 HD22 ' A' ' 88' ' ' LEU . 6.3 tp -111.29 128.95 56.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.062 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.56 146.61 18.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.088 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -147.95 178.55 8.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.981 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.55 173.35 6.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.32 128.71 36.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 -13.24 56.16 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.288 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.12 165.63 0.96 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.9 mt-30 -124.71 146.79 48.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.605 0.717 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.57 128.2 15.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.983 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.523 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.8 103.85 9.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.821 HD11 HG21 ' A' ' 66' ' ' VAL . 27.3 mm -58.72 112.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.222 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.819 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.9 mt -79.39 -46.9 16.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.53 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 151.25 39.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.494 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.9 pt20 -135.67 37.63 2.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.37 131.26 34.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.331 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.67 15.67 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.0 tt0 -47.66 -21.53 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.106 -0.547 . . . . 0.0 111.586 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.0 m95 -109.63 120.9 43.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 110.738 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.518 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.33 143.92 32.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.102 0.477 . . . . 0.0 112.212 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -89.03 114.55 25.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.256 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.02 144.2 48.66 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.055 0.455 . . . . 0.0 111.851 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.819 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.49 111.01 22.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.63 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.75 166.96 0.05 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.042 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.36 -23.76 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.603 -0.439 . . . . 0.0 112.091 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.64 -40.09 21.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.88 0.848 . . . . 0.0 108.911 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.495 ' HB ' HE22 ' A' ' 107' ' ' GLN . 0.9 OUTLIER -110.04 -35.9 6.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.471 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.32 -0.7 88.69 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.243 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.495 HE22 ' HB ' ' A' ' 105' ' ' THR . 2.5 mp0 -51.02 122.9 8.22 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.246 0.546 . . . . 0.0 111.067 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -88.98 146.56 24.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.588 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.74 177.49 42.13 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.191 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.48 142.51 27.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.72 0.295 . . . . 0.0 110.779 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 88' ' ' LEU . 7.8 pt -136.7 144.88 48.77 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.453 0.644 . . . . 0.0 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.8 Cg_endo -55.63 116.18 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.293 2.662 . . . . 0.0 111.154 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.63 -19.6 17.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.412 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 p-10 -100.62 32.3 3.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.514 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.22 -29.57 4.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.732 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.708 HG11 HD12 ' A' ' 88' ' ' LEU . 18.9 m -110.21 152.13 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.39 141.17 35.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.346 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HD3' HG12 ' A' ' 66' ' ' VAL . 31.1 mmtp -39.42 139.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.94 54.0 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.925 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.3 tp -83.32 141.55 31.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.019 0.914 . . . . 0.0 112.041 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.752 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -125.51 -177.65 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.774 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.92 124.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.774 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.86 151.34 25.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.957 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.35 12.45 12.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.772 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.68 141.94 2.96 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.665 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.1 124.47 19.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.4 t80 -103.98 147.15 27.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.6 mt-10 -137.63 94.42 11.82 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.926 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.73 126.81 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.354 3.369 . . . . 0.0 113.377 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -124.67 -40.75 2.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m-70 -79.89 171.38 15.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.42 142.65 39.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.56 40.71 98.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.376 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -106.21 155.12 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.192 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.9 tp -111.04 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.982 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.24 16.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.273 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.54 176.5 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.01 0.433 . . . . 0.0 110.736 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.39 174.34 5.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.751 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.02 129.91 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.79 -11.58 56.17 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.419 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.52 165.85 1.03 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.559 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.78 146.21 47.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.509 0.671 . . . . 0.0 111.163 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.6 128.06 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.385 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.51 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.8 ttt180 -79.88 103.57 9.87 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 66' ' ' VAL . 22.3 mm -59.94 112.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.218 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.737 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.4 mt -79.52 -47.35 15.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.713 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.93 139.87 34.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.936 178.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.2 pt20 -126.18 35.38 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 111.23 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 122.2 37.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.021 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.89 160.77 36.86 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.775 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.9 tt0 -49.63 -19.95 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.277 -0.462 . . . . 0.0 111.383 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.3 m95 -113.17 112.93 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.327 . . . . 0.0 110.573 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -94.73 136.92 34.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.108 0.48 . . . . 0.0 112.228 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.3 113.33 20.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.234 178.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.65 143.36 47.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.024 0.44 . . . . 0.0 111.678 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.675 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.84 110.78 22.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 168.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.136 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.51 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.69 -23.74 3.97 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.939 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.83 -41.05 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.009 0.909 . . . . 0.0 108.913 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.69 -35.62 6.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.04 -0.77 86.81 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.203 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.486 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.34 121.71 5.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.265 0.555 . . . . 0.0 111.078 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.71 143.76 26.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.525 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 178.52 44.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.71 149.02 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.704 0.288 . . . . 0.0 110.67 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.665 HD13 HD13 ' A' ' 88' ' ' LEU . 5.1 pt -143.99 143.24 22.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 112.065 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.6 Cg_endo -51.3 111.5 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.175 2.584 . . . . 0.0 111.299 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.75 -25.74 1.98 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 113' ' ' PHE . 8.8 p-10 -98.99 30.83 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 111.062 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.51 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -124.06 19.84 9.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.9 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.1 m -153.63 150.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.1 138.05 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.619 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD3' HG12 ' A' ' 66' ' ' VAL . 60.7 mmtt -39.38 139.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.14 53.67 0.13 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.913 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 120.602 0.239 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.5 tp -43.27 142.31 1.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.911 0.862 . . . . 0.0 112.099 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -127.04 -176.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.176 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.47 128.06 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.622 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -64.83 150.71 47.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.66 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 mt -109.9 -6.94 15.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.964 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.673 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -152.19 173.44 14.97 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.598 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.34 124.47 28.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.533 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 18.7 t80 -102.69 146.7 27.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.207 0.527 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.13 15.25 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.148 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.2 Cg_exo -37.9 123.71 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.28 3.32 . . . . 0.0 113.223 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -40.67 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.559 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.3 m80 -80.37 157.18 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.17 142.99 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.22 39.69 98.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.545 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.22 155.31 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.21 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 88' ' ' LEU . 7.2 tp -110.83 129.15 55.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.0 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.2 144.9 17.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.112 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.653 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.66 175.47 10.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.952 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.08 173.53 6.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.859 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -72.01 127.33 32.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.32 -11.86 59.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.354 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.53 165.52 1.11 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.76 147.85 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.31 127.22 13.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.95 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 40.0 ttt-85 -79.87 102.28 9.04 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.389 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.701 HD11 ' CG2' ' A' ' 66' ' ' VAL . 31.5 mm -56.82 111.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.171 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.52 -46.89 16.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.443 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.61 154.04 43.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.241 178.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.5 pt20 -139.44 37.33 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 0.0 111.819 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.3 131.2 34.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.9 166.6 17.63 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.041 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -47.51 -20.91 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.608 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 77.7 m95 -110.42 120.27 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.764 0.316 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.5 m0 -102.72 142.34 34.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.151 0.501 . . . . 0.0 112.101 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.06 114.46 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.374 178.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.45 142.8 48.92 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.0 111.635 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.84 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -107.57 110.97 23.0 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.639 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.82 166.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.048 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.9 -23.75 4.22 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.066 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.92 -40.56 19.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.891 0.853 . . . . 0.0 108.881 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.19 -35.61 6.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.445 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.64 -0.24 88.36 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.283 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.447 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.95 122.36 7.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.271 0.558 . . . . 0.0 110.971 179.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.75 145.41 25.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.541 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.37 177.4 42.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.15 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.63 142.69 27.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.796 0.332 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.725 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -135.99 145.05 50.9 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.38 0.609 . . . . 0.0 112.109 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.18 114.93 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.318 2.679 . . . . 0.0 111.125 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.94 -22.89 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 18.3 p-10 -102.56 34.92 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.339 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.673 ' CZ ' ' CD2' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -122.45 -9.01 8.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.121 -179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 66' ' ' VAL . 14.5 m -133.76 153.11 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.59 143.17 41.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.488 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.3 mmtt -39.53 139.4 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.59 53.47 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.875 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.3 tp -82.43 142.44 31.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.832 0.825 . . . . 0.0 111.412 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.819 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.91 -177.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.981 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 125.29 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.654 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.32 149.06 21.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.5 -25.41 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.737 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.427 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -144.3 -177.25 5.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.57 125.01 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 19.5 t80 -103.68 145.58 29.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.311 0.576 . . . . 0.0 112.496 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.35 94.58 15.44 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.76 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 2.6 Cg_exo -35.03 126.73 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.384 3.39 . . . . 0.0 113.359 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -121.9 -42.45 2.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.729 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.13 170.85 15.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.74 145.59 40.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.03 35.37 83.48 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.405 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.418 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.2 m-20 -97.99 156.73 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.414 . . . . 0.0 111.176 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 107' ' ' GLN . 4.4 tp -115.63 127.53 55.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.889 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.84 142.6 16.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.118 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 p90 -142.04 177.52 8.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.014 0.435 . . . . 0.0 110.899 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -108.26 172.71 6.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.838 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -72.36 128.98 37.31 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.58 -10.23 59.96 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.4 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.29 165.38 2.04 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.56 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -123.52 147.88 46.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 111.215 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.718 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.61 127.84 13.84 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.3 ttt180 -79.81 103.63 9.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.819 HD11 HG21 ' A' ' 66' ' ' VAL . 30.4 mm -58.42 111.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.313 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.752 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.6 mt -79.55 -46.21 17.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.603 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.37 137.07 30.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.8 178.317 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.6 pt20 -125.73 36.15 4.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 0.0 111.34 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.29 122.81 38.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.6 161.26 37.28 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.7 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -48.47 -21.15 0.5 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.449 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.9 m95 -112.03 119.86 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.297 . . . . 0.0 110.529 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.541 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -101.8 138.21 39.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 112.223 -179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.752 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.91 114.4 22.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.954 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.88 143.12 49.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.995 0.426 . . . . 0.0 111.839 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.717 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -106.61 111.16 23.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.38 165.38 0.1 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.787 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.26 -23.59 4.48 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.218 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.02 -40.41 19.98 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.881 0.848 . . . . 0.0 108.983 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.48 ' HB ' HE22 ' A' ' 107' ' ' GLN . 0.9 OUTLIER -109.46 -35.74 6.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.498 179.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.67 -1.37 88.15 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.134 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.533 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.5 mp0 -50.31 122.64 7.21 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.173 0.511 . . . . 0.0 110.946 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.94 149.19 21.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.598 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.44 178.78 41.45 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.38 139.57 30.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.752 0.31 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 88' ' ' LEU . 6.1 pt -133.46 145.68 57.48 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.421 0.629 . . . . 0.0 111.998 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.69 119.61 6.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.198 2.599 . . . . 0.0 111.398 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.4 -19.13 33.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -103.45 34.9 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.66 -30.25 3.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.661 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 88' ' ' LEU . 31.5 m -111.43 147.73 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.48 141.01 46.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.365 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.503 ' HD3' HG12 ' A' ' 66' ' ' VAL . 42.4 mmtm -39.47 138.24 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.8 54.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.949 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.753 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.7 tp -80.03 142.21 35.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.03 0.919 . . . . 0.0 112.233 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.11 -176.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.402 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.85 125.22 5.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.813 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.58 152.11 27.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.918 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.6 mt -119.63 8.46 11.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.864 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.88 142.52 5.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.63 124.46 18.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.421 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -104.14 146.6 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -137.28 94.25 12.42 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.924 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.48 128.22 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 124.396 3.397 . . . . 0.0 113.346 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -126.35 -41.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.2 m-70 -79.85 156.11 27.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.66 130.49 43.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.832 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.71 33.41 42.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.457 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.32 154.6 19.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.15 0.5 . . . . 0.0 111.112 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 88' ' ' LEU . 5.8 tp -110.08 131.8 54.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.71 143.91 16.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.358 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.607 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.63 176.62 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.66 171.58 7.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.879 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -70.39 126.84 30.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.42 -16.53 52.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.291 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.09 165.72 0.29 Allowed 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.68 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -123.92 145.96 48.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.629 0.728 . . . . 0.0 111.324 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.726 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.6 128.69 16.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.162 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.527 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.2 ttt180 -79.95 103.53 9.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.843 HD11 HG21 ' A' ' 66' ' ' VAL . 22.5 mm -58.98 111.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.184 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.717 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.4 mt -79.63 -47.12 15.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.685 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -141.23 137.08 32.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.798 178.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.84 36.1 4.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.09 122.37 38.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.896 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.3 159.4 35.53 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.707 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.6 tt0 -48.33 -21.22 0.49 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.498 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.5 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.0 m95 -112.51 112.4 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.741 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -94.32 139.66 30.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 112.166 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.07 114.96 23.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.03 178.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.51 142.76 49.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.991 0.424 . . . . 0.0 111.808 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.699 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.01 110.7 22.48 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.21 167.58 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.149 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.9 -23.58 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.577 -0.449 . . . . 0.0 112.013 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.88 -40.4 20.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.851 0.834 . . . . 0.0 108.9 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 -35.83 6.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.328 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.08 -0.5 88.57 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.268 -1.787 . . . . 0.0 113.297 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.405 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.91 123.23 8.74 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.22 0.533 . . . . 0.0 110.995 179.077 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.79 144.19 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.628 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.56 177.68 43.88 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.169 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -86.02 152.0 23.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 110.686 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.02 142.96 17.05 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.264 0.554 . . . . 0.0 112.08 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.502 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.9 Cg_endo -52.67 112.32 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.171 2.58 . . . . 0.0 111.369 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.24 -23.52 9.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.819 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.1 p-10 -100.13 31.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.38 -22.78 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.957 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.665 HG11 HD12 ' A' ' 88' ' ' LEU . 18.2 m -115.6 151.24 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.2 140.17 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.388 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.48 140.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.31 51.4 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.993 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 CA--C 1.518 -0.256 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.7 tp -86.37 141.84 28.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.98 0.895 . . . . 0.0 112.042 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.94 -177.67 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.832 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.18 126.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.64 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.61 151.84 36.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -120.04 13.0 12.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.778 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.51 141.74 3.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.715 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.33 124.27 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.448 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.0 t80 -104.12 146.37 28.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.9 94.45 12.84 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.918 178.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.12 125.86 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.299 3.332 . . . . 0.0 113.364 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -40.34 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.0 m80 -79.93 167.64 20.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.46 142.49 44.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.62 41.9 99.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.425 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.31 155.35 20.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.069 0.461 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -110.96 132.27 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.059 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.59 143.02 16.47 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.461 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.608 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.32 176.11 10.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.07 175.14 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.656 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -72.84 131.98 42.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.79 -11.23 48.14 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.488 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.18 165.79 1.28 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.2 mt-30 -123.04 146.54 47.58 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.436 0.636 . . . . 0.0 111.183 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.13 14.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.259 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.93 103.81 10.07 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 66' ' ' VAL . 26.8 mm -59.81 111.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.215 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.56 -47.82 14.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.29 136.47 33.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.841 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.1 pt20 -123.95 36.03 4.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.06 0.457 . . . . 0.0 111.355 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.0 122.36 39.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.907 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.33 159.87 35.52 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.758 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 tt0 -49.77 -20.11 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.383 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.9 m95 -113.62 112.01 22.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -93.51 138.39 31.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 112.307 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.719 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.14 112.96 21.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.158 178.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.39 143.25 47.55 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 120.999 0.428 . . . . 0.0 111.692 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.704 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.52 110.81 22.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.626 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.54 167.96 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.089 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.76 -23.79 3.95 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.994 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.67 -40.98 19.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.974 0.892 . . . . 0.0 108.883 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.77 -35.66 6.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.947 -1.478 . . . . 0.0 109.407 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.01 -0.44 87.3 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.286 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.464 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.89 121.53 6.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.222 0.534 . . . . 0.0 111.061 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.09 143.75 26.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.556 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.16 177.52 43.39 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.79 149.72 24.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.661 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -144.87 143.46 20.96 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.371 0.605 . . . . 0.0 112.137 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.14 111.38 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.257 2.638 . . . . 0.0 111.315 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p30 -99.84 31.7 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.36 14.34 9.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -150.85 150.48 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.38 140.16 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HD3' HG12 ' A' ' 66' ' ' VAL . 44.2 mmtt -39.5 139.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.48 54.19 0.11 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.046 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.915 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.3 tp -83.22 142.0 31.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.913 0.863 . . . . 0.0 111.794 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.822 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.31 -177.43 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.788 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -144.71 125.61 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.759 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -56.56 149.54 17.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 mt -100.37 -24.48 14.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -145.49 -176.87 5.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.899 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.72 125.39 29.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.452 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.3 t80 -104.87 147.0 28.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.249 0.547 . . . . 0.0 112.429 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -136.45 93.83 14.14 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.041 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -39.41 112.93 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.169 3.246 . . . . 0.0 113.251 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -29.6 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -84.7 170.22 13.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.02 141.77 35.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 59.98 41.6 97.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.306 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -109.52 155.65 21.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 88' ' ' LEU . 6.5 tp -110.17 129.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.981 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.23 147.79 18.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.941 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -148.25 177.91 9.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 110.896 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.1 174.71 5.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.848 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -73.37 129.1 37.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.51 -10.54 58.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.393 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.43 165.61 1.47 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.609 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -124.31 147.11 48.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.528 0.68 . . . . 0.0 111.295 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.758 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.02 14.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.065 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.8 ttt180 -79.91 104.03 10.21 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.822 HD11 HG21 ' A' ' 66' ' ' VAL . 22.6 mm -58.54 112.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.317 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 27.6 mt -79.68 -46.62 16.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.573 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.4 134.83 26.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.023 178.158 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -120.56 36.65 4.5 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.222 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.36 122.52 39.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.993 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.15 159.92 36.03 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.851 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.01 -20.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.429 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.1 m95 -113.79 115.39 27.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.45 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -96.4 139.26 32.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.249 0.547 . . . . 0.0 112.358 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.39 113.6 21.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 177.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.09 143.27 48.23 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.893 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -107.27 110.8 22.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.645 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 166.34 0.06 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -124.82 -23.24 4.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.123 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.03 -40.34 20.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.812 0.815 . . . . 0.0 108.915 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.73 -35.93 6.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.472 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.26 -0.32 88.99 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.262 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.02 122.52 7.67 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.282 0.563 . . . . 0.0 111.01 179.067 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.7 146.0 25.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.547 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.05 41.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.3 m-85 -89.85 142.39 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.699 0.285 . . . . 0.0 110.823 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.758 HD13 HD13 ' A' ' 88' ' ' LEU . 7.4 pt -135.67 146.29 56.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 112.1 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.47 118.73 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.257 2.638 . . . . 0.0 111.335 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.24 -19.19 32.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -102.89 34.17 2.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.64 -30.14 3.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.635 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 88' ' ' LEU . 29.0 m -108.09 149.47 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.24 139.09 39.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.29 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.0 mmtt -39.33 139.17 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.93 54.54 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.92 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp -81.61 142.36 32.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.834 0.826 . . . . 0.0 111.617 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.94 -176.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.991 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.87 126.87 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.576 179.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.05 152.16 41.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.111 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.87 13.73 11.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.865 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.53 141.67 3.0 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.735 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.61 124.48 19.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.297 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -103.94 146.78 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.2 mt-10 -137.06 94.15 12.8 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.852 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.61 125.63 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.336 3.358 . . . . 0.0 113.364 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -123.32 -41.53 2.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.684 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.405 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -80.0 159.67 26.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.26 137.05 52.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.31 36.37 78.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -104.74 154.84 19.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.103 0.477 . . . . 0.0 111.124 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 88' ' ' LEU . 6.2 tp -110.59 130.85 55.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.082 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.99 143.9 16.88 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.313 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.593 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -146.99 176.91 9.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -109.36 173.67 6.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -71.89 128.75 36.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.04 -12.92 56.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.42 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.46 165.42 0.8 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.7 mt-30 -123.04 147.38 46.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.532 0.682 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.39 128.02 14.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.147 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 27.9 ttt180 -79.87 103.23 9.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.791 HD11 HG21 ' A' ' 66' ' ' VAL . 28.6 mm -58.5 111.9 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.035 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.5 mt -79.37 -46.69 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.679 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 152.49 40.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.412 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -137.12 36.78 2.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.895 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.61 131.23 34.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.155 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.75 164.78 16.23 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -47.64 -21.0 0.31 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.681 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.3 m95 -110.6 116.95 32.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.507 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.9 m0 -99.26 144.81 27.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.102 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -90.01 115.36 27.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 143.18 49.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.119 0.485 . . . . 0.0 111.636 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.797 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.4 111.12 22.86 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.622 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 167.43 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.45 -23.67 4.06 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.08 -40.56 19.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.918 0.866 . . . . 0.0 108.91 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.24 -35.57 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.41 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.74 -1.6 85.68 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 113.221 -1.809 . . . . 0.0 113.252 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -49.7 122.49 6.48 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.256 0.551 . . . . 0.0 111.13 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.0 145.19 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.544 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.02 177.93 42.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.26 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -86.21 153.8 21.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.663 0.268 . . . . 0.0 110.459 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 88' ' ' LEU . 5.0 pt -149.12 143.78 17.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 112.1 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.9 Cg_endo -52.32 111.74 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.265 2.643 . . . . 0.0 111.286 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.5 -23.08 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -102.5 32.27 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.308 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.97 -15.14 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.124 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG21 HG21 ' A' ' 66' ' ' VAL . 19.8 m -124.86 151.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.47 142.9 41.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.572 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 6.6 mmtp -39.6 138.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 54.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.087 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.871 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.2 tp -81.27 141.54 34.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.854 0.835 . . . . 0.0 111.668 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.837 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.39 -177.4 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.841 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.19 123.55 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.86 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.9 153.3 17.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.804 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.02 8.59 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.47 143.02 5.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.702 -179.113 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.68 123.95 16.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.279 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HH ' ' HD3' ' A' ' 112' ' ' PRO . 12.7 t80 -103.01 146.63 28.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -137.92 94.28 11.51 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.89 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.91 128.72 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.357 3.371 . . . . 0.0 113.356 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -44.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.651 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.6 m-70 -80.01 149.1 30.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.17 130.74 48.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.58 29.3 53.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.855 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 2.9 m-20 -97.3 157.99 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.06 0.457 . . . . 0.0 111.023 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -114.24 129.64 56.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.904 179.564 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.5 142.1 15.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.441 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -147.53 176.82 9.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.962 0.41 . . . . 0.0 110.511 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -107.34 172.51 6.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -72.53 129.57 38.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.69 -12.37 56.76 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.403 -177.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.82 165.77 0.85 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -122.38 146.24 47.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.556 0.693 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.61 128.2 15.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.532 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.9 ttt-85 -79.94 103.86 10.12 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 66' ' ' VAL . 26.9 mm -58.23 112.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.116 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.762 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.7 mt -79.47 -46.84 16.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.777 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.82 136.29 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.634 178.331 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -123.23 35.89 4.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.44 122.44 39.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.869 179.165 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.07 160.3 35.94 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.757 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.5 tt0 -49.84 -19.99 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.476 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 66.8 m95 -114.1 109.68 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.295 . . . . 0.0 110.794 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.3 m0 -91.48 137.41 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.122 0.487 . . . . 0.0 112.059 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.28 115.98 22.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.159 178.122 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.08 144.12 48.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.887 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.762 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.32 110.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.6 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.91 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.162 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.76 -23.89 3.92 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.999 -178.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.99 -40.71 19.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.952 0.882 . . . . 0.0 108.933 178.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -35.6 6.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.549 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.24 -2.03 85.64 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.199 -1.819 . . . . 0.0 113.173 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.702 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.44 123.45 7.62 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.167 0.508 . . . . 0.0 111.104 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.88 147.68 22.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.725 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.46 177.87 41.49 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -86.32 144.56 27.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.651 0.263 . . . . 0.0 110.56 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 88' ' ' LEU . 4.6 pt -139.12 142.72 34.0 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.335 0.588 . . . . 0.0 112.135 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.5 Cg_endo -52.42 113.98 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.212 2.608 . . . . 0.0 111.385 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -22.72 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.022 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' CD1' ' A' ' 113' ' ' PHE . 7.9 p-10 -101.95 32.88 3.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.705 0.288 . . . . 0.0 111.115 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -120.33 -23.91 6.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.004 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.668 HG21 HG21 ' A' ' 66' ' ' VAL . 28.4 m -114.9 147.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -177.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.15 139.7 46.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.57 140.72 0.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.944 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.06 50.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.104 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp -84.19 142.27 30.44 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.025 0.917 . . . . 0.0 112.061 -178.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.17 -177.17 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.576 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.3 124.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.816 179.15 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -55.55 147.95 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.457 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 mt -100.26 -24.96 14.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -143.46 -177.15 5.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 179.47 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.67 124.92 29.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.2 t80 -103.94 146.94 27.95 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -137.63 94.23 11.94 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.6 Cg_exo -37.08 127.28 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.303 3.335 . . . . 0.0 113.354 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -41.54 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.607 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m170 -80.01 156.72 27.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.46 140.75 58.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 38.57 95.51 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.39 156.0 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 111.139 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -111.3 131.41 55.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.23 147.79 18.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.179 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -150.69 179.05 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.009 0.433 . . . . 0.0 110.786 -179.745 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.76 177.92 4.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.762 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -75.38 134.79 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.68 -7.31 41.8 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.473 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -60.2 165.77 3.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.974 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.58 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.71 146.29 48.38 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.511 0.672 . . . . 0.0 111.157 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.5 128.22 15.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.143 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.83 104.28 10.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.802 HD11 HG21 ' A' ' 66' ' ' VAL . 29.6 mm -60.38 112.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.294 -178.062 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.718 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.59 -47.76 14.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.751 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.15 136.27 33.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.793 178.305 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -124.19 36.49 4.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.352 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.79 40.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.996 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.64 159.88 35.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.726 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.1 tt0 -49.19 -20.57 0.62 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.35 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.3 m95 -113.2 114.6 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.9 m0 -96.42 139.44 32.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.58 113.19 21.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.987 177.985 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.76 144.04 47.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.092 0.472 . . . . 0.0 111.697 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.684 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.03 110.65 21.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.632 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.52 167.72 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.067 -179.475 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.4 mp -125.64 -23.32 4.07 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.003 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.82 -40.89 19.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.968 0.89 . . . . 0.0 108.932 178.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.97 -36.04 6.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.342 179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.45 0.68 89.47 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.348 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.451 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.68 122.45 8.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.236 0.541 . . . . 0.0 110.978 179.037 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.85 143.77 26.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.493 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.59 177.02 43.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.272 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.98 143.34 27.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.666 0.269 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.728 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -137.53 145.14 47.9 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.387 0.613 . . . . 0.0 112.125 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.02 116.46 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.21 2.606 . . . . 0.0 111.189 178.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.39 -20.01 10.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -101.98 33.94 2.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 111.154 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.35 -30.43 4.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.618 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 88' ' ' LEU . 29.8 m -109.44 147.32 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.37 139.87 44.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.143 178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.39 140.15 0.48 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.92 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.41 51.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.553 0.216 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 66' ' ' VAL . 19.0 tp -81.95 141.38 33.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.784 0.802 . . . . 0.0 111.249 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -126.57 -178.41 2.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.229 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -142.36 124.55 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.616 179.434 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -60.66 151.07 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.039 -179.003 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.88 13.19 12.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 141.81 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.629 -179.185 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.21 124.48 19.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.452 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.2 t80 -104.1 146.64 28.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -136.77 94.38 13.11 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.963 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.4 132.93 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 124.332 3.355 . . . . 0.0 113.41 -179.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -42.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -79.91 157.55 26.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 179.882 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.43 133.66 49.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 35.32 55.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.373 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.422 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -103.96 155.56 18.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 107' ' ' GLN . 5.7 tp -112.21 132.26 55.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.924 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.14 143.2 16.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.17 176.41 9.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.987 0.422 . . . . 0.0 110.782 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -109.27 173.47 6.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.957 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -72.22 127.71 33.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 -13.58 58.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.309 -177.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.32 165.64 0.72 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.915 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.05 147.63 46.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.405 0.621 . . . . 0.0 111.057 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.97 127.52 13.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.176 -179.88 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.515 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.2 ttt180 -79.86 103.66 9.91 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.659 HD11 HG21 ' A' ' 66' ' ' VAL . 27.1 mm -59.13 111.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.223 -178.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' A' ' 101' ' ' GLN . 19.9 mt -79.5 -47.15 16.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.544 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 155.1 45.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.431 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.478 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -140.63 37.51 1.83 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.811 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 131.48 34.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.216 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.86 167.08 10.47 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.046 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -47.14 -20.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.071 -0.564 . . . . 0.0 111.685 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m95 -108.86 118.45 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 110.911 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.4 m0 -101.82 139.87 36.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.157 0.504 . . . . 0.0 111.944 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -85.51 114.73 22.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.358 178.303 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.29 143.52 49.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.791 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.11 111.12 22.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.627 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.01 167.17 0.06 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.99 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.515 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.15 -23.55 4.18 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.032 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.21 -41.4 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.883 0.849 . . . . 0.0 108.894 178.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.91 -35.51 6.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.456 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.15 -0.76 86.99 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.221 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.47 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.6 121.91 6.46 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.32 0.581 . . . . 0.0 111.053 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -88.7 145.75 25.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.549 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.15 177.89 41.99 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.309 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.47 151.9 23.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.647 0.26 . . . . 0.0 110.449 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 88' ' ' LEU . 7.6 pt -147.88 143.01 17.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 112.191 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.3 Cg_endo -52.01 110.16 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.098 2.532 . . . . 0.0 111.161 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.08 -25.77 2.28 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 7.2 p30 -96.99 29.16 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.722 0.296 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.12 18.96 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.984 -179.289 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.3 m -154.1 150.65 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.4 139.03 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.615 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HD3' HG12 ' A' ' 66' ' ' VAL . 35.3 mmtm -39.49 138.84 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 112.008 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.47 54.31 0.11 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.027 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.924 179.984 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 CA--C 1.518 -0.281 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.7 tp -80.51 141.68 34.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.936 0.874 . . . . 0.0 111.958 -178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.83 -177.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.657 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.95 125.76 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.78 179.157 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.47 151.78 40.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.03 14.78 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.712 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -169.32 142.28 2.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 -179.227 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.02 124.73 20.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.6 t80 -104.75 146.47 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.98 94.6 12.58 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.054 178.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.09 128.71 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.43 3.42 . . . . 0.0 113.379 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -126.75 -42.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 5.3 m170 -79.97 158.42 26.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.707 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.38 142.32 57.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.33 42.22 99.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -110.57 155.38 22.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.127 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.4 tp -111.0 133.0 53.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.054 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -98.54 143.94 16.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.453 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.93 175.97 10.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.407 . . . . 0.0 110.822 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -109.02 175.93 5.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.699 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -72.86 132.22 43.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.76 -10.06 48.25 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.67 -177.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.8 165.83 1.61 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.899 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.621 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.24 146.0 48.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.545 0.688 . . . . 0.0 111.148 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.696 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.24 128.3 15.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.7 ttt180 -79.93 103.51 9.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -59.81 111.31 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.061 -178.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.8 mt -79.62 -48.16 14.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.722 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 136.85 35.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.803 178.276 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.564 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.4 35.89 4.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 111.334 -178.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.62 122.53 39.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.823 179.192 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.02 159.25 35.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.671 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.3 -20.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.442 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.7 m95 -113.19 110.63 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.8 m0 -92.48 138.36 31.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.235 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -84.73 113.37 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.138 178.147 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.62 143.05 47.89 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.054 0.454 . . . . 0.0 111.659 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.719 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.48 110.52 22.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 168.0 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.185 -179.54 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.89 -23.62 3.93 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.055 -179.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.71 -41.01 19.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.968 0.89 . . . . 0.0 108.876 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.67 -35.97 6.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.314 179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.26 0.62 89.25 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.362 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.56 121.98 7.29 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.991 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.36 143.4 27.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.561 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 177.16 43.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.239 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -85.2 153.93 22.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.604 0.24 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.696 HD13 HD13 ' A' ' 88' ' ' LEU . 6.6 pt -149.62 143.29 16.64 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.372 0.606 . . . . 0.0 112.125 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.523 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.7 Cg_endo -51.08 110.16 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 111.191 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.28 -26.29 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -99.08 30.81 3.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 111.232 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.5 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -122.58 17.67 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.953 -179.581 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -154.16 150.67 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.48 139.56 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.51 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.584 ' HD3' HG12 ' A' ' 66' ' ' VAL . 38.9 mmtm -39.56 139.33 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.42 54.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.5 tp -81.82 142.03 32.93 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.901 0.857 . . . . 0.0 111.766 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.61 -177.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.033 -1.439 . . . . 0.0 111.949 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.83 123.98 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.748 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.92 153.74 16.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.914 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.91 6.92 10.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.885 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.16 143.29 6.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 -179.163 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.22 124.27 17.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.9 t80 -104.96 146.39 29.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.5 mt-10 -138.05 94.69 11.08 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.811 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.66 129.87 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.316 3.344 . . . . 0.0 113.365 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.9 t -128.3 -42.02 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.7 m-70 -79.99 158.67 26.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.8 139.2 57.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.37 40.6 96.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.67 155.43 20.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.027 0.442 . . . . 0.0 111.11 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.2 tp -111.29 133.29 53.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.042 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.6 145.79 17.97 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.441 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -150.55 177.71 9.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.47 175.58 5.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.708 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -73.89 131.68 41.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.09 -10.8 51.88 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.355 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.5 165.59 1.52 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -122.55 146.55 47.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.6 0.714 . . . . 0.0 111.197 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.753 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.55 127.81 14.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.504 ' N ' HD11 ' A' ' 103' ' ' LEU . 37.2 ttt180 -79.95 103.2 9.68 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.829 HD11 HG21 ' A' ' 66' ' ' VAL . 28.5 mm -59.69 111.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.264 -178.05 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.3 mt -79.63 -47.04 16.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.47 178.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.46 155.63 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.309 178.127 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -141.47 37.39 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.09 131.96 34.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.301 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.44 166.5 15.57 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.992 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.4 tt0 -47.76 -20.75 0.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.499 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.7 m95 -110.22 118.21 35.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.477 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.3 m0 -100.63 143.63 30.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.121 0.486 . . . . 0.0 112.033 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.26 114.85 25.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.482 178.464 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.555 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.61 143.8 49.11 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.962 0.41 . . . . 0.0 111.697 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.738 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.5 tt0 -109.09 110.99 22.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.19 -179.453 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.27 -23.25 4.2 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.663 -0.415 . . . . 0.0 112.025 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.18 -41.7 18.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.976 0.893 . . . . 0.0 108.943 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.13 -36.04 6.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.334 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 0.06 88.72 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 113.176 -1.829 . . . . 0.0 113.423 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.471 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.16 122.57 7.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.276 0.56 . . . . 0.0 111.08 179.071 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.78 146.01 25.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.616 -178.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.99 177.77 41.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.54 155.53 21.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.658 HD13 HD13 ' A' ' 88' ' ' LEU . 5.5 pt -150.03 144.36 17.54 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.344 0.592 . . . . 0.0 112.205 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.499 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.9 Cg_endo -53.45 112.17 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.209 2.606 . . . . 0.0 111.251 178.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -54.74 -21.11 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.91 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 6.2 p-10 -101.6 30.72 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.25 -26.33 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 88' ' ' LEU . 17.2 m -113.22 149.6 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.55 140.67 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.23 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 140.47 0.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.908 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.26 50.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.754 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.6 tp . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.937 0.875 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.86 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.78 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.24 126.7 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.668 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.99 151.73 42.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.992 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.9 13.33 12.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.862 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.585 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.93 141.1 2.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.661 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.65 124.08 17.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.308 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.0 t80 -103.27 145.46 29.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -135.73 94.3 15.03 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.91 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.21 126.22 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.327 3.351 . . . . 0.0 113.327 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -124.01 -41.83 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.631 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -79.98 159.09 26.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.704 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 141.67 56.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.923 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 39.11 97.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.613 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.12 155.49 19.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.059 0.456 . . . . 0.0 111.141 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD21 HD22 ' A' ' 88' ' ' LEU . 3.5 tp -111.15 129.91 55.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.53 142.19 15.92 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.57 176.2 9.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.993 0.425 . . . . 0.0 110.711 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.73 171.59 7.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -70.98 128.58 36.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.29 -13.4 55.2 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.427 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.87 165.61 0.61 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.5 mt-30 -123.21 146.48 47.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.67 0.748 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.711 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.44 128.55 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.177 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.533 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -79.89 103.59 9.88 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 66' ' ' VAL . 26.2 mm -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.17 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.733 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.2 mt -79.53 -47.76 15.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.722 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.5 135.48 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.807 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.562 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.8 pt20 -121.94 35.92 4.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.369 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.65 122.23 38.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.92 158.54 34.61 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.691 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.3 tt0 -48.55 -21.51 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.457 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.488 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.1 m95 -112.46 109.69 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.717 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.562 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -91.38 139.34 30.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.199 0.524 . . . . 0.0 112.184 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.72 114.35 22.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.239 177.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.85 144.68 47.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 0.0 111.785 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.733 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.87 110.7 21.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.35 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.186 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.88 -23.66 3.93 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.007 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -40.21 20.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.959 0.885 . . . . 0.0 108.914 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -35.78 6.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.411 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.83 -0.18 88.65 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 113.285 -1.78 . . . . 0.0 113.384 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.49 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.12 122.8 8.17 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.236 0.541 . . . . 0.0 111.003 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.95 144.2 26.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.47 177.59 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.199 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.18 152.38 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.661 0.267 . . . . 0.0 110.55 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.711 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.14 143.49 17.65 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 112.086 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.4 Cg_endo -52.64 108.34 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.152 2.568 . . . . 0.0 111.281 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -50.64 -24.9 3.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.4 p30 -98.97 30.36 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -118.0 -24.41 7.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.01 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.683 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -115.46 150.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 142.58 44.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.487 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.6 mmtt -39.67 139.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.35 54.44 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.003 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.6 tp . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.86 0.838 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.28 -176.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.856 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.97 126.66 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.62 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.67 152.23 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.01 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.48 14.2 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.884 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.578 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 140.76 2.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.672 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.87 124.13 17.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.244 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.551 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 13.1 t80 -103.78 146.19 28.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -137.15 94.31 12.55 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.914 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.65 120.45 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.259 3.306 . . . . 0.0 113.426 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -118.79 -36.79 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.7 m80 -81.35 172.68 13.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.624 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -80.07 142.82 34.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.28 38.08 94.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.438 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.73 155.55 18.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 111.211 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.829 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -111.42 128.58 56.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.082 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.08 144.71 17.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.354 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.82 176.22 10.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.989 0.423 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -107.15 173.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.729 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -72.58 129.08 37.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.86 -11.0 58.59 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.512 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.47 165.56 1.08 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.557 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -122.77 146.6 47.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.552 0.691 . . . . 0.0 111.212 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.829 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.99 128.07 14.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.204 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.0 ttt180 -79.85 103.52 9.8 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 66' ' ' VAL . 29.1 mm -57.77 112.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.223 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.1 mt -79.41 -46.87 16.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.704 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.32 135.69 27.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.626 178.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.3 pt20 -122.26 35.69 4.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.076 0.465 . . . . 0.0 111.239 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 122.66 38.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.876 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.19 158.65 34.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.613 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.8 tt0 -49.38 -20.84 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.435 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.17 107.78 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.9 m0 -89.34 140.41 29.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 112.201 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.82 115.73 24.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.191 178.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 144.14 48.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.937 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.793 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.6 110.93 22.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.592 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.98 167.81 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.123 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.54 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.79 -24.04 3.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.914 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -83.15 -40.47 19.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.913 0.863 . . . . 0.0 108.942 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.84 -35.47 6.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.502 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.77 -2.89 85.29 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.035 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.9 mp0 -48.8 124.75 8.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.98 151.05 20.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.716 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 167.61 176.91 38.68 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.61 142.69 28.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.69 0.281 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -136.76 144.57 47.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.62 . . . . 0.0 112.176 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 9.0 Cg_endo -53.62 109.77 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.195 2.597 . . . . 0.0 111.29 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.54 -23.85 7.09 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.814 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.1 p-10 -99.12 30.87 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.99 -22.73 6.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.043 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 88' ' ' LEU . 16.5 m -117.23 150.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.43 142.36 43.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.39 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 66' ' ' VAL . 7.2 mmtp -39.59 139.09 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.01 53.98 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.075 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.8 tp . . . . . 0 N--CA 1.445 -0.697 0 CA-C-O 121.982 0.896 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -125.48 -177.28 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 113.826 -1.533 . . . . 0.0 111.779 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.28 126.1 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.636 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.84 151.93 41.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.091 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.17 14.38 12.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.94 141.12 2.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.14 124.6 19.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.325 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.6 t80 -103.92 146.09 29.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.89 94.44 12.86 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.963 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -36.34 132.43 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.336 3.358 . . . . 0.0 113.381 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 t -130.53 -43.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.741 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.438 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.8 m80 -79.96 149.09 30.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 129.76 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.044 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.82 28.78 49.75 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.624 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 3.2 m-20 -96.98 158.47 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.2 132.73 56.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.831 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.33 141.87 15.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.626 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -144.8 176.8 9.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.471 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.09 170.5 8.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.055 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -69.71 126.63 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.72 -15.65 50.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.323 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.17 166.21 0.26 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -123.34 145.81 48.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.5 0.667 . . . . 0.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.26 127.69 15.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.258 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.6 ttt180 -79.74 103.41 9.62 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.779 HD11 HG21 ' A' ' 66' ' ' VAL . 23.0 mm -58.25 111.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.119 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.837 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.34 -46.68 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.554 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.24 154.89 44.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -140.25 36.7 1.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 0.0 111.863 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.33 131.28 34.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.93 166.81 18.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.027 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.04 -20.36 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.662 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 71.2 m95 -110.18 116.85 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.0 m0 -99.74 140.5 33.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.084 0.469 . . . . 0.0 111.994 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.81 116.76 25.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.54 178.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -123.2 144.6 49.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.031 0.443 . . . . 0.0 111.722 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.837 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.65 111.24 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.615 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.52 167.09 0.07 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.871 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -124.62 -23.41 4.39 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.426 -0.51 . . . . 0.0 112.105 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.84 -41.15 17.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 0.0 108.989 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.12 -35.57 6.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.427 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.63 -1.74 84.98 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.239 -1.801 . . . . 0.0 113.218 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.37 123.37 7.41 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.177 0.513 . . . . 0.0 111.15 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.79 149.5 21.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.607 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 168.46 177.02 39.22 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.313 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.35 143.42 28.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.658 0.266 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -137.84 142.14 35.25 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 0.0 112.126 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.512 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.9 Cg_endo -51.26 112.06 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.264 2.643 . . . . 0.0 111.242 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -49.84 -24.87 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.3 p-10 -100.52 31.42 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.39 17.07 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.946 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.8 m -154.23 150.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.23 140.75 37.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.548 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.53 138.91 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.25 54.38 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.89 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.2 tp . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.951 0.881 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.838 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -124.04 -176.64 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.894 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.48 128.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.749 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -65.62 150.55 48.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.641 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.98 -6.22 15.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.482 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -153.52 172.89 16.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.676 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.05 123.99 27.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.513 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.58 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 20.4 t80 -101.51 145.96 28.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.289 0.566 . . . . 0.0 112.331 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.24 15.15 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.038 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.22 129.36 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.368 3.379 . . . . 0.0 113.293 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -125.76 -40.7 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.791 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.3 m-70 -79.94 174.99 11.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.695 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.21 144.9 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.97 37.29 84.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.634 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -98.47 156.2 16.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.168 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.3 tp -115.2 125.23 53.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.54 141.35 15.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.108 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.62 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -141.19 175.62 9.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -107.05 172.7 6.68 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.813 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.18 127.92 34.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.63 59.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.355 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.74 165.59 1.15 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.0 mt-30 -123.9 146.71 48.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.521 0.677 . . . . 0.0 111.202 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.73 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.12 128.47 15.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -80.03 103.31 9.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 66' ' ' VAL . 27.5 mm -59.36 111.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.216 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.741 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.5 mt -79.55 -47.25 15.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.813 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.43 136.37 29.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.739 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.563 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -124.19 35.92 4.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.473 . . . . 0.0 111.32 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 122.41 38.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.959 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.58 160.91 36.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.798 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.0 tt0 -48.79 -20.96 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.501 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.25 117.19 31.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.563 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.7 m0 -98.82 137.57 37.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.13 0.49 . . . . 0.0 112.169 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.92 112.68 20.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.061 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -118.96 143.28 47.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.93 110.53 21.87 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.08 167.17 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.104 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.45 -23.7 4.06 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.099 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.73 -40.49 20.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.909 0.861 . . . . 0.0 108.936 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.37 -35.57 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.408 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.46 -0.0 88.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.299 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.548 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.24 121.63 6.51 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.261 0.553 . . . . 0.0 111.058 179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.93 142.55 27.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.601 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 177.09 -179.94 47.75 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.249 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.34 139.8 30.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.695 0.284 . . . . 0.0 110.97 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.722 HD13 HD13 ' A' ' 88' ' ' LEU . 6.0 pt -134.26 144.18 50.16 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.421 0.629 . . . . 0.0 111.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.4 Cg_endo -53.11 119.18 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.218 2.612 . . . . 0.0 111.265 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.69 -20.97 16.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -105.18 35.4 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.244 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.541 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -120.96 -17.49 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 88' ' ' LEU . 14.8 m -126.88 152.33 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.62 143.27 43.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.388 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.59 139.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.19 54.51 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.046 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.864 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.4 tp . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 121.877 0.846 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -126.72 -176.89 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.894 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.63 125.94 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.629 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.67 146.85 29.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.466 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 mt -97.98 -24.54 15.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.418 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -145.87 -177.37 5.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.965 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.31 125.22 29.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.214 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -103.64 145.39 30.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.34 94.13 15.9 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.046 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.14 133.58 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.304 3.336 . . . . 0.0 113.432 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.46 -43.57 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.41 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 8.3 m80 -80.0 150.57 30.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.722 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -62.31 136.16 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.96 61.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.6 m-20 -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 0.0 111.024 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.761 HD21 HD22 ' A' ' 88' ' ' LEU . 1.1 tp -116.34 123.99 48.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.899 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -90.3 143.12 16.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.137 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p90 -143.93 178.19 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -108.3 172.98 6.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.89 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -72.71 128.77 36.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 -10.73 59.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.286 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.33 165.5 1.44 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.545 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.69 147.33 47.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.465 0.65 . . . . 0.0 111.111 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.772 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.48 127.67 14.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.951 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.542 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.7 ttt180 -79.84 101.37 8.48 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.418 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 66' ' ' VAL . 37.0 mm -55.4 112.11 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.079 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.838 HD21 ' CB ' ' A' ' 101' ' ' GLN . 25.2 mt -79.4 -46.5 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.578 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -145.71 148.36 32.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.344 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -132.1 37.14 3.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.23 131.78 34.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.91 164.57 20.75 Favored Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.979 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -48.43 -20.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.59 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.0 m95 -111.1 119.47 39.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.523 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.0 m0 -101.53 142.26 33.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.109 0.481 . . . . 0.0 112.21 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.99 114.74 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.2 178.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.62 143.31 48.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 111.814 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.838 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.37 110.83 22.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.621 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.51 166.66 0.05 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.101 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.04 -23.95 4.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.055 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.95 -39.98 20.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.841 . . . . 0.0 109.046 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.4 -35.47 6.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.554 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.56 -1.23 88.27 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.154 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.682 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.28 123.16 7.96 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 146.65 23.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.734 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.09 179.44 43.77 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.111 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -90.39 139.83 30.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.789 0.328 . . . . 0.0 110.737 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.737 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -133.69 144.48 52.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.517 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.5 116.77 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.263 2.642 . . . . 0.0 111.182 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.488 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.31 -19.9 16.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 5.9 p-10 -101.99 33.75 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.069 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.82 -30.33 4.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.651 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 88' ' ' LEU . 27.4 m -111.13 148.61 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.69 142.21 45.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.408 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.9 mmtp -39.36 137.98 0.71 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.08 54.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.061 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.768 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.2 tp . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.988 0.899 . . . . 0.0 112.109 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.82 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.08 -176.64 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.594 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.69 125.13 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.733 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.51 150.94 29.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.928 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.81 10.68 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -167.43 142.85 4.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.653 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.5 124.82 20.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.384 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -104.62 146.8 28.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.419 0.628 . . . . 0.0 112.658 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -138.11 94.53 11.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.954 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.83 127.56 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.304 3.336 . . . . 0.0 113.33 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.37 -40.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m80 -79.85 170.83 15.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.768 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.99 137.2 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.76 38.57 94.57 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.607 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -104.17 154.45 19.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 88' ' ' LEU . 4.9 tp -110.48 133.01 53.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.089 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.1 143.74 16.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.402 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.606 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.78 176.7 9.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.79 172.96 6.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.863 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.93 128.84 37.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.85 -15.02 50.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.327 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.16 165.75 0.47 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -123.58 145.98 48.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.58 0.705 . . . . 0.0 111.29 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.31 128.36 15.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.149 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.0 ttt180 -79.84 103.77 9.97 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.82 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -58.92 111.47 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.148 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 101' ' ' GLN . 24.5 mt -79.56 -47.4 15.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.821 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.73 137.79 33.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.861 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -125.29 35.71 4.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.61 122.55 38.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.936 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.84 159.09 35.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.724 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.483 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.4 tt0 -48.49 -20.92 0.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.42 -0.39 . . . . 0.0 111.476 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.6 m95 -112.59 111.98 23.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.679 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -93.97 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.75 114.85 24.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.194 178.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.43 143.04 48.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.048 0.451 . . . . 0.0 111.774 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -107.93 110.88 22.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.42 167.64 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.95 -24.06 3.84 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.968 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.44 -40.64 20.9 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.906 0.86 . . . . 0.0 108.919 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.22 -35.3 6.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.29 -1.23 86.0 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.53 121.86 6.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 0.0 111.082 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.47 145.13 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.619 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.66 176.63 42.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.402 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -84.78 151.78 24.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.609 0.242 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.684 HD13 HD13 ' A' ' 88' ' ' LEU . 5.7 pt -148.08 143.11 17.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.292 0.568 . . . . 0.0 112.148 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.7 Cg_endo -51.8 112.59 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.235 2.623 . . . . 0.0 111.339 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.47 -23.7 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 14.1 p30 -101.83 32.45 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.74 -17.06 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -121.61 150.42 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.24 140.77 41.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.477 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.5 mmtp -39.46 139.48 0.56 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.84 53.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.966 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.5 tp . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.904 0.859 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.23 -176.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.884 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.7 124.92 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.61 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -59.84 152.96 21.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.03 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -121.4 8.9 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.916 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.596 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -166.32 143.36 5.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.24 123.74 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.332 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.575 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -103.03 146.94 27.59 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -138.2 94.53 10.99 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.847 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.4 Cg_exo -36.27 131.69 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.45 3.434 . . . . 0.0 113.299 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -130.1 -43.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.439 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 13.1 m-70 -79.96 157.31 26.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.33 128.45 36.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.64 47.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.657 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.3 m-20 -96.27 156.9 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.109 0.48 . . . . 0.0 110.991 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.735 HD21 HD22 ' A' ' 88' ' ' LEU . 1.4 tp -114.69 130.13 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.38 141.67 15.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.391 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -146.57 176.89 9.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -108.83 172.03 7.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.003 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -71.56 127.23 31.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.5 -15.32 55.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.286 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.41 165.53 0.36 Allowed 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.556 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.7 mt-30 -122.68 146.7 47.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.567 0.699 . . . . 0.0 111.216 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.746 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.77 127.97 14.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.8 ttt180 -79.93 103.07 9.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 66' ' ' VAL . 25.0 mm -58.67 113.48 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.141 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.736 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 39.2 mt -79.51 -46.37 17.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.748 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -145.2 134.56 23.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.911 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.9 OUTLIER -119.77 36.05 4.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.77 122.24 37.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.925 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.39 159.53 35.61 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.696 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.85 -20.81 0.54 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 68.4 m95 -113.03 110.95 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.561 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -92.66 136.86 32.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.736 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 114.84 21.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.239 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.87 143.74 47.76 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.073 0.463 . . . . 0.0 111.745 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.658 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.96 110.58 21.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.41 168.4 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.223 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -126.12 -23.55 3.88 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.015 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.86 -40.4 20.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.868 0.842 . . . . 0.0 108.923 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -35.8 6.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.471 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.1 -0.62 88.48 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.271 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.45 123.17 8.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.231 0.539 . . . . 0.0 111.097 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -90.01 144.54 25.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.562 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.52 178.64 44.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.372 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -87.52 146.53 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.618 0.247 . . . . 0.0 110.643 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -142.25 142.07 23.05 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.0 112.125 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.548 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.1 Cg_endo -51.94 112.24 0.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.193 2.595 . . . . 0.0 111.385 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.64 -23.76 7.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p-10 -100.57 31.6 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.09 -25.63 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 88' ' ' LEU . 17.1 m -114.32 149.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 141.81 44.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.478 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.495 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.4 mmtt -39.58 138.94 0.64 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.61 54.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.083 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.975 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 22.9 tp . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.745 0.783 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.24 -177.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.105 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.51 126.03 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.608 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.82 152.03 37.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.132 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.05 12.69 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.26 142.73 3.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.585 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 124.19 18.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.389 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.4 t80 -104.07 146.18 29.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.69 94.38 13.26 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.927 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.5 Cg_exo -37.04 122.14 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.313 3.342 . . . . 0.0 113.336 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -41.16 2.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.508 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m-70 -80.51 159.05 25.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.21 143.48 56.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.17 41.65 99.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.593 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.59 155.61 21.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.162 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.506 HD21 HD22 ' A' ' 88' ' ' LEU . 6.6 tp -111.41 131.56 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.75 144.59 17.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.401 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.75 176.66 9.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -109.42 172.35 6.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.802 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -71.31 127.33 32.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.3 -14.34 57.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.347 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.9 165.61 0.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -123.2 147.49 46.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.668 . . . . 0.0 111.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -147.31 127.96 14.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.102 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.522 ' N ' HD11 ' A' ' 103' ' ' LEU . 33.1 ttt180 -79.82 103.46 9.74 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 66' ' ' VAL . 28.1 mm -59.07 111.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.202 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.6 mt -79.34 -47.02 16.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.505 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.97 154.24 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.336 178.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -139.47 36.71 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.842 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.56 131.26 34.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.235 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.75 15.93 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.108 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -47.46 -21.19 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.084 -0.558 . . . . 0.0 111.625 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m95 -109.99 118.1 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.7 m0 -100.4 143.18 30.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 112.021 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.725 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.22 114.71 25.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.468 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.9 142.98 49.18 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.051 0.453 . . . . 0.0 111.77 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.779 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.23 111.08 22.87 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.624 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.57 167.43 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.114 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.43 -23.52 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.056 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -41.06 19.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.919 0.866 . . . . 0.0 108.881 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.13 -35.66 6.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.419 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.98 -1.45 86.62 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.329 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.459 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.2 mp0 -49.77 122.06 6.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.289 0.566 . . . . 0.0 111.07 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.44 145.03 26.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.665 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.62 42.24 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.36 155.39 20.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.614 0.245 . . . . 0.0 110.442 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 4.5 pt -150.11 144.25 17.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.609 . . . . 0.0 112.157 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.493 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.5 Cg_endo -52.88 111.15 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.226 2.617 . . . . 0.0 111.25 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.03 -22.97 6.55 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.6 p-10 -101.04 30.97 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.454 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.37 -19.75 8.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.985 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.641 HG11 HD12 ' A' ' 88' ' ' LEU . 16.2 m -119.7 150.63 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.81 141.34 42.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.325 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.65 140.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.8 50.89 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.897 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.063 0.935 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.7 -176.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.546 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 126.46 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.687 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.66 147.97 25.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.401 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 mt -100.43 -23.07 14.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -145.54 -176.72 5.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.888 0.375 . . . . 0.0 110.776 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.25 125.26 30.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.9 t80 -104.66 146.57 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 mt-10 -136.41 94.13 13.97 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.024 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.72 120.02 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.327 3.352 . . . . 0.0 113.366 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -117.07 -34.75 4.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.539 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 5.6 m80 -84.12 169.72 14.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.798 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -79.0 143.43 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.91 35.95 92.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.354 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -104.29 155.75 18.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 111.202 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 88' ' ' LEU . 1.9 tp -111.85 127.45 55.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.136 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.77 144.2 16.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.03 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.543 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.9 OUTLIER -145.21 179.21 7.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.924 0.392 . . . . 0.0 110.949 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.89 175.41 5.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.956 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 131.22 41.28 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.34 -9.1 56.39 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.331 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.63 165.6 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.6 mt-30 -124.58 146.07 49.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 111.258 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.804 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.15 128.04 15.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.272 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.1 ttt180 -79.67 104.27 10.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.827 HD11 HG21 ' A' ' 66' ' ' VAL . 25.3 mm -59.57 112.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.388 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.808 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.8 mt -79.44 -47.43 15.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.475 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 154.27 43.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.413 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -138.61 38.02 2.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 111.888 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 131.27 34.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.283 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.8 166.42 9.7 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.12 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -46.77 -21.55 0.21 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.52 . . . . 0.0 111.655 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 80.3 m95 -108.52 121.01 44.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.506 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.97 143.14 33.27 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.39 113.94 24.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.228 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.64 47.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.136 0.493 . . . . 0.0 111.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.808 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.84 110.88 22.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.618 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.86 167.75 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.043 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.63 -23.49 4.04 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.073 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -83.12 -39.91 20.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.863 0.84 . . . . 0.0 109.015 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.21 -35.8 5.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.428 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.76 -0.34 88.37 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.286 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.595 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.03 122.62 7.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.225 0.536 . . . . 0.0 111.098 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.81 146.03 25.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.51 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.0 177.33 42.2 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.69 140.38 29.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.659 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 88' ' ' LEU . 8.6 pt -134.78 145.34 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 112.161 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.9 Cg_endo -56.06 114.04 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.164 2.576 . . . . 0.0 111.156 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -21.64 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.426 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.5 p30 -98.81 31.63 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.851 0.357 . . . . 0.0 111.041 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -120.99 -27.13 5.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.632 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 88' ' ' LEU . 23.0 m -112.9 148.74 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.3 141.35 41.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.374 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' HG12 ' A' ' 66' ' ' VAL . 13.7 mmtp -39.4 138.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.56 54.41 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.029 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.923 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.9 tp . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 121.985 0.898 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.858 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.19 -177.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.672 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.09 125.33 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.753 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.12 147.24 25.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.508 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.14 -24.4 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.419 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -146.39 -177.17 5.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.991 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 125.47 29.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.305 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -104.05 145.72 29.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.43 94.1 15.78 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.996 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.92 124.46 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.387 3.392 . . . . 0.0 113.365 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -40.44 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -83.74 157.19 22.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.87 147.3 53.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.09 33.87 85.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.599 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -101.55 156.86 17.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.178 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.703 HD21 HD22 ' A' ' 88' ' ' LEU . 1.3 tp -114.36 125.04 53.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.095 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.92 142.64 16.14 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.176 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.1 p90 -143.06 178.35 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.922 0.391 . . . . 0.0 110.939 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -108.32 174.89 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.838 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.27 130.04 38.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.25 -8.76 60.06 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.382 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.75 165.4 2.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.612 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -124.31 146.12 49.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.651 0.738 . . . . 0.0 111.142 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.78 128.23 15.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 103' ' ' LEU . 29.7 ttt180 -79.99 104.21 10.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.858 HD11 HG21 ' A' ' 66' ' ' VAL . 24.9 mm -59.5 112.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.34 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 101' ' ' GLN . 21.9 mt -79.54 -46.94 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.388 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.85 155.02 43.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.347 178.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.51 HE21 HG21 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -139.74 37.56 2.0 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.836 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.08 131.01 34.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.358 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.84 167.14 14.47 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.086 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.5 tt0 -47.29 -21.29 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.605 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.7 m95 -109.25 121.67 45.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.4 m0 -104.29 142.65 34.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.043 0.449 . . . . 0.0 112.144 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.8 113.97 23.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.334 178.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.28 47.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 111.817 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.8 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.88 111.02 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.614 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.69 167.7 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.064 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.42 -23.61 4.08 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.084 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.99 -40.87 19.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.943 0.878 . . . . 0.0 109.013 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.12 -36.07 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.43 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.14 -0.27 88.91 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.288 -1.778 . . . . 0.0 113.257 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.681 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.98 123.3 8.96 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.229 0.538 . . . . 0.0 111.018 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 145.95 24.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.582 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.15 178.62 43.27 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -90.3 140.81 29.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 110.622 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 88' ' ' LEU . 7.7 pt -134.74 145.31 54.29 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.347 0.594 . . . . 0.0 112.152 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 11.0 Cg_endo -55.89 115.36 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.238 2.626 . . . . 0.0 111.157 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.83 -19.72 12.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 13.9 p30 -101.22 32.5 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.516 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.18 -30.45 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.536 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 88' ' ' LEU . 31.1 m -109.67 149.27 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.13 139.88 41.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.364 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.58 ' HD3' HG12 ' A' ' 66' ' ' VAL . 41.7 mmtm -39.38 138.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.32 54.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.3 tp . . . . . 0 N--CA 1.447 -0.622 0 CA-C-O 121.937 0.875 . . . . 0.0 112.017 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.774 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.58 -177.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.746 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.55 126.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.601 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.07 151.53 39.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.212 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.08 13.67 12.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.757 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.87 141.35 2.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.736 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.35 124.27 18.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.408 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.8 t80 -103.73 146.26 28.87 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.3 94.32 14.0 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.01 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.77 123.93 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.382 3.388 . . . . 0.0 113.292 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -122.34 -39.35 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.804 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.9 m80 -79.93 174.39 11.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.89 141.99 35.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.22 40.24 97.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -105.15 154.53 20.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.147 0.499 . . . . 0.0 111.189 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.509 HD21 HD22 ' A' ' 88' ' ' LEU . 5.7 tp -110.64 131.75 54.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.907 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.59 16.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.369 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.622 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.3 175.97 9.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.802 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.1 173.22 6.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -71.65 128.45 35.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.95 -13.92 54.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.407 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.02 165.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.595 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.52 146.52 48.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.59 128.43 15.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.25 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.92 103.62 9.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 66' ' ' VAL . 25.9 mm -59.57 111.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.232 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.724 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.8 mt -79.65 -47.93 14.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.786 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.74 136.99 34.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.849 178.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.0 pt20 -124.84 35.88 4.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.107 0.479 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.4 122.44 39.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.92 159.69 35.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.672 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.29 -21.29 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.351 -0.425 . . . . 0.0 111.538 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.1 m95 -111.75 113.3 25.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -95.59 136.46 35.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.069 0.461 . . . . 0.0 112.156 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.724 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 113.24 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.104 177.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.29 142.99 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 111.675 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.71 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.36 110.7 22.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.628 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 167.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.165 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.82 -23.71 3.94 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.968 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -82.7 -40.69 20.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.868 0.842 . . . . 0.0 108.859 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 -35.74 6.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.395 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 -0.85 87.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.293 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.21 121.94 6.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.82 143.35 26.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.579 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.99 177.51 44.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.341 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.64 149.18 25.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.68 0.276 . . . . 0.0 110.614 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.736 HD13 HD13 ' A' ' 88' ' ' LEU . 7.1 pt -145.31 143.15 19.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.355 0.598 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.8 Cg_endo -51.68 109.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.45 -26.12 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -98.69 30.37 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 0.0 111.205 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.493 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.79 10.93 10.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.987 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.9 m -147.53 151.01 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.86 140.49 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.592 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.516 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.8 mmtp -39.47 139.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 53.95 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.077 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.923 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.848 0.832 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -127.08 -176.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.968 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.24 124.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.01 152.05 20.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.786 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.22 7.48 10.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.983 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.14 143.88 6.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.14 124.13 17.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.318 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.56 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.96 146.96 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -138.59 94.51 10.46 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.886 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.95 131.38 0.33 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.359 3.372 . . . . 0.0 113.44 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -130.01 -43.48 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.711 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.5 m-70 -79.84 156.38 27.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.35 130.59 43.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.017 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.81 55.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.65 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.4 m-20 -97.1 157.23 16.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 110.973 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -114.19 131.15 56.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.967 179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.31 142.31 16.01 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.489 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -148.13 177.13 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -108.12 176.48 5.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.702 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -74.24 134.36 42.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.39 -8.78 38.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.566 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.7 165.65 2.18 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.07 146.76 46.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.676 . . . . 0.0 111.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.792 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.95 127.44 14.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.931 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.4 ttt180 -79.63 101.43 8.34 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.796 HD11 HG21 ' A' ' 66' ' ' VAL . 36.8 mm -55.43 111.76 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.038 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 33.8 mt -79.45 -46.0 18.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.675 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.79 135.95 26.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.735 178.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -122.31 35.96 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.073 0.463 . . . . 0.0 111.437 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.35 122.49 39.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.834 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.17 159.51 35.32 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.756 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -49.73 -20.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.312 -0.444 . . . . 0.0 111.476 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 65.2 m95 -113.95 108.3 16.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.676 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -90.3 138.27 31.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.083 0.468 . . . . 0.0 112.08 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.735 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.55 116.6 23.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.09 178.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.64 142.65 49.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.794 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.722 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.17 110.76 22.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.602 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.7 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 -179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.56 -23.9 3.98 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.953 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.9 -40.22 20.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 108.986 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.28 -35.75 5.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.63 -1.29 88.26 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.175 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.713 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -49.78 123.16 7.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.251 0.548 . . . . 0.0 111.114 179.017 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.28 146.92 23.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.686 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.64 177.36 41.27 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.211 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.43 143.83 28.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.641 0.257 . . . . 0.0 110.475 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.655 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -138.17 142.31 35.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.307 0.575 . . . . 0.0 112.205 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.529 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.7 Cg_endo -52.41 113.17 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.222 2.614 . . . . 0.0 111.312 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.85 -23.09 6.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -101.28 32.68 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 111.08 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.37 -17.71 7.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 66' ' ' VAL . 30.5 m -121.27 149.04 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.68 140.91 44.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.594 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' HD3' HG12 ' A' ' 66' ' ' VAL . 71.3 mmtt -39.52 138.76 0.65 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.67 53.78 0.12 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.946 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.7 tp . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.966 0.888 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.821 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.46 -176.64 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -145.55 126.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.723 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.64 148.3 29.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.464 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 mt -101.67 -22.81 14.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -143.36 -178.12 5.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.813 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.3 125.52 31.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.273 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.4 t80 -104.67 146.37 29.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.62 93.99 13.69 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.4 123.19 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.338 3.359 . . . . 0.0 113.34 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -39.05 2.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.413 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -80.0 167.84 19.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.12 143.11 41.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.07 38.97 96.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -106.07 155.21 19.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.489 . . . . 0.0 111.087 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.578 HD21 HD22 ' A' ' 88' ' ' LEU . 6.3 tp -111.29 128.95 56.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.062 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.56 146.61 18.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.088 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -147.95 178.55 8.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.981 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.55 173.35 6.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.32 128.71 36.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 -13.24 56.16 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.288 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.12 165.63 0.96 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.9 mt-30 -124.71 146.79 48.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.605 0.717 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.57 128.2 15.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.983 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.523 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.8 103.85 9.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.821 HD11 HG21 ' A' ' 66' ' ' VAL . 27.3 mm -58.72 112.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.222 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.819 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.9 mt -79.39 -46.9 16.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.53 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 151.25 39.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.494 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.9 pt20 -135.67 37.63 2.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.37 131.26 34.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.331 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.67 15.67 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.0 tt0 -47.66 -21.53 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.106 -0.547 . . . . 0.0 111.586 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.0 m95 -109.63 120.9 43.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 110.738 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.518 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.33 143.92 32.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.102 0.477 . . . . 0.0 112.212 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -89.03 114.55 25.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.256 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.02 144.2 48.66 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.055 0.455 . . . . 0.0 111.851 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.819 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.49 111.01 22.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.63 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.75 166.96 0.05 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.042 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.36 -23.76 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.603 -0.439 . . . . 0.0 112.091 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.64 -40.09 21.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.88 0.848 . . . . 0.0 108.911 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.04 -35.9 6.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.471 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.32 -0.7 88.69 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.243 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.458 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.02 122.9 8.22 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.246 0.546 . . . . 0.0 111.067 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -88.98 146.56 24.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.588 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.74 177.49 42.13 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.191 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.48 142.51 27.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.72 0.295 . . . . 0.0 110.779 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 88' ' ' LEU . 7.8 pt -136.7 144.88 48.77 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.453 0.644 . . . . 0.0 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.8 Cg_endo -55.63 116.18 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.293 2.662 . . . . 0.0 111.154 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.63 -19.6 17.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.412 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 p-10 -100.62 32.3 3.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.514 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.22 -29.57 4.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.732 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.708 HG11 HD12 ' A' ' 88' ' ' LEU . 18.9 m -110.21 152.13 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.39 141.17 35.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.346 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HD3' HG12 ' A' ' 66' ' ' VAL . 31.1 mmtp -39.42 139.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.94 54.0 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.925 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.3 tp . . . . . 0 N--CA 1.446 -0.653 0 CA-C-O 122.019 0.914 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.752 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -125.51 -177.65 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.774 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.92 124.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.774 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.86 151.34 25.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.957 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.35 12.45 12.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.772 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.68 141.94 2.96 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.665 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.1 124.47 19.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.4 t80 -103.98 147.15 27.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.6 mt-10 -137.63 94.42 11.82 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.926 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.73 126.81 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.354 3.369 . . . . 0.0 113.377 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -124.67 -40.75 2.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m-70 -79.89 171.38 15.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.42 142.65 39.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.56 40.71 98.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.376 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -106.21 155.12 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.192 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.9 tp -111.04 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.982 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.24 16.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.273 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.54 176.5 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.01 0.433 . . . . 0.0 110.736 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.39 174.34 5.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.751 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.02 129.91 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.79 -11.58 56.17 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.419 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.52 165.85 1.03 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.559 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.78 146.21 47.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.509 0.671 . . . . 0.0 111.163 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.6 128.06 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.385 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.51 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.8 ttt180 -79.88 103.57 9.87 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 66' ' ' VAL . 22.3 mm -59.94 112.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.218 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.737 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.4 mt -79.52 -47.35 15.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.713 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.93 139.87 34.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.936 178.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -126.18 35.38 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 111.23 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 122.2 37.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.021 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.89 160.77 36.86 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.775 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.9 tt0 -49.63 -19.95 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.277 -0.462 . . . . 0.0 111.383 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.3 m95 -113.17 112.93 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.327 . . . . 0.0 110.573 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -94.73 136.92 34.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.108 0.48 . . . . 0.0 112.228 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.3 113.33 20.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.234 178.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.65 143.36 47.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.024 0.44 . . . . 0.0 111.678 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.675 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.84 110.78 22.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 168.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.136 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.51 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.69 -23.74 3.97 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.939 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.83 -41.05 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.009 0.909 . . . . 0.0 108.913 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.69 -35.62 6.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.04 -0.77 86.81 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.203 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.486 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.34 121.71 5.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.265 0.555 . . . . 0.0 111.078 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.71 143.76 26.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.525 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 178.52 44.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.71 149.02 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.704 0.288 . . . . 0.0 110.67 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.665 HD13 HD13 ' A' ' 88' ' ' LEU . 5.1 pt -143.99 143.24 22.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 112.065 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.6 Cg_endo -51.3 111.5 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.175 2.584 . . . . 0.0 111.299 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.75 -25.74 1.98 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 113' ' ' PHE . 8.8 p-10 -98.99 30.83 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 111.062 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.51 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -124.06 19.84 9.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.9 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.1 m -153.63 150.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.1 138.05 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.619 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD3' HG12 ' A' ' 66' ' ' VAL . 60.7 mmtt -39.38 139.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.14 53.67 0.13 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.913 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.5 tp . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.911 0.862 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -127.04 -176.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.176 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.47 128.06 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.622 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -64.83 150.71 47.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.66 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 mt -109.9 -6.94 15.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.964 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.487 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -152.19 173.44 14.97 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.598 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.34 124.47 28.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.533 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 18.7 t80 -102.69 146.7 27.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.207 0.527 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.13 15.25 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.148 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.2 Cg_exo -37.9 123.71 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.28 3.32 . . . . 0.0 113.223 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -40.67 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.559 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.3 m80 -80.37 157.18 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.17 142.99 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.22 39.69 98.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.545 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.22 155.31 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.21 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 88' ' ' LEU . 7.2 tp -110.83 129.15 55.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.0 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.2 144.9 17.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.112 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.653 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.66 175.47 10.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.952 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.08 173.53 6.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.859 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -72.01 127.33 32.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.32 -11.86 59.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.354 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.53 165.52 1.11 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.76 147.85 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.31 127.22 13.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.95 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 40.0 ttt-85 -79.87 102.28 9.04 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.389 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.701 HD11 ' CG2' ' A' ' 66' ' ' VAL . 31.5 mm -56.82 111.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.171 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.84 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.52 -46.89 16.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.443 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.61 154.04 43.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.241 178.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.5 pt20 -139.44 37.33 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 0.0 111.819 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.3 131.2 34.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.9 166.6 17.63 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.041 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -47.51 -20.91 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.608 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 77.7 m95 -110.42 120.27 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.764 0.316 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.5 m0 -102.72 142.34 34.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.151 0.501 . . . . 0.0 112.101 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.06 114.46 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.374 178.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.45 142.8 48.92 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.0 111.635 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.84 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -107.57 110.97 23.0 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.639 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.82 166.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.048 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.9 -23.75 4.22 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.066 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.92 -40.56 19.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.891 0.853 . . . . 0.0 108.881 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.19 -35.61 6.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.445 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.64 -0.24 88.36 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.283 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.447 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.95 122.36 7.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.271 0.558 . . . . 0.0 110.971 179.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.75 145.41 25.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.541 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.37 177.4 42.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.15 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.63 142.69 27.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.796 0.332 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.725 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -135.99 145.05 50.9 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.38 0.609 . . . . 0.0 112.109 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.18 114.93 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.318 2.679 . . . . 0.0 111.125 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.94 -22.89 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 18.3 p-10 -102.56 34.92 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.339 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.551 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -122.45 -9.01 8.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.121 -179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 66' ' ' VAL . 14.5 m -133.76 153.11 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.59 143.17 41.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.488 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.3 mmtt -39.53 139.4 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.59 53.47 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.875 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.3 tp . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.832 0.825 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.819 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.91 -177.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.981 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 125.29 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.654 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.32 149.06 21.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.5 -25.41 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.737 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.427 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -144.3 -177.25 5.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.57 125.01 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 19.5 t80 -103.68 145.58 29.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.311 0.576 . . . . 0.0 112.496 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.35 94.58 15.44 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.76 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 2.6 Cg_exo -35.03 126.73 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.384 3.39 . . . . 0.0 113.359 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -121.9 -42.45 2.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.729 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.13 170.85 15.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.74 145.59 40.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.03 35.37 83.48 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.405 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.418 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.2 m-20 -97.99 156.73 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.414 . . . . 0.0 111.176 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 107' ' ' GLN . 4.4 tp -115.63 127.53 55.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.889 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.84 142.6 16.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.118 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 p90 -142.04 177.52 8.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.014 0.435 . . . . 0.0 110.899 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -108.26 172.71 6.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.838 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -72.36 128.98 37.31 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.58 -10.23 59.96 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.4 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.29 165.38 2.04 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.56 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -123.52 147.88 46.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 111.215 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.718 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.61 127.84 13.84 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.3 ttt180 -79.81 103.63 9.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.819 HD11 HG21 ' A' ' 66' ' ' VAL . 30.4 mm -58.42 111.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.313 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.752 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.6 mt -79.55 -46.21 17.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.603 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.37 137.07 30.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.8 178.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.6 pt20 -125.73 36.15 4.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 0.0 111.34 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.29 122.81 38.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.6 161.26 37.28 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.7 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -48.47 -21.15 0.5 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.449 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.9 m95 -112.03 119.86 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.297 . . . . 0.0 110.529 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.541 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -101.8 138.21 39.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 112.223 -179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.752 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.91 114.4 22.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.954 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.88 143.12 49.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.995 0.426 . . . . 0.0 111.839 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.717 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -106.61 111.16 23.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.38 165.38 0.1 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.787 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.26 -23.59 4.48 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.218 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.02 -40.41 19.98 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.881 0.848 . . . . 0.0 108.983 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -35.74 6.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.498 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.67 -1.37 88.15 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.134 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.533 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.31 122.64 7.21 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.173 0.511 . . . . 0.0 110.946 179.022 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.94 149.19 21.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.598 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.44 178.78 41.45 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.38 139.57 30.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.752 0.31 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 88' ' ' LEU . 6.1 pt -133.46 145.68 57.48 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.421 0.629 . . . . 0.0 111.998 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.69 119.61 6.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.198 2.599 . . . . 0.0 111.398 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.4 -19.13 33.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -103.45 34.9 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.66 -30.25 3.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.661 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 88' ' ' LEU . 31.5 m -111.43 147.73 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.48 141.01 46.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.365 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.503 ' HD3' HG12 ' A' ' 66' ' ' VAL . 42.4 mmtm -39.47 138.24 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.8 54.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.949 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.753 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.7 tp . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 122.03 0.919 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.11 -176.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.402 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.85 125.22 5.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.813 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.58 152.11 27.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.918 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.6 mt -119.63 8.46 11.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.864 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.88 142.52 5.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.63 124.46 18.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.421 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -104.14 146.6 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -137.28 94.25 12.42 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.924 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.48 128.22 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 124.396 3.397 . . . . 0.0 113.346 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -126.35 -41.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.2 m-70 -79.85 156.11 27.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.66 130.49 43.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.832 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.71 33.41 42.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.457 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.32 154.6 19.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.15 0.5 . . . . 0.0 111.112 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 88' ' ' LEU . 5.8 tp -110.08 131.8 54.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.71 143.91 16.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.358 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.607 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.63 176.62 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.66 171.58 7.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.879 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -70.39 126.84 30.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.42 -16.53 52.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.291 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.09 165.72 0.29 Allowed 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.68 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -123.92 145.96 48.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.629 0.728 . . . . 0.0 111.324 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.726 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.6 128.69 16.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.162 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.527 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.2 ttt180 -79.95 103.53 9.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.843 HD11 HG21 ' A' ' 66' ' ' VAL . 22.5 mm -58.98 111.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.184 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.717 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.4 mt -79.63 -47.12 15.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.685 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -141.23 137.08 32.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.798 178.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.84 36.1 4.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.09 122.37 38.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.896 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.3 159.4 35.53 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.707 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.6 tt0 -48.33 -21.22 0.49 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.498 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.5 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.0 m95 -112.51 112.4 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.741 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -94.32 139.66 30.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 112.166 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.07 114.96 23.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.03 178.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.51 142.76 49.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.991 0.424 . . . . 0.0 111.808 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.699 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.01 110.7 22.48 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.21 167.58 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.149 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.9 -23.58 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.577 -0.449 . . . . 0.0 112.013 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.88 -40.4 20.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.851 0.834 . . . . 0.0 108.9 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 -35.83 6.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.328 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.08 -0.5 88.57 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.268 -1.787 . . . . 0.0 113.297 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.405 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.91 123.23 8.74 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.22 0.533 . . . . 0.0 110.995 179.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.79 144.19 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.628 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.56 177.68 43.88 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.169 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -86.02 152.0 23.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 110.686 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.02 142.96 17.05 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.264 0.554 . . . . 0.0 112.08 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.502 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.9 Cg_endo -52.67 112.32 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.171 2.58 . . . . 0.0 111.369 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.24 -23.52 9.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.819 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.1 p-10 -100.13 31.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.38 -22.78 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.957 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.665 HG11 HD12 ' A' ' 88' ' ' LEU . 18.2 m -115.6 151.24 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.2 140.17 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.388 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.48 140.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.31 51.4 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.993 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.956 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.7 tp . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 121.98 0.895 . . . . 0.0 112.042 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.94 -177.67 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.832 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.18 126.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.64 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.61 151.84 36.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -120.04 13.0 12.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.778 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.51 141.74 3.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.715 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.33 124.27 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.448 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.0 t80 -104.12 146.37 28.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.9 94.45 12.84 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.918 178.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.12 125.86 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.299 3.332 . . . . 0.0 113.364 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -40.34 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.0 m80 -79.93 167.64 20.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.46 142.49 44.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.62 41.9 99.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.425 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.31 155.35 20.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.069 0.461 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -110.96 132.27 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.059 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.59 143.02 16.47 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.461 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.608 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.32 176.11 10.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.07 175.14 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.656 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -72.84 131.98 42.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.79 -11.23 48.14 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.488 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.18 165.79 1.28 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.2 mt-30 -123.04 146.54 47.58 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.436 0.636 . . . . 0.0 111.183 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.13 14.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.259 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.93 103.81 10.07 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 66' ' ' VAL . 26.8 mm -59.81 111.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.215 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.56 -47.82 14.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.29 136.47 33.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.841 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.1 pt20 -123.95 36.03 4.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.06 0.457 . . . . 0.0 111.355 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.0 122.36 39.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.907 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.33 159.87 35.52 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.758 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 tt0 -49.77 -20.11 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.383 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.9 m95 -113.62 112.01 22.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -93.51 138.39 31.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 112.307 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.719 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.14 112.96 21.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.158 178.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.39 143.25 47.55 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 120.999 0.428 . . . . 0.0 111.692 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.704 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.52 110.81 22.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.626 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.54 167.96 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.089 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.76 -23.79 3.95 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.994 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.67 -40.98 19.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.974 0.892 . . . . 0.0 108.883 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.77 -35.66 6.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.947 -1.478 . . . . 0.0 109.407 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.01 -0.44 87.3 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.286 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.464 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.89 121.53 6.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.222 0.534 . . . . 0.0 111.061 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.09 143.75 26.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.556 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.16 177.52 43.39 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.79 149.72 24.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.661 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -144.87 143.46 20.96 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.371 0.605 . . . . 0.0 112.137 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.14 111.38 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.257 2.638 . . . . 0.0 111.315 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p30 -99.84 31.7 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.36 14.34 9.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -150.85 150.48 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.38 140.16 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HD3' HG12 ' A' ' 66' ' ' VAL . 44.2 mmtt -39.5 139.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.48 54.19 0.11 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.046 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.915 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.3 tp . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.913 0.863 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.822 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.31 -177.43 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.788 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -144.71 125.61 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.759 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -56.56 149.54 17.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 mt -100.37 -24.48 14.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -145.49 -176.87 5.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.899 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.72 125.39 29.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.452 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.3 t80 -104.87 147.0 28.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.249 0.547 . . . . 0.0 112.429 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -136.45 93.83 14.14 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.041 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -39.41 112.93 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.169 3.246 . . . . 0.0 113.251 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -29.6 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -84.7 170.22 13.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.02 141.77 35.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 59.98 41.6 97.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.306 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -109.52 155.65 21.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 88' ' ' LEU . 6.5 tp -110.17 129.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.981 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.23 147.79 18.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.941 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -148.25 177.91 9.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 110.896 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.1 174.71 5.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.848 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -73.37 129.1 37.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.51 -10.54 58.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.393 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.43 165.61 1.47 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.609 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -124.31 147.11 48.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.528 0.68 . . . . 0.0 111.295 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.758 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.02 14.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.065 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.8 ttt180 -79.91 104.03 10.21 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.822 HD11 HG21 ' A' ' 66' ' ' VAL . 22.6 mm -58.54 112.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.317 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 27.6 mt -79.68 -46.62 16.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.573 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.4 134.83 26.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.023 178.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.8 OUTLIER -120.56 36.65 4.5 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.222 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.36 122.52 39.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.993 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.15 159.92 36.03 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.851 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.01 -20.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.429 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.1 m95 -113.79 115.39 27.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.45 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -96.4 139.26 32.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.249 0.547 . . . . 0.0 112.358 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.39 113.6 21.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 177.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.09 143.27 48.23 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.893 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -107.27 110.8 22.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.645 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 166.34 0.06 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -124.82 -23.24 4.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.123 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.03 -40.34 20.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.812 0.815 . . . . 0.0 108.915 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.73 -35.93 6.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.472 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.26 -0.32 88.99 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.262 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.02 122.52 7.67 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.282 0.563 . . . . 0.0 111.01 179.067 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.7 146.0 25.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.547 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.05 41.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.3 m-85 -89.85 142.39 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.699 0.285 . . . . 0.0 110.823 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.758 HD13 HD13 ' A' ' 88' ' ' LEU . 7.4 pt -135.67 146.29 56.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 112.1 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.47 118.73 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.257 2.638 . . . . 0.0 111.335 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.24 -19.19 32.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -102.89 34.17 2.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.64 -30.14 3.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.635 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 88' ' ' LEU . 29.0 m -108.09 149.47 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.24 139.09 39.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.29 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.0 mmtt -39.33 139.17 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.93 54.54 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.92 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.834 0.826 . . . . 0.0 111.617 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.94 -176.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.991 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.87 126.87 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.576 179.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.05 152.16 41.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.111 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.87 13.73 11.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.865 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.53 141.67 3.0 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.735 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.61 124.48 19.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.297 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -103.94 146.78 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.2 mt-10 -137.06 94.15 12.8 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.852 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.61 125.63 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.336 3.358 . . . . 0.0 113.364 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -123.32 -41.53 2.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.684 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.405 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -80.0 159.67 26.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.26 137.05 52.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.31 36.37 78.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -104.74 154.84 19.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.103 0.477 . . . . 0.0 111.124 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 88' ' ' LEU . 6.2 tp -110.59 130.85 55.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.082 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.99 143.9 16.88 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.313 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.593 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -146.99 176.91 9.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -109.36 173.67 6.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -71.89 128.75 36.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.04 -12.92 56.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.42 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.46 165.42 0.8 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.7 mt-30 -123.04 147.38 46.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.532 0.682 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.39 128.02 14.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.147 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 27.9 ttt180 -79.87 103.23 9.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.791 HD11 HG21 ' A' ' 66' ' ' VAL . 28.6 mm -58.5 111.9 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.035 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.5 mt -79.37 -46.69 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.679 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 152.49 40.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.412 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -137.12 36.78 2.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.895 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.61 131.23 34.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.155 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.75 164.78 16.23 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -47.64 -21.0 0.31 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.681 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.3 m95 -110.6 116.95 32.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.507 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.9 m0 -99.26 144.81 27.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.102 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -90.01 115.36 27.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 143.18 49.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.119 0.485 . . . . 0.0 111.636 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.797 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.4 111.12 22.86 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.622 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 167.43 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.45 -23.67 4.06 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.08 -40.56 19.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.918 0.866 . . . . 0.0 108.91 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.24 -35.57 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.41 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.74 -1.6 85.68 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 113.221 -1.809 . . . . 0.0 113.252 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -49.7 122.49 6.48 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.256 0.551 . . . . 0.0 111.13 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.0 145.19 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.544 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.02 177.93 42.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.26 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -86.21 153.8 21.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.663 0.268 . . . . 0.0 110.459 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 88' ' ' LEU . 5.0 pt -149.12 143.78 17.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 112.1 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.9 Cg_endo -52.32 111.74 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.265 2.643 . . . . 0.0 111.286 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.5 -23.08 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -102.5 32.27 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.308 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.97 -15.14 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.124 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG21 HG21 ' A' ' 66' ' ' VAL . 19.8 m -124.86 151.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.47 142.9 41.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.572 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 6.6 mmtp -39.6 138.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 54.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.087 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.871 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.2 tp . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 121.854 0.835 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.837 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.39 -177.4 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.841 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.19 123.55 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.86 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.9 153.3 17.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.804 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.02 8.59 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.47 143.02 5.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.702 -179.113 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.68 123.95 16.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.279 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HH ' ' HD3' ' A' ' 112' ' ' PRO . 12.7 t80 -103.01 146.63 28.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -137.92 94.28 11.51 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.89 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.91 128.72 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.357 3.371 . . . . 0.0 113.356 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -44.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.651 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.6 m-70 -80.01 149.1 30.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.17 130.74 48.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.58 29.3 53.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.855 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 2.9 m-20 -97.3 157.99 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.06 0.457 . . . . 0.0 111.023 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -114.24 129.64 56.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.904 179.564 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.5 142.1 15.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.441 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -147.53 176.82 9.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.962 0.41 . . . . 0.0 110.511 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -107.34 172.51 6.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -72.53 129.57 38.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.69 -12.37 56.76 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.403 -177.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.82 165.77 0.85 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -122.38 146.24 47.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.556 0.693 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.61 128.2 15.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.532 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.9 ttt-85 -79.94 103.86 10.12 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 66' ' ' VAL . 26.9 mm -58.23 112.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.116 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.762 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.7 mt -79.47 -46.84 16.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.777 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.82 136.29 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.634 178.331 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -123.23 35.89 4.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.44 122.44 39.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.869 179.165 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.07 160.3 35.94 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.757 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.5 tt0 -49.84 -19.99 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.476 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 66.8 m95 -114.1 109.68 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.295 . . . . 0.0 110.794 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.3 m0 -91.48 137.41 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.122 0.487 . . . . 0.0 112.059 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.28 115.98 22.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.159 178.122 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.08 144.12 48.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.887 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.762 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.32 110.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.6 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.91 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.162 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.76 -23.89 3.92 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.999 -178.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.99 -40.71 19.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.952 0.882 . . . . 0.0 108.933 178.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -35.6 6.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.549 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.24 -2.03 85.64 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.199 -1.819 . . . . 0.0 113.173 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.702 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.44 123.45 7.62 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.167 0.508 . . . . 0.0 111.104 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.88 147.68 22.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.725 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.46 177.87 41.49 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -86.32 144.56 27.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.651 0.263 . . . . 0.0 110.56 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 88' ' ' LEU . 4.6 pt -139.12 142.72 34.0 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.335 0.588 . . . . 0.0 112.135 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.5 Cg_endo -52.42 113.98 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.212 2.608 . . . . 0.0 111.385 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -22.72 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.022 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' CD1' ' A' ' 113' ' ' PHE . 7.9 p-10 -101.95 32.88 3.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.705 0.288 . . . . 0.0 111.115 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -120.33 -23.91 6.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.004 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.668 HG21 HG21 ' A' ' 66' ' ' VAL . 28.4 m -114.9 147.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -177.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.15 139.7 46.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.57 140.72 0.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.944 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.06 50.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.104 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp . . . . . 0 N--CA 1.447 -0.624 0 CA-C-O 122.025 0.917 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.17 -177.17 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.576 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.3 124.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.816 179.15 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -55.55 147.95 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.457 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 mt -100.26 -24.96 14.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -143.46 -177.15 5.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 179.47 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.67 124.92 29.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.2 t80 -103.94 146.94 27.95 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -137.63 94.23 11.94 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.6 Cg_exo -37.08 127.28 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.303 3.335 . . . . 0.0 113.354 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -41.54 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.607 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m170 -80.01 156.72 27.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.46 140.75 58.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 38.57 95.51 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.39 156.0 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 111.139 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -111.3 131.41 55.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.23 147.79 18.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.179 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -150.69 179.05 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.009 0.433 . . . . 0.0 110.786 -179.745 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.76 177.92 4.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.762 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -75.38 134.79 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.68 -7.31 41.8 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.473 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -60.2 165.77 3.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.58 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.71 146.29 48.38 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.511 0.672 . . . . 0.0 111.157 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.5 128.22 15.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.143 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.83 104.28 10.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.802 HD11 HG21 ' A' ' 66' ' ' VAL . 29.6 mm -60.38 112.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.294 -178.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.718 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.59 -47.76 14.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.751 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.15 136.27 33.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.793 178.305 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -124.19 36.49 4.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.352 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.79 40.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.996 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.64 159.88 35.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.726 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.1 tt0 -49.19 -20.57 0.62 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.35 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.3 m95 -113.2 114.6 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.9 m0 -96.42 139.44 32.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.58 113.19 21.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.987 177.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.76 144.04 47.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.092 0.472 . . . . 0.0 111.697 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.684 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.03 110.65 21.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.632 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.52 167.72 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.067 -179.475 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.4 mp -125.64 -23.32 4.07 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.003 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.82 -40.89 19.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.968 0.89 . . . . 0.0 108.932 178.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.97 -36.04 6.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.342 179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.45 0.68 89.47 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.348 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.451 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.68 122.45 8.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.236 0.541 . . . . 0.0 110.978 179.037 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.85 143.77 26.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.493 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.59 177.02 43.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.272 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.98 143.34 27.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.666 0.269 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.728 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -137.53 145.14 47.9 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.387 0.613 . . . . 0.0 112.125 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.02 116.46 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.21 2.606 . . . . 0.0 111.189 178.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.39 -20.01 10.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -101.98 33.94 2.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 111.154 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.35 -30.43 4.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.618 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 88' ' ' LEU . 29.8 m -109.44 147.32 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.37 139.87 44.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.143 178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.39 140.15 0.48 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.92 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.41 51.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 66' ' ' VAL . 19.0 tp . . . . . 0 N--CA 1.446 -0.639 0 CA-C-O 121.784 0.802 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -126.57 -178.41 2.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.229 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -142.36 124.55 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.616 179.434 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -60.66 151.07 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.039 -179.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.88 13.19 12.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 141.81 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.629 -179.185 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.21 124.48 19.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.452 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.2 t80 -104.1 146.64 28.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -136.77 94.38 13.11 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.963 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.4 132.93 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 124.332 3.355 . . . . 0.0 113.41 -179.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -42.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -79.91 157.55 26.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 179.882 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.43 133.66 49.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 35.32 55.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.373 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.422 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -103.96 155.56 18.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 107' ' ' GLN . 5.7 tp -112.21 132.26 55.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.924 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.14 143.2 16.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.17 176.41 9.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.987 0.422 . . . . 0.0 110.782 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -109.27 173.47 6.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.957 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -72.22 127.71 33.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 -13.58 58.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.309 -177.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.32 165.64 0.72 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.05 147.63 46.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.405 0.621 . . . . 0.0 111.057 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.97 127.52 13.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.176 -179.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.515 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.2 ttt180 -79.86 103.66 9.91 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.659 HD11 HG21 ' A' ' 66' ' ' VAL . 27.1 mm -59.13 111.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.223 -178.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' A' ' 101' ' ' GLN . 19.9 mt -79.5 -47.15 16.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.544 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 155.1 45.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.431 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.478 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -140.63 37.51 1.83 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.811 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 131.48 34.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.216 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.86 167.08 10.47 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.046 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -47.14 -20.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.071 -0.564 . . . . 0.0 111.685 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m95 -108.86 118.45 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 110.911 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.4 m0 -101.82 139.87 36.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.157 0.504 . . . . 0.0 111.944 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -85.51 114.73 22.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.358 178.303 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.29 143.52 49.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.791 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.11 111.12 22.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.627 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.01 167.17 0.06 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.99 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.515 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.15 -23.55 4.18 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.032 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.21 -41.4 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.883 0.849 . . . . 0.0 108.894 178.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.91 -35.51 6.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.456 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.15 -0.76 86.99 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.221 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.47 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.6 121.91 6.46 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.32 0.581 . . . . 0.0 111.053 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -88.7 145.75 25.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.549 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.15 177.89 41.99 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.309 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.47 151.9 23.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.647 0.26 . . . . 0.0 110.449 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 88' ' ' LEU . 7.6 pt -147.88 143.01 17.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 112.191 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.3 Cg_endo -52.01 110.16 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.098 2.532 . . . . 0.0 111.161 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.08 -25.77 2.28 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 7.2 p30 -96.99 29.16 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.722 0.296 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.12 18.96 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.984 -179.289 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.3 m -154.1 150.65 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.4 139.03 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.615 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HD3' HG12 ' A' ' 66' ' ' VAL . 35.3 mmtm -39.49 138.84 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 112.008 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.47 54.31 0.11 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.027 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.924 179.984 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.7 tp . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.936 0.874 . . . . 0.0 111.958 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.83 -177.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.657 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.95 125.76 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.78 179.157 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.47 151.78 40.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.03 14.78 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.712 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -169.32 142.28 2.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 -179.227 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.02 124.73 20.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.6 t80 -104.75 146.47 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.98 94.6 12.58 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.054 178.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.09 128.71 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.43 3.42 . . . . 0.0 113.379 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -126.75 -42.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.1 m-70 -79.97 158.42 26.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.707 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.38 142.32 57.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.33 42.22 99.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -110.57 155.38 22.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.127 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.4 tp -111.0 133.0 53.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.054 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -98.54 143.94 16.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.453 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.93 175.97 10.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.407 . . . . 0.0 110.822 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -109.02 175.93 5.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.699 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -72.86 132.22 43.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.76 -10.06 48.25 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.67 -177.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.8 165.83 1.61 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.621 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.24 146.0 48.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.545 0.688 . . . . 0.0 111.148 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.696 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.24 128.3 15.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.7 ttt180 -79.93 103.51 9.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -59.81 111.31 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.061 -178.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.8 mt -79.62 -48.16 14.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.722 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 136.85 35.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.803 178.276 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.564 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.4 35.89 4.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 111.334 -178.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.62 122.53 39.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.823 179.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.02 159.25 35.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.671 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.3 -20.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.442 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.7 m95 -113.19 110.63 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.8 m0 -92.48 138.36 31.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.235 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -84.73 113.37 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.138 178.147 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.62 143.05 47.89 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.054 0.454 . . . . 0.0 111.659 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.719 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.48 110.52 22.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 168.0 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.185 -179.54 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.89 -23.62 3.93 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.055 -179.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.71 -41.01 19.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.968 0.89 . . . . 0.0 108.876 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.67 -35.97 6.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.314 179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.26 0.62 89.25 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.362 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.56 121.98 7.29 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.991 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.36 143.4 27.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.561 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 177.16 43.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.239 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -85.2 153.93 22.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.604 0.24 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.696 HD13 HD13 ' A' ' 88' ' ' LEU . 6.6 pt -149.62 143.29 16.64 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.372 0.606 . . . . 0.0 112.125 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.523 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.7 Cg_endo -51.08 110.16 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 111.191 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.28 -26.29 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -99.08 30.81 3.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 111.232 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.5 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -122.58 17.67 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.953 -179.581 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -154.16 150.67 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.48 139.56 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.51 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.584 ' HD3' HG12 ' A' ' 66' ' ' VAL . 38.9 mmtm -39.56 139.33 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.42 54.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.5 tp . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.901 0.857 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.61 -177.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.033 -1.439 . . . . 0.0 111.949 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.83 123.98 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.748 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.92 153.74 16.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.914 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.91 6.92 10.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.885 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.16 143.29 6.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 -179.163 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.22 124.27 17.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.9 t80 -104.96 146.39 29.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.5 mt-10 -138.05 94.69 11.08 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.811 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.66 129.87 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.316 3.344 . . . . 0.0 113.365 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.9 t -128.3 -42.02 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.7 m-70 -79.99 158.67 26.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.8 139.2 57.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.37 40.6 96.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.67 155.43 20.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.027 0.442 . . . . 0.0 111.11 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.2 tp -111.29 133.29 53.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.042 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.6 145.79 17.97 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.441 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -150.55 177.71 9.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.47 175.58 5.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.708 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -73.89 131.68 41.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.09 -10.8 51.88 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.355 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.5 165.59 1.52 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -122.55 146.55 47.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.6 0.714 . . . . 0.0 111.197 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.753 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.55 127.81 14.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.504 ' N ' HD11 ' A' ' 103' ' ' LEU . 37.2 ttt180 -79.95 103.2 9.68 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.829 HD11 HG21 ' A' ' 66' ' ' VAL . 28.5 mm -59.69 111.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.264 -178.05 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.3 mt -79.63 -47.04 16.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.47 178.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.46 155.63 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.309 178.127 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -141.47 37.39 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.09 131.96 34.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.301 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.44 166.5 15.57 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.992 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.4 tt0 -47.76 -20.75 0.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.499 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.7 m95 -110.22 118.21 35.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.477 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.3 m0 -100.63 143.63 30.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.121 0.486 . . . . 0.0 112.033 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.26 114.85 25.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.482 178.464 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.555 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.61 143.8 49.11 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.962 0.41 . . . . 0.0 111.697 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.738 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.5 tt0 -109.09 110.99 22.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.19 -179.453 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.27 -23.25 4.2 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.663 -0.415 . . . . 0.0 112.025 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.18 -41.7 18.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.976 0.893 . . . . 0.0 108.943 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.13 -36.04 6.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.334 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 0.06 88.72 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 113.176 -1.829 . . . . 0.0 113.423 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.471 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.16 122.57 7.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.276 0.56 . . . . 0.0 111.08 179.071 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.78 146.01 25.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.616 -178.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.99 177.77 41.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.54 155.53 21.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.658 HD13 HD13 ' A' ' 88' ' ' LEU . 5.5 pt -150.03 144.36 17.54 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.344 0.592 . . . . 0.0 112.205 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.499 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.9 Cg_endo -53.45 112.17 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.209 2.606 . . . . 0.0 111.251 178.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -54.74 -21.11 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 6.2 p-10 -101.6 30.72 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.25 -26.33 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 88' ' ' LEU . 17.2 m -113.22 149.6 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.55 140.67 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.23 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 140.47 0.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.908 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.26 50.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 . . . . . 0 CA--C 1.516 -0.342 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.754 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.6 tp -82.25 142.52 32.05 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.937 0.875 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.86 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.78 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.24 126.7 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.668 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.99 151.73 42.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.992 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.9 13.33 12.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.862 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.585 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.93 141.1 2.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.661 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.65 124.08 17.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.308 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.0 t80 -103.27 145.46 29.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -135.73 94.3 15.03 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.91 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.21 126.22 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.327 3.351 . . . . 0.0 113.327 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -124.01 -41.83 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.631 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -79.98 159.09 26.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.704 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 141.67 56.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.923 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 39.11 97.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.613 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.12 155.49 19.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.059 0.456 . . . . 0.0 111.141 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD21 HD22 ' A' ' 88' ' ' LEU . 3.5 tp -111.15 129.91 55.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.53 142.19 15.92 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.57 176.2 9.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.993 0.425 . . . . 0.0 110.711 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.73 171.59 7.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -70.98 128.58 36.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.29 -13.4 55.2 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.427 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.87 165.61 0.61 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.5 mt-30 -123.21 146.48 47.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.67 0.748 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.711 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.44 128.55 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.177 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -79.89 103.59 9.88 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 66' ' ' VAL . 26.2 mm -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.17 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.733 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.2 mt -79.53 -47.76 15.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.722 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.5 135.48 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.807 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.562 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.8 pt20 -121.94 35.92 4.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 0.0 111.369 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.65 122.23 38.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.92 158.54 34.61 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.691 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.3 tt0 -48.55 -21.51 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.457 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.488 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.1 m95 -112.46 109.69 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.717 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.562 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -91.38 139.34 30.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.199 0.524 . . . . 0.0 112.184 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.72 114.35 22.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.239 177.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.85 144.68 47.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 0.0 111.785 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.733 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.87 110.7 21.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.35 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.186 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.88 -23.66 3.93 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.007 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -40.21 20.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.959 0.885 . . . . 0.0 108.914 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.2 -35.78 6.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.411 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.83 -0.18 88.65 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 113.285 -1.78 . . . . 0.0 113.384 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.49 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.12 122.8 8.17 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.236 0.541 . . . . 0.0 111.003 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.95 144.2 26.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.47 177.59 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.199 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.18 152.38 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.661 0.267 . . . . 0.0 110.55 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.711 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.14 143.49 17.65 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 112.086 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.4 Cg_endo -52.64 108.34 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.152 2.568 . . . . 0.0 111.281 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -50.64 -24.9 3.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.4 p30 -98.97 30.36 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -118.0 -24.41 7.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.01 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.683 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -115.46 150.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 142.58 44.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.487 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.6 mmtt -39.67 139.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.35 54.44 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.003 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.6 tp -83.15 142.28 31.34 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.86 0.838 . . . . 0.0 111.709 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.28 -176.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.856 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.97 126.66 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.62 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.67 152.23 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.01 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.48 14.2 11.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.884 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.578 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 140.76 2.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.672 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.87 124.13 17.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.244 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.551 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 13.1 t80 -103.78 146.19 28.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -137.15 94.31 12.55 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.914 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.65 120.45 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.259 3.306 . . . . 0.0 113.426 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -118.79 -36.79 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.7 m80 -81.35 172.68 13.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.624 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -80.07 142.82 34.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.28 38.08 94.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.438 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.73 155.55 18.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 111.211 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.829 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -111.42 128.58 56.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.082 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.08 144.71 17.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.354 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.82 176.22 10.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.989 0.423 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -107.15 173.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.729 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -72.58 129.08 37.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.86 -11.0 58.59 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.512 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.47 165.56 1.08 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.557 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -122.77 146.6 47.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.552 0.691 . . . . 0.0 111.212 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.829 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.99 128.07 14.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.204 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.0 ttt180 -79.85 103.52 9.8 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 66' ' ' VAL . 29.1 mm -57.77 112.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.223 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.1 mt -79.41 -46.87 16.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.704 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.32 135.69 27.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.626 178.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.3 pt20 -122.26 35.69 4.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.076 0.465 . . . . 0.0 111.239 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 122.66 38.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.876 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.19 158.65 34.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.613 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.8 tt0 -49.38 -20.84 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.435 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.17 107.78 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.9 m0 -89.34 140.41 29.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 112.201 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.82 115.73 24.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.191 178.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 144.14 48.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.937 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.793 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.6 110.93 22.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.592 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.98 167.81 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.123 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.54 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.79 -24.04 3.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.914 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -83.15 -40.47 19.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.913 0.863 . . . . 0.0 108.942 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.84 -35.47 6.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.502 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.77 -2.89 85.29 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.035 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 80' ' ' LEU . 2.9 mp0 -48.8 124.75 8.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.98 151.05 20.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.716 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 167.61 176.91 38.68 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.61 142.69 28.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.69 0.281 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -136.76 144.57 47.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.62 . . . . 0.0 112.176 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.485 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 9.0 Cg_endo -53.62 109.77 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.195 2.597 . . . . 0.0 111.29 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.54 -23.85 7.09 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.814 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.1 p-10 -99.12 30.87 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.99 -22.73 6.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.043 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 88' ' ' LEU . 16.5 m -117.23 150.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.43 142.36 43.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.39 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 66' ' ' VAL . 7.2 mmtp -39.59 139.09 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.01 53.98 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.075 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.8 tp -84.79 141.73 30.29 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.982 0.896 . . . . 0.0 112.096 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -125.48 -177.28 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 113.826 -1.533 . . . . 0.0 111.779 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.28 126.1 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.636 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.84 151.93 41.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.091 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.17 14.38 12.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.94 141.12 2.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.14 124.6 19.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.325 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.6 t80 -103.92 146.09 29.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.89 94.44 12.86 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.963 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -36.34 132.43 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.336 3.358 . . . . 0.0 113.381 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 t -130.53 -43.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.741 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.438 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.8 m80 -79.96 149.09 30.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 129.76 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.044 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.82 28.78 49.75 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.624 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 3.2 m-20 -96.98 158.47 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.2 132.73 56.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.831 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.33 141.87 15.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.626 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -144.8 176.8 9.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.471 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.09 170.5 8.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.055 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -69.71 126.63 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.72 -15.65 50.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.323 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.17 166.21 0.26 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -123.34 145.81 48.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.5 0.667 . . . . 0.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -145.26 127.69 15.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.258 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.6 ttt180 -79.74 103.41 9.62 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.779 HD11 HG21 ' A' ' 66' ' ' VAL . 23.0 mm -58.25 111.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.119 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.837 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.34 -46.68 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.554 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.24 154.89 44.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -140.25 36.7 1.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 0.0 111.863 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.33 131.28 34.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.93 166.81 18.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.027 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.04 -20.36 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.662 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 71.2 m95 -110.18 116.85 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.0 m0 -99.74 140.5 33.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.084 0.469 . . . . 0.0 111.994 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.81 116.76 25.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.54 178.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -123.2 144.6 49.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.031 0.443 . . . . 0.0 111.722 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.837 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.65 111.24 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.615 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.52 167.09 0.07 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.871 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -124.62 -23.41 4.39 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.426 -0.51 . . . . 0.0 112.105 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.84 -41.15 17.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 0.0 108.989 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.12 -35.57 6.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.427 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.63 -1.74 84.98 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.239 -1.801 . . . . 0.0 113.218 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.37 123.37 7.41 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.177 0.513 . . . . 0.0 111.15 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.79 149.5 21.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.607 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 168.46 177.02 39.22 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.313 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.35 143.42 28.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.658 0.266 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -137.84 142.14 35.25 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 0.0 112.126 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.512 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.9 Cg_endo -51.26 112.06 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.264 2.643 . . . . 0.0 111.242 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -49.84 -24.87 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.3 p-10 -100.52 31.42 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.39 17.07 9.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.946 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.8 m -154.23 150.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.23 140.75 37.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.548 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.53 138.91 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.25 54.38 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.89 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.2 tp -81.96 142.25 32.58 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.951 0.881 . . . . 0.0 111.838 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.838 HG21 HD11 ' A' ' 90' ' ' ILE . 2.5 m -124.04 -176.64 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.894 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -147.48 128.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.749 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -65.62 150.55 48.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.641 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.98 -6.22 15.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.482 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -153.52 172.89 16.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.676 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.05 123.99 27.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.513 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.58 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 20.4 t80 -101.51 145.96 28.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.289 0.566 . . . . 0.0 112.331 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.24 15.15 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.038 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.22 129.36 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.368 3.379 . . . . 0.0 113.293 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -125.76 -40.7 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.791 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.3 m-70 -79.94 174.99 11.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.695 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.21 144.9 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.97 37.29 84.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.634 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -98.47 156.2 16.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.168 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.3 tp -115.2 125.23 53.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.54 141.35 15.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.108 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.62 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -141.19 175.62 9.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -107.05 172.7 6.68 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.813 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.18 127.92 34.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.63 59.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.355 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.74 165.59 1.15 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.0 mt-30 -123.9 146.71 48.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.521 0.677 . . . . 0.0 111.202 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.73 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.12 128.47 15.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.0 ttt180 -80.03 103.31 9.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 66' ' ' VAL . 27.5 mm -59.36 111.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.216 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.741 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.5 mt -79.55 -47.25 15.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.813 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.43 136.37 29.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.739 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.563 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -124.19 35.92 4.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.473 . . . . 0.0 111.32 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 122.41 38.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.959 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.58 160.91 36.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.798 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.0 tt0 -48.79 -20.96 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.501 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.5 m95 -113.25 117.19 31.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.563 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.7 m0 -98.82 137.57 37.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.13 0.49 . . . . 0.0 112.169 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.92 112.68 20.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.061 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -118.96 143.28 47.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.93 110.53 21.87 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.08 167.17 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.104 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.45 -23.7 4.06 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.099 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.73 -40.49 20.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.909 0.861 . . . . 0.0 108.936 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.37 -35.57 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.408 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.46 -0.0 88.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.299 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.548 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.24 121.63 6.51 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.261 0.553 . . . . 0.0 111.058 179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.93 142.55 27.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.601 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 177.09 -179.94 47.75 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.249 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.34 139.8 30.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.695 0.284 . . . . 0.0 110.97 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.722 HD13 HD13 ' A' ' 88' ' ' LEU . 6.0 pt -134.26 144.18 50.16 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.421 0.629 . . . . 0.0 111.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 8.4 Cg_endo -53.11 119.18 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.218 2.612 . . . . 0.0 111.265 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.69 -20.97 16.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -105.18 35.4 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 0.0 111.244 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.541 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -120.96 -17.49 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 88' ' ' LEU . 14.8 m -126.88 152.33 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.62 143.27 43.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.388 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.9 mmtp -39.59 139.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.19 54.51 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.046 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.864 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.4 tp -44.0 142.86 1.26 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.877 0.846 . . . . 0.0 112.091 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -126.72 -176.89 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.894 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.63 125.94 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.629 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.67 146.85 29.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.466 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 mt -97.98 -24.54 15.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.418 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -145.87 -177.37 5.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.965 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.31 125.22 29.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.214 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -103.64 145.39 30.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.34 94.13 15.9 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.046 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.14 133.58 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.304 3.336 . . . . 0.0 113.432 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.46 -43.57 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.41 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 8.3 m80 -80.0 150.57 30.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.722 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -62.31 136.16 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.96 61.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 2.6 m-20 -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 0.0 111.024 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.761 HD21 HD22 ' A' ' 88' ' ' LEU . 1.1 tp -116.34 123.99 48.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.899 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -90.3 143.12 16.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.137 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p90 -143.93 178.19 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -108.3 172.98 6.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.89 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -72.71 128.77 36.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 -10.73 59.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.286 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.33 165.5 1.44 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.545 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.69 147.33 47.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.465 0.65 . . . . 0.0 111.111 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.772 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.48 127.67 14.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.951 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.542 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.7 ttt180 -79.84 101.37 8.48 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.418 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 66' ' ' VAL . 37.0 mm -55.4 112.11 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.079 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.838 HD21 ' CB ' ' A' ' 101' ' ' GLN . 25.2 mt -79.4 -46.5 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.578 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -145.71 148.36 32.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.344 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -132.1 37.14 3.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.23 131.78 34.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.91 164.57 20.75 Favored Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.979 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -48.43 -20.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.59 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.0 m95 -111.1 119.47 39.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.523 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.0 m0 -101.53 142.26 33.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.109 0.481 . . . . 0.0 112.21 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.99 114.74 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.2 178.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.62 143.31 48.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 111.814 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.838 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.37 110.83 22.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.621 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.51 166.66 0.05 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.101 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.04 -23.95 4.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.055 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.95 -39.98 20.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.841 . . . . 0.0 109.046 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.4 -35.47 6.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.554 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.56 -1.23 88.27 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.154 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.682 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.28 123.16 7.96 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.263 0.554 . . . . 0.0 111.024 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 146.65 23.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.734 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.09 179.44 43.77 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.111 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -90.39 139.83 30.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.789 0.328 . . . . 0.0 110.737 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.737 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -133.69 144.48 52.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.517 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.5 116.77 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.263 2.642 . . . . 0.0 111.182 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.488 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.31 -19.9 16.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 5.9 p-10 -101.99 33.75 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.069 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.82 -30.33 4.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.651 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 88' ' ' LEU . 27.4 m -111.13 148.61 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.69 142.21 45.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.408 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 66' ' ' VAL . 22.9 mmtp -39.36 137.98 0.71 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.08 54.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.061 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.768 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.2 tp -79.79 142.43 35.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.988 0.899 . . . . 0.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.82 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.08 -176.64 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.594 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.69 125.13 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.733 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.51 150.94 29.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.928 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.81 10.68 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -167.43 142.85 4.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.653 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.5 124.82 20.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.384 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -104.62 146.8 28.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.419 0.628 . . . . 0.0 112.658 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.4 mt-10 -138.11 94.53 11.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.954 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.83 127.56 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.304 3.336 . . . . 0.0 113.33 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.37 -40.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m80 -79.85 170.83 15.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.768 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.99 137.2 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.76 38.57 94.57 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.607 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -104.17 154.45 19.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 88' ' ' LEU . 4.9 tp -110.48 133.01 53.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.089 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.1 143.74 16.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.402 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.606 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.78 176.7 9.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.79 172.96 6.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.863 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.93 128.84 37.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.85 -15.02 50.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.327 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.16 165.75 0.47 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -123.58 145.98 48.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.58 0.705 . . . . 0.0 111.29 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.31 128.36 15.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.149 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.0 ttt180 -79.84 103.77 9.97 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.82 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -58.92 111.47 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.148 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 101' ' ' GLN . 24.5 mt -79.56 -47.4 15.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.821 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.73 137.79 33.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.861 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.572 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -125.29 35.71 4.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.61 122.55 38.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.936 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.84 159.09 35.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.724 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.483 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.4 tt0 -48.49 -20.92 0.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.42 -0.39 . . . . 0.0 111.476 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.6 m95 -112.59 111.98 23.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.679 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -93.97 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.75 114.85 24.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.194 178.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.43 143.04 48.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.048 0.451 . . . . 0.0 111.774 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -107.93 110.88 22.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.42 167.64 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.95 -24.06 3.84 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.968 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.44 -40.64 20.9 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.906 0.86 . . . . 0.0 108.919 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.22 -35.3 6.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.29 -1.23 86.0 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.53 121.86 6.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 0.0 111.082 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.47 145.13 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.619 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.66 176.63 42.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.402 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -84.78 151.78 24.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.609 0.242 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.684 HD13 HD13 ' A' ' 88' ' ' LEU . 5.7 pt -148.08 143.11 17.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.292 0.568 . . . . 0.0 112.148 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.7 Cg_endo -51.8 112.59 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.235 2.623 . . . . 0.0 111.339 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.47 -23.7 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 14.1 p30 -101.83 32.45 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.74 -17.06 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 88' ' ' LEU . 16.7 m -121.61 150.42 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.24 140.77 41.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.477 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.5 mmtp -39.46 139.48 0.56 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.84 53.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.966 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 66' ' ' VAL . 26.5 tp -82.36 142.51 31.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.904 0.859 . . . . 0.0 111.822 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.23 -176.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.884 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -146.7 124.92 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.61 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -59.84 152.96 21.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.03 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -121.4 8.9 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.916 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.596 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -166.32 143.36 5.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.24 123.74 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.332 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.575 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -103.03 146.94 27.59 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -138.2 94.53 10.99 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.847 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.4 Cg_exo -36.27 131.69 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.45 3.434 . . . . 0.0 113.299 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -130.1 -43.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.439 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 13.1 m-70 -79.96 157.31 26.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.33 128.45 36.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.64 47.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.657 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.3 m-20 -96.27 156.9 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.109 0.48 . . . . 0.0 110.991 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.735 HD21 HD22 ' A' ' 88' ' ' LEU . 1.4 tp -114.69 130.13 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.38 141.67 15.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.391 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -146.57 176.89 9.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -108.83 172.03 7.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.003 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -71.56 127.23 31.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.5 -15.32 55.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.286 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.41 165.53 0.36 Allowed 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.556 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.7 mt-30 -122.68 146.7 47.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.567 0.699 . . . . 0.0 111.216 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.746 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.77 127.97 14.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.8 ttt180 -79.93 103.07 9.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 66' ' ' VAL . 25.0 mm -58.67 113.48 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.141 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.736 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 39.2 mt -79.51 -46.37 17.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.748 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -145.2 134.56 23.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.911 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.561 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.9 OUTLIER -119.77 36.05 4.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.77 122.24 37.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.925 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.39 159.53 35.61 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.696 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.85 -20.81 0.54 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 68.4 m95 -113.03 110.95 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.647 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.561 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -92.66 136.86 32.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.736 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 114.84 21.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.239 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.87 143.74 47.76 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.073 0.463 . . . . 0.0 111.745 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.658 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.96 110.58 21.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.608 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.41 168.4 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.223 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -126.12 -23.55 3.88 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.015 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.86 -40.4 20.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.868 0.842 . . . . 0.0 108.923 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -35.8 6.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.471 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.1 -0.62 88.48 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.271 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.45 123.17 8.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.231 0.539 . . . . 0.0 111.097 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -90.01 144.54 25.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.562 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.52 178.64 44.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.372 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -87.52 146.53 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.618 0.247 . . . . 0.0 110.643 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -142.25 142.07 23.05 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.0 112.125 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.548 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.1 Cg_endo -51.94 112.24 0.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.193 2.595 . . . . 0.0 111.385 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.64 -23.76 7.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p-10 -100.57 31.6 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.09 -25.63 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 88' ' ' LEU . 17.1 m -114.32 149.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.05 141.81 44.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.478 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.495 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.4 mmtt -39.58 138.94 0.64 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.61 54.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.083 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.975 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 CA--C 1.517 -0.303 0 CA-C-O 120.64 0.257 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 66' ' ' VAL . 22.9 tp -82.39 141.84 32.47 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.745 0.783 . . . . 0.0 111.464 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.24 -177.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.105 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.51 126.03 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.608 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.82 152.03 37.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.132 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.05 12.69 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.895 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.26 142.73 3.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.585 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 124.19 18.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.389 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.4 t80 -104.07 146.18 29.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.69 94.38 13.26 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.927 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.5 Cg_exo -37.04 122.14 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.313 3.342 . . . . 0.0 113.336 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -41.16 2.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.508 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 4.5 m-70 -80.51 159.05 25.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.21 143.48 56.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.17 41.65 99.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.593 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.59 155.61 21.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.162 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.506 HD21 HD22 ' A' ' 88' ' ' LEU . 6.6 tp -111.41 131.56 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.75 144.59 17.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.401 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.75 176.66 9.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -109.42 172.35 6.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.802 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -71.31 127.33 32.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.3 -14.34 57.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.347 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.537 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -54.9 165.61 0.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 65' ' ' LEU . 3.3 mt-30 -123.2 147.49 46.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.668 . . . . 0.0 111.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -147.31 127.96 14.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.102 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' N ' HD11 ' A' ' 103' ' ' LEU . 33.1 ttt180 -79.82 103.46 9.74 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 66' ' ' VAL . 28.1 mm -59.07 111.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.202 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.6 mt -79.34 -47.02 16.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.505 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.97 154.24 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.336 178.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -139.47 36.71 2.05 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.842 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.56 131.26 34.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.235 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.75 15.93 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.108 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 tt0 -47.46 -21.19 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.084 -0.558 . . . . 0.0 111.625 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m95 -109.99 118.1 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.7 m0 -100.4 143.18 30.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 112.021 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.725 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.22 114.71 25.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.468 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.9 142.98 49.18 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.051 0.453 . . . . 0.0 111.77 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.779 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.23 111.08 22.87 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.624 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.57 167.43 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.114 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.43 -23.52 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.056 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.85 -41.06 19.48 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.919 0.866 . . . . 0.0 108.881 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.13 -35.66 6.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.419 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.98 -1.45 86.62 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.329 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.459 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.2 mp0 -49.77 122.06 6.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.289 0.566 . . . . 0.0 111.07 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.44 145.03 26.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.665 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.62 42.24 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.206 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.36 155.39 20.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.614 0.245 . . . . 0.0 110.442 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.633 HD13 HD13 ' A' ' 88' ' ' LEU . 4.5 pt -150.11 144.25 17.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.609 . . . . 0.0 112.157 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.493 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 7.5 Cg_endo -52.88 111.15 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.226 2.617 . . . . 0.0 111.25 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.03 -22.97 6.55 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.6 p-10 -101.04 30.97 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.454 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.37 -19.75 8.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.985 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.641 HG11 HD12 ' A' ' 88' ' ' LEU . 16.2 m -119.7 150.63 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.81 141.34 42.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.325 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.65 140.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.8 50.89 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.897 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp -82.22 142.19 32.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.063 0.935 . . . . 0.0 112.077 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.7 -176.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.546 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 126.46 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.687 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.66 147.97 25.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.401 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 mt -100.43 -23.07 14.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -145.54 -176.72 5.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.888 0.375 . . . . 0.0 110.776 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.25 125.26 30.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.9 t80 -104.66 146.57 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 mt-10 -136.41 94.13 13.97 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.024 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 Cg_exo -37.72 120.02 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.327 3.352 . . . . 0.0 113.366 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -117.07 -34.75 4.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.539 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 5.6 m80 -84.12 169.72 14.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.798 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -79.0 143.43 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.91 35.95 92.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.354 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -104.29 155.75 18.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 111.202 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 88' ' ' LEU . 1.9 tp -111.85 127.45 55.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.136 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.77 144.2 16.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.03 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.543 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.9 OUTLIER -145.21 179.21 7.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.924 0.392 . . . . 0.0 110.949 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.89 175.41 5.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.956 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 131.22 41.28 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.34 -9.1 56.39 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.331 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.63 165.6 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.6 mt-30 -124.58 146.07 49.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 111.258 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.804 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.15 128.04 15.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.272 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.1 ttt180 -79.67 104.27 10.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.827 HD11 HG21 ' A' ' 66' ' ' VAL . 25.3 mm -59.57 112.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.388 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.808 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.8 mt -79.44 -47.43 15.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.475 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 154.27 43.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.413 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.7 pt20 -138.61 38.02 2.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 111.888 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 131.27 34.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.283 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.8 166.42 9.7 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.12 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -46.77 -21.55 0.21 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.52 . . . . 0.0 111.655 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 80.3 m95 -108.52 121.01 44.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.506 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.97 143.14 33.27 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.39 113.94 24.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.228 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.64 47.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.136 0.493 . . . . 0.0 111.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.808 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.84 110.88 22.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.618 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.86 167.75 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.043 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.63 -23.49 4.04 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.073 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -83.12 -39.91 20.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.863 0.84 . . . . 0.0 109.015 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.21 -35.8 5.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.428 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.76 -0.34 88.37 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.286 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.595 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.03 122.62 7.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.225 0.536 . . . . 0.0 111.098 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.81 146.03 25.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.51 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.0 177.33 42.2 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.69 140.38 29.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.659 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 88' ' ' LEU . 8.6 pt -134.78 145.34 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 112.161 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.9 Cg_endo -56.06 114.04 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.164 2.576 . . . . 0.0 111.156 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -21.64 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.426 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.5 p30 -98.81 31.63 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.851 0.357 . . . . 0.0 111.041 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -120.99 -27.13 5.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.632 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 88' ' ' LEU . 23.0 m -112.9 148.74 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.3 141.35 41.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.374 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' HG12 ' A' ' 66' ' ' VAL . 13.7 mmtp -39.4 138.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.56 54.41 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.029 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.923 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.9 tp -83.54 142.03 31.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.985 0.898 . . . . 0.0 111.991 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.858 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.19 -177.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.672 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.09 125.33 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.753 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.12 147.24 25.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.508 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.14 -24.4 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -146.39 -177.17 5.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.991 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 125.47 29.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.305 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.7 t80 -104.05 145.72 29.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.43 94.1 15.78 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.996 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.92 124.46 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.387 3.392 . . . . 0.0 113.365 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -40.44 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -83.74 157.19 22.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.87 147.3 53.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 61.09 33.87 85.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.599 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -101.55 156.86 17.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.178 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.703 HD21 HD22 ' A' ' 88' ' ' LEU . 1.3 tp -114.36 125.04 53.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.095 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -91.92 142.64 16.14 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.176 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.1 p90 -143.06 178.35 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.922 0.391 . . . . 0.0 110.939 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -108.32 174.89 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.838 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.27 130.04 38.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.25 -8.76 60.06 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.382 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.75 165.4 2.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.612 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.6 mt-30 -124.31 146.12 49.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.651 0.738 . . . . 0.0 111.142 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.78 128.23 15.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 103' ' ' LEU . 29.7 ttt180 -79.99 104.21 10.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.858 HD11 HG21 ' A' ' 66' ' ' VAL . 24.9 mm -59.5 112.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.34 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 101' ' ' GLN . 21.9 mt -79.54 -46.94 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.388 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.85 155.02 43.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.347 178.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.51 HE21 HG21 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -139.74 37.56 2.0 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.836 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.08 131.01 34.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.358 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.84 167.14 14.47 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.086 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.5 tt0 -47.29 -21.29 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.605 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.7 m95 -109.25 121.67 45.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.4 m0 -104.29 142.65 34.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.043 0.449 . . . . 0.0 112.144 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.8 113.97 23.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.334 178.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.9 145.28 47.83 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 111.817 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.8 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -109.88 111.02 22.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.614 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.69 167.7 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.064 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.42 -23.61 4.08 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.084 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.99 -40.87 19.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.943 0.878 . . . . 0.0 109.013 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.12 -36.07 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.43 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.14 -0.27 88.91 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.288 -1.778 . . . . 0.0 113.257 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.681 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.98 123.3 8.96 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.229 0.538 . . . . 0.0 111.018 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 145.95 24.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.582 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.15 178.62 43.27 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 2.5 m-85 -90.3 140.81 29.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 110.622 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 88' ' ' LEU . 7.7 pt -134.74 145.31 54.29 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.347 0.594 . . . . 0.0 112.152 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 11.0 Cg_endo -55.89 115.36 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.238 2.626 . . . . 0.0 111.157 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.83 -19.72 12.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 13.9 p30 -101.22 32.5 3.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.516 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.18 -30.45 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.536 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 88' ' ' LEU . 31.1 m -109.67 149.27 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.13 139.88 41.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.364 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.58 ' HD3' HG12 ' A' ' 66' ' ' VAL . 41.7 mmtm -39.38 138.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.32 54.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.3 tp -83.76 141.94 31.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.937 0.875 . . . . 0.0 112.017 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.774 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -125.58 -177.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.746 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.55 126.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.601 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.07 151.53 39.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.212 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.6 mt -120.08 13.67 12.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.757 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.87 141.35 2.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.736 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.35 124.27 18.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.408 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.8 t80 -103.73 146.26 28.87 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -136.3 94.32 14.0 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.01 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.4 Cg_exo -36.77 123.93 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.382 3.388 . . . . 0.0 113.292 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -122.34 -39.35 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.804 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 3.9 m80 -79.93 174.39 11.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.89 141.99 35.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.22 40.24 97.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -105.15 154.53 20.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.147 0.499 . . . . 0.0 111.189 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.509 HD21 HD22 ' A' ' 88' ' ' LEU . 5.7 tp -110.64 131.75 54.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.907 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.59 16.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.369 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.622 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.3 175.97 9.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.802 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -109.1 173.22 6.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -71.65 128.45 35.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.95 -13.92 54.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.407 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.02 165.78 0.61 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.595 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.3 mt-30 -123.52 146.52 48.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.59 128.43 15.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.25 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.92 103.62 9.93 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 66' ' ' VAL . 25.9 mm -59.57 111.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.232 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.724 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.8 mt -79.65 -47.93 14.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.786 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.74 136.99 34.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.849 178.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.0 pt20 -124.84 35.88 4.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.107 0.479 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.4 122.44 39.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.92 159.69 35.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.672 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -48.29 -21.29 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.351 -0.425 . . . . 0.0 111.538 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.1 m95 -111.75 113.3 25.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -95.59 136.46 35.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.069 0.461 . . . . 0.0 112.156 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.724 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.38 113.24 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.104 177.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.29 142.99 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 111.675 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.71 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.36 110.7 22.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.628 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 167.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.165 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.82 -23.71 3.94 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.968 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -82.7 -40.69 20.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.868 0.842 . . . . 0.0 108.859 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 -35.74 6.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.395 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 -0.85 87.49 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.293 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.21 121.94 6.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.82 143.35 26.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.579 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.99 177.51 44.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.341 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -86.64 149.18 25.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.68 0.276 . . . . 0.0 110.614 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.736 HD13 HD13 ' A' ' 88' ' ' LEU . 7.1 pt -145.31 143.15 19.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.355 0.598 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.8 Cg_endo -51.68 109.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.45 -26.12 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -98.69 30.37 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 0.0 111.205 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.493 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.79 10.93 10.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.987 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 16.9 m -147.53 151.01 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.86 140.49 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.592 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.516 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.8 mmtp -39.47 139.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 53.95 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.077 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.923 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp -43.89 142.52 1.31 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.848 0.832 . . . . 0.0 112.103 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 90' ' ' ILE . 2.9 m -127.08 -176.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.968 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.24 124.44 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.01 152.05 20.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.786 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.22 7.48 10.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.983 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.14 143.88 6.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.14 124.13 17.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.318 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.56 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.7 t80 -103.96 146.96 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -138.59 94.51 10.46 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.886 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.95 131.38 0.33 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.359 3.372 . . . . 0.0 113.44 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -130.01 -43.48 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.711 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.5 m-70 -79.84 156.38 27.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.35 130.59 43.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.017 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.81 55.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.65 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 1.4 m-20 -97.1 157.23 16.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 110.973 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 HD22 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -114.19 131.15 56.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.967 179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.31 142.31 16.01 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.489 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -148.13 177.13 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -108.12 176.48 5.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.702 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -74.24 134.36 42.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.39 -8.78 38.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.566 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.7 165.65 2.18 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.07 146.76 46.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.676 . . . . 0.0 111.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.792 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.95 127.44 14.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.931 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' N ' HD11 ' A' ' 103' ' ' LEU . 41.4 ttt180 -79.63 101.43 8.34 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.796 HD11 HG21 ' A' ' 66' ' ' VAL . 36.8 mm -55.43 111.76 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.038 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 33.8 mt -79.45 -46.0 18.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.675 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.79 135.95 26.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.735 178.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.1 pt20 -122.31 35.96 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.073 0.463 . . . . 0.0 111.437 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.35 122.49 39.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.834 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.17 159.51 35.32 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.756 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tt0 -49.73 -20.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.312 -0.444 . . . . 0.0 111.476 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 65.2 m95 -113.95 108.3 16.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 110.676 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.6 m0 -90.3 138.27 31.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.083 0.468 . . . . 0.0 112.08 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.735 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.55 116.6 23.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.09 178.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.64 142.65 49.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.794 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.722 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -108.17 110.76 22.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.602 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.7 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 -179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.1 mp -125.56 -23.9 3.98 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.953 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.9 -40.22 20.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 108.986 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.28 -35.75 5.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.63 -1.29 88.26 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.175 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.713 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -49.78 123.16 7.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.251 0.548 . . . . 0.0 111.114 179.017 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.28 146.92 23.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.686 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.64 177.36 41.27 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.211 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.43 143.83 28.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.641 0.257 . . . . 0.0 110.475 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.655 HD13 HD13 ' A' ' 88' ' ' LEU . 6.4 pt -138.17 142.31 35.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.307 0.575 . . . . 0.0 112.205 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.529 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.7 Cg_endo -52.41 113.17 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.222 2.614 . . . . 0.0 111.312 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.85 -23.09 6.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -101.28 32.68 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 111.08 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -121.37 -17.71 7.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 66' ' ' VAL . 30.5 m -121.27 149.04 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.68 140.91 44.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.594 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' HD3' HG12 ' A' ' 66' ' ' VAL . 71.3 mmtt -39.52 138.76 0.65 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.67 53.78 0.12 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.946 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.7 tp -82.88 142.39 31.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.966 0.888 . . . . 0.0 112.06 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.821 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.46 -176.64 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -145.55 126.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.723 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.64 148.3 29.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.464 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 mt -101.67 -22.81 14.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.2 OUTLIER -143.36 -178.12 5.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.813 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.3 125.52 31.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.273 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.4 t80 -104.67 146.37 29.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.62 93.99 13.69 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.4 123.19 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.338 3.359 . . . . 0.0 113.34 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -39.05 2.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.413 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -80.0 167.84 19.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.12 143.11 41.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.07 38.97 96.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -106.07 155.21 19.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.489 . . . . 0.0 111.087 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.578 HD21 HD22 ' A' ' 88' ' ' LEU . 6.3 tp -111.29 128.95 56.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.062 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.56 146.61 18.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.088 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -147.95 178.55 8.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.981 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.55 173.35 6.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.32 128.71 36.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 -13.24 56.16 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.288 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.12 165.63 0.96 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.9 mt-30 -124.71 146.79 48.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.605 0.717 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.57 128.2 15.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.983 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.523 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.8 103.85 9.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.821 HD11 HG21 ' A' ' 66' ' ' VAL . 27.3 mm -58.72 112.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.222 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.819 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.9 mt -79.39 -46.9 16.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.53 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 151.25 39.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.494 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 1.9 pt20 -135.67 37.63 2.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.37 131.26 34.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.331 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.11 165.67 15.67 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.0 tt0 -47.66 -21.53 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.106 -0.547 . . . . 0.0 111.586 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 76.0 m95 -109.63 120.9 43.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 110.738 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.518 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.5 m0 -103.33 143.92 32.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.102 0.477 . . . . 0.0 112.212 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -89.03 114.55 25.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.256 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.02 144.2 48.66 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.055 0.455 . . . . 0.0 111.851 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.819 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.49 111.01 22.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.63 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.75 166.96 0.05 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.042 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.36 -23.76 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.603 -0.439 . . . . 0.0 112.091 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -82.64 -40.09 21.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.88 0.848 . . . . 0.0 108.911 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.04 -35.9 6.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.471 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.32 -0.7 88.69 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.243 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.458 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.02 122.9 8.22 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.246 0.546 . . . . 0.0 111.067 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -88.98 146.56 24.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.588 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.74 177.49 42.13 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.191 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.48 142.51 27.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.72 0.295 . . . . 0.0 110.779 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 88' ' ' LEU . 7.8 pt -136.7 144.88 48.77 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.453 0.644 . . . . 0.0 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 10.8 Cg_endo -55.63 116.18 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.293 2.662 . . . . 0.0 111.154 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -56.63 -19.6 17.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.412 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 p-10 -100.62 32.3 3.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.514 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.22 -29.57 4.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.732 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.708 HG11 HD12 ' A' ' 88' ' ' LEU . 18.9 m -110.21 152.13 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.39 141.17 35.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.346 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HD3' HG12 ' A' ' 66' ' ' VAL . 31.1 mmtp -39.42 139.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.94 54.0 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.925 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.3 tp -83.32 141.55 31.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.019 0.914 . . . . 0.0 112.041 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.752 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -125.51 -177.65 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.774 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.92 124.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.774 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -59.86 151.34 25.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.957 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.35 12.45 12.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.772 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.68 141.94 2.96 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.665 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.1 124.47 19.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.4 t80 -103.98 147.15 27.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.6 mt-10 -137.63 94.42 11.82 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.926 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.73 126.81 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.354 3.369 . . . . 0.0 113.377 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -124.67 -40.75 2.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m-70 -79.89 171.38 15.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.42 142.65 39.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.56 40.71 98.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.376 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -106.21 155.12 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.192 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.9 tp -111.04 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.982 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -96.52 142.24 16.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.273 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -145.54 176.5 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.01 0.433 . . . . 0.0 110.736 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.39 174.34 5.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.751 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.02 129.91 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.79 -11.58 56.17 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.419 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.52 165.85 1.03 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.559 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.2 mt-30 -122.78 146.21 47.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.509 0.671 . . . . 0.0 111.163 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.6 128.06 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.385 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.51 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.8 ttt180 -79.88 103.57 9.87 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 66' ' ' VAL . 22.3 mm -59.94 112.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.218 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.737 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 25.4 mt -79.52 -47.35 15.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.713 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.93 139.87 34.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.936 178.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -126.18 35.38 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 111.23 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 122.2 37.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.021 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.89 160.77 36.86 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.775 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.9 tt0 -49.63 -19.95 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.277 -0.462 . . . . 0.0 111.383 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 72.3 m95 -113.17 112.93 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.327 . . . . 0.0 110.573 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.6 m0 -94.73 136.92 34.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.108 0.48 . . . . 0.0 112.228 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -83.3 113.33 20.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.234 178.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.65 143.36 47.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.024 0.44 . . . . 0.0 111.678 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.675 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.84 110.78 22.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.625 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 168.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.136 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.51 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.69 -23.74 3.97 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.939 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.83 -41.05 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.009 0.909 . . . . 0.0 108.913 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.69 -35.62 6.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.04 -0.77 86.81 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.203 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.486 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.34 121.71 5.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.265 0.555 . . . . 0.0 111.078 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.71 143.76 26.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.525 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 178.52 44.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.71 149.02 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.704 0.288 . . . . 0.0 110.67 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.665 HD13 HD13 ' A' ' 88' ' ' LEU . 5.1 pt -143.99 143.24 22.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 112.065 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.6 Cg_endo -51.3 111.5 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.175 2.584 . . . . 0.0 111.299 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.75 -25.74 1.98 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 113' ' ' PHE . 8.8 p-10 -98.99 30.83 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 111.062 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.51 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -124.06 19.84 9.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.9 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.1 m -153.63 150.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -140.1 138.05 35.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.619 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD3' HG12 ' A' ' 66' ' ' VAL . 60.7 mmtt -39.38 139.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.14 53.67 0.13 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.913 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 120.602 0.239 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.5 tp -43.27 142.31 1.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.911 0.862 . . . . 0.0 112.099 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -127.04 -176.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.176 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.47 128.06 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.622 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -64.83 150.71 47.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.66 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 mt -109.9 -6.94 15.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.964 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.487 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -152.19 173.44 14.97 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.598 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.34 124.47 28.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.533 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 18.7 t80 -102.69 146.7 27.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.207 0.527 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -135.7 94.13 15.25 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.148 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 6.2 Cg_exo -37.9 123.71 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.28 3.32 . . . . 0.0 113.223 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -40.67 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.559 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.3 m80 -80.37 157.18 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.17 142.99 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.22 39.69 98.19 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.545 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -109.22 155.31 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.21 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 88' ' ' LEU . 7.2 tp -110.83 129.15 55.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.0 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.2 144.9 17.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.112 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.653 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -144.66 175.47 10.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.952 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -108.08 173.53 6.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.859 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -72.01 127.33 32.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.32 -11.86 59.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.354 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -56.53 165.52 1.11 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.76 147.85 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.31 127.22 13.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.95 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 40.0 ttt-85 -79.87 102.28 9.04 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.389 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.701 HD11 ' CG2' ' A' ' 66' ' ' VAL . 31.5 mm -56.82 111.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.171 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD21 ' CB ' ' A' ' 101' ' ' GLN . 20.7 mt -79.52 -46.89 16.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.443 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -143.61 154.04 43.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.241 178.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.5 pt20 -139.44 37.33 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 0.0 111.819 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.3 131.2 34.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.9 166.6 17.63 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.041 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.7 tt0 -47.51 -20.91 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.608 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 77.7 m95 -110.42 120.27 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.764 0.316 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.486 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.5 m0 -102.72 142.34 34.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.151 0.501 . . . . 0.0 112.101 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -87.06 114.46 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.374 178.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.45 142.8 48.92 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.0 111.635 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.84 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.3 tt0 -107.57 110.97 23.0 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.639 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.82 166.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.048 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.9 -23.75 4.22 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.066 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.92 -40.56 19.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.891 0.853 . . . . 0.0 108.881 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.19 -35.61 6.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.445 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.64 -0.24 88.36 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.283 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.447 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.95 122.36 7.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.271 0.558 . . . . 0.0 110.971 179.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.75 145.41 25.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.541 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.37 177.4 42.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.15 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.63 142.69 27.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.796 0.332 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.725 HD13 HD13 ' A' ' 88' ' ' LEU . 7.0 pt -135.99 145.05 50.9 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.38 0.609 . . . . 0.0 112.109 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.18 114.93 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.318 2.679 . . . . 0.0 111.125 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.94 -22.89 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 18.3 p-10 -102.56 34.92 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.339 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.551 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -122.45 -9.01 8.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.121 -179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 66' ' ' VAL . 14.5 m -133.76 153.11 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.59 143.17 41.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.488 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HD3' HG12 ' A' ' 66' ' ' VAL . 30.3 mmtt -39.53 139.4 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.59 53.47 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.875 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.3 tp -82.43 142.44 31.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.832 0.825 . . . . 0.0 111.412 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.819 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.91 -177.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.981 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.05 125.29 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.654 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -57.32 149.06 21.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.479 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.5 -25.41 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.737 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.427 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -144.3 -177.25 5.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.57 125.01 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 19.5 t80 -103.68 145.58 29.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.311 0.576 . . . . 0.0 112.496 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -135.35 94.58 15.44 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.76 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 2.6 Cg_exo -35.03 126.73 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.384 3.39 . . . . 0.0 113.359 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -121.9 -42.45 2.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.729 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.13 170.85 15.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.74 145.59 40.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.03 35.37 83.48 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.405 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.418 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.2 m-20 -97.99 156.73 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.414 . . . . 0.0 111.176 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 107' ' ' GLN . 4.4 tp -115.63 127.53 55.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.889 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.84 142.6 16.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.118 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.2 p90 -142.04 177.52 8.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.014 0.435 . . . . 0.0 110.899 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -108.26 172.71 6.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.838 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -72.36 128.98 37.31 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.58 -10.23 59.96 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.4 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -58.29 165.38 2.04 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.56 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -123.52 147.88 46.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 111.215 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.718 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.61 127.84 13.84 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.524 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.3 ttt180 -79.81 103.63 9.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.819 HD11 HG21 ' A' ' 66' ' ' VAL . 30.4 mm -58.42 111.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.313 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.752 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.6 mt -79.55 -46.21 17.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.603 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.37 137.07 30.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.8 178.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 5.6 pt20 -125.73 36.15 4.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 0.0 111.34 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.29 122.81 38.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.6 161.26 37.28 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.7 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -48.47 -21.15 0.5 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.449 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.9 m95 -112.03 119.86 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.297 . . . . 0.0 110.529 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.541 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -101.8 138.21 39.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 112.223 -179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.752 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.91 114.4 22.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.954 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.88 143.12 49.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.995 0.426 . . . . 0.0 111.839 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.717 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -106.61 111.16 23.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.38 165.38 0.1 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.787 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -124.26 -23.59 4.48 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.218 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.02 -40.41 19.98 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.881 0.848 . . . . 0.0 108.983 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -35.74 6.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.498 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.67 -1.37 88.15 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.134 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.533 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.31 122.64 7.21 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.173 0.511 . . . . 0.0 110.946 179.022 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.94 149.19 21.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.598 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.44 178.78 41.45 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.194 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.38 139.57 30.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.752 0.31 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 88' ' ' LEU . 6.1 pt -133.46 145.68 57.48 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.421 0.629 . . . . 0.0 111.998 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.8 Cg_endo -55.69 119.61 6.85 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.198 2.599 . . . . 0.0 111.398 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.4 -19.13 33.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -103.45 34.9 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.524 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.66 -30.25 3.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.661 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 88' ' ' LEU . 31.5 m -111.43 147.73 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.48 141.01 46.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.365 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.503 ' HD3' HG12 ' A' ' 66' ' ' VAL . 42.4 mmtm -39.47 138.24 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.8 54.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.949 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.753 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.7 tp -80.03 142.21 35.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.03 0.919 . . . . 0.0 112.233 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.11 -176.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.402 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.85 125.22 5.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.813 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -60.58 152.11 27.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.918 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.6 mt -119.63 8.46 11.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.864 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.88 142.52 5.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.63 124.46 18.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.421 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.1 t80 -104.14 146.6 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 mt-10 -137.28 94.25 12.42 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.924 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.48 128.22 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 124.396 3.397 . . . . 0.0 113.346 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -126.35 -41.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 1.2 m-70 -79.85 156.11 27.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.66 130.49 43.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.832 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.71 33.41 42.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.457 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -103.32 154.6 19.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.15 0.5 . . . . 0.0 111.112 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 88' ' ' LEU . 5.8 tp -110.08 131.8 54.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.954 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.71 143.91 16.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.358 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.607 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -147.63 176.62 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.66 171.58 7.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.879 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -70.39 126.84 30.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.42 -16.53 52.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.291 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -53.09 165.72 0.29 Allowed 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.68 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -123.92 145.96 48.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.629 0.728 . . . . 0.0 111.324 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.726 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -145.6 128.69 16.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.162 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.527 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.2 ttt180 -79.95 103.53 9.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.843 HD11 HG21 ' A' ' 66' ' ' VAL . 22.5 mm -58.98 111.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.184 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.717 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 26.4 mt -79.63 -47.12 15.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.685 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -141.23 137.08 32.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.798 178.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.84 36.1 4.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.09 122.37 38.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.896 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.3 159.4 35.53 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.707 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.6 tt0 -48.33 -21.22 0.49 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.498 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.5 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.0 m95 -112.51 112.4 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.741 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.0 m0 -94.32 139.66 30.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 112.166 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -86.07 114.96 23.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.03 178.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.51 142.76 49.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.991 0.424 . . . . 0.0 111.808 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.699 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.01 110.7 22.48 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.6 OUTLIER -49.21 167.58 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.149 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.9 -23.58 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.577 -0.449 . . . . 0.0 112.013 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.88 -40.4 20.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.851 0.834 . . . . 0.0 108.9 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 -35.83 6.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.328 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.08 -0.5 88.57 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 113.268 -1.787 . . . . 0.0 113.297 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.405 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -50.91 123.23 8.74 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.22 0.533 . . . . 0.0 110.995 179.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.79 144.19 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.628 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.56 177.68 43.88 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.169 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 2.2 m-85 -86.02 152.0 23.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 110.686 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 88' ' ' LEU . 6.2 pt -148.02 142.96 17.05 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.264 0.554 . . . . 0.0 112.08 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.502 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 7.9 Cg_endo -52.67 112.32 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.171 2.58 . . . . 0.0 111.369 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.24 -23.52 9.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.819 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 8.1 p-10 -100.13 31.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.38 -22.78 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.957 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.665 HG11 HD12 ' A' ' 88' ' ' LEU . 18.2 m -115.6 151.24 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.2 140.17 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.388 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.48 140.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.31 51.4 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.993 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.956 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 CA--C 1.518 -0.256 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 66' ' ' VAL . 28.7 tp -86.37 141.84 28.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.98 0.895 . . . . 0.0 112.042 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.94 -177.67 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.832 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.18 126.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.64 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -62.61 151.84 36.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -120.04 13.0 12.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.778 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.51 141.74 3.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.715 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.33 124.27 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.448 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.0 t80 -104.12 146.37 28.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -136.9 94.45 12.84 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.918 178.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.9 Cg_exo -37.12 125.86 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.299 3.332 . . . . 0.0 113.364 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -40.34 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 9.0 m80 -79.93 167.64 20.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.46 142.49 44.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.62 41.9 99.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.425 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.31 155.35 20.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.069 0.461 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.3 tp -110.96 132.27 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.059 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.59 143.02 16.47 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.461 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.608 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.32 176.11 10.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -109.07 175.14 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.656 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -72.84 131.98 42.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.79 -11.23 48.14 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.488 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.18 165.79 1.28 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.2 mt-30 -123.04 146.54 47.58 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.436 0.636 . . . . 0.0 111.183 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.13 14.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.259 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' N ' HD11 ' A' ' 103' ' ' LEU . 32.4 ttt180 -79.93 103.81 10.07 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 66' ' ' VAL . 26.8 mm -59.81 111.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.215 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.56 -47.82 14.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -140.29 136.47 33.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.841 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.556 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.1 pt20 -123.95 36.03 4.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.06 0.457 . . . . 0.0 111.355 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.0 122.36 39.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.907 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.33 159.87 35.52 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.758 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 tt0 -49.77 -20.11 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.383 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.9 m95 -113.62 112.01 22.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -93.51 138.39 31.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 112.307 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.719 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.14 112.96 21.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.158 178.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -119.39 143.25 47.55 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 120.999 0.428 . . . . 0.0 111.692 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.704 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.1 tt0 -108.52 110.81 22.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.626 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.54 167.96 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.089 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.76 -23.79 3.95 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.994 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.67 -40.98 19.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.974 0.892 . . . . 0.0 108.883 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.77 -35.66 6.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.947 -1.478 . . . . 0.0 109.407 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.01 -0.44 87.3 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.286 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.464 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -50.89 121.53 6.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.222 0.534 . . . . 0.0 111.061 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.09 143.75 26.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.556 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.16 177.52 43.39 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.79 149.72 24.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.661 HD13 HD13 ' A' ' 88' ' ' LEU . 4.9 pt -144.87 143.46 20.96 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.371 0.605 . . . . 0.0 112.137 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 5.9 Cg_endo -51.14 111.38 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.257 2.638 . . . . 0.0 111.315 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 15.9 p30 -99.84 31.7 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.36 14.34 9.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 18.2 m -150.85 150.48 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.38 140.16 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HD3' HG12 ' A' ' 66' ' ' VAL . 44.2 mmtt -39.5 139.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.48 54.19 0.11 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.046 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.915 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.747 HD12 ' H ' ' A' ' 66' ' ' VAL . 25.3 tp -83.22 142.0 31.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.913 0.863 . . . . 0.0 111.794 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.822 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.31 -177.43 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.788 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -144.71 125.61 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.759 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -56.56 149.54 17.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 mt -100.37 -24.48 14.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' ND1' ' CZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -145.49 -176.87 5.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.899 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.72 125.39 29.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.452 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.3 t80 -104.87 147.0 28.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.249 0.547 . . . . 0.0 112.429 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -136.45 93.83 14.14 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.041 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 4.6 Cg_exo -39.41 112.93 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.169 3.246 . . . . 0.0 113.251 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -29.6 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -84.7 170.22 13.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.02 141.77 35.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 110' ' ' PHE . . . 59.98 41.6 97.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.306 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.4 m-20 -109.52 155.65 21.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 88' ' ' LEU . 6.5 tp -110.17 129.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.981 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -95.23 147.79 18.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.941 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 88' ' ' LEU . 1.0 OUTLIER -148.25 177.91 9.01 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 110.896 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.1 174.71 5.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.848 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -73.37 129.1 37.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.51 -10.54 58.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.393 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.43 165.61 1.47 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.609 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -124.31 147.11 48.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.528 0.68 . . . . 0.0 111.295 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.758 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.91 128.02 14.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.065 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.8 ttt180 -79.91 104.03 10.21 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.822 HD11 HG21 ' A' ' 66' ' ' VAL . 22.6 mm -58.54 112.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.317 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 27.6 mt -79.68 -46.62 16.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.573 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -143.4 134.83 26.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.023 178.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 0.8 OUTLIER -120.56 36.65 4.5 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.222 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.36 122.52 39.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.993 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.15 159.92 36.03 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.851 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.01 -20.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.429 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 73.1 m95 -113.79 115.39 27.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.45 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.7 m0 -96.4 139.26 32.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.249 0.547 . . . . 0.0 112.358 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.39 113.6 21.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 177.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -120.09 143.27 48.23 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.893 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.0 tt0 -107.27 110.8 22.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.645 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 166.34 0.06 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -124.82 -23.24 4.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.123 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.03 -40.34 20.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.812 0.815 . . . . 0.0 108.915 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.73 -35.93 6.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.472 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.26 -0.32 88.99 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.262 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.02 122.52 7.67 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.282 0.563 . . . . 0.0 111.01 179.067 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.7 146.0 25.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.547 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.78 177.05 41.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 3.3 m-85 -89.85 142.39 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.699 0.285 . . . . 0.0 110.823 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.758 HD13 HD13 ' A' ' 88' ' ' LEU . 7.4 pt -135.67 146.29 56.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 112.1 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.47 118.73 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.257 2.638 . . . . 0.0 111.335 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -58.24 -19.19 32.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -102.89 34.17 2.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -122.64 -30.14 3.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.635 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 88' ' ' LEU . 29.0 m -108.09 149.47 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -138.24 139.09 39.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.29 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HD3' HG12 ' A' ' 66' ' ' VAL . 70.0 mmtt -39.33 139.17 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.93 54.54 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.92 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.8 tp -81.61 142.36 32.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.834 0.826 . . . . 0.0 111.617 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 HD11 ' A' ' 90' ' ' ILE . 2.8 m -125.94 -176.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.991 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.87 126.87 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.576 179.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -64.05 152.16 41.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.111 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.87 13.73 11.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.865 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.53 141.67 3.0 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.735 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.61 124.48 19.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.297 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 14.2 t80 -103.94 146.78 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.2 mt-10 -137.06 94.15 12.8 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.852 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.61 125.63 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.336 3.358 . . . . 0.0 113.364 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -123.32 -41.53 2.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.684 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.405 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -80.0 159.67 26.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.26 137.05 52.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.31 36.37 78.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -104.74 154.84 19.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.103 0.477 . . . . 0.0 111.124 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 88' ' ' LEU . 6.2 tp -110.59 130.85 55.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.082 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -94.99 143.9 16.88 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.313 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.593 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -146.99 176.91 9.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -109.36 173.67 6.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -71.89 128.75 36.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.04 -12.92 56.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.42 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.46 165.42 0.8 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.7 mt-30 -123.04 147.38 46.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.532 0.682 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.39 128.02 14.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.147 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' N ' HD11 ' A' ' 103' ' ' LEU . 27.9 ttt180 -79.87 103.23 9.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.791 HD11 HG21 ' A' ' 66' ' ' VAL . 28.6 mm -58.5 111.9 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.035 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.5 mt -79.37 -46.69 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.679 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 152.49 40.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.412 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -137.12 36.78 2.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.895 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.61 131.23 34.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.155 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.75 164.78 16.23 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.3 tt0 -47.64 -21.0 0.31 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.681 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.3 m95 -110.6 116.95 32.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.507 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 46.9 m0 -99.26 144.81 27.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.102 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.708 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -90.01 115.36 27.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.43 143.18 49.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.119 0.485 . . . . 0.0 111.636 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.797 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.4 111.12 22.86 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.622 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.73 167.43 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.45 -23.67 4.06 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.08 -40.56 19.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.918 0.866 . . . . 0.0 108.91 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.24 -35.57 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.41 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.74 -1.6 85.68 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 113.221 -1.809 . . . . 0.0 113.252 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.1 mp0 -49.7 122.49 6.48 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.256 0.551 . . . . 0.0 111.13 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.0 145.19 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.544 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 173.02 177.93 42.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.26 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -86.21 153.8 21.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.663 0.268 . . . . 0.0 110.459 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 88' ' ' LEU . 5.0 pt -149.12 143.78 17.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 112.1 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 6.9 Cg_endo -52.32 111.74 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.265 2.643 . . . . 0.0 111.286 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -52.5 -23.08 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -102.5 32.27 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.308 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -119.97 -15.14 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.124 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG21 HG21 ' A' ' 66' ' ' VAL . 19.8 m -124.86 151.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -137.47 142.9 41.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.572 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 6.6 mmtp -39.6 138.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 54.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.087 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.871 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 66' ' ' VAL . 23.2 tp -81.27 141.54 34.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.854 0.835 . . . . 0.0 111.668 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.837 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -124.39 -177.4 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.841 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.19 123.55 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.86 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . . . -58.9 153.3 17.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.804 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.02 8.59 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.47 143.02 5.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.702 -179.113 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.68 123.95 16.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.279 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HH ' ' HD3' ' A' ' 112' ' ' PRO . 12.7 t80 -103.01 146.63 28.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -137.92 94.28 11.51 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.89 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 3.9 Cg_exo -35.91 128.72 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.357 3.371 . . . . 0.0 113.356 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -44.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.651 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.6 m-70 -80.01 149.1 30.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.17 130.74 48.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.58 29.3 53.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.855 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 76' ' ' HIS . 2.9 m-20 -97.3 157.99 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.06 0.457 . . . . 0.0 111.023 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -114.24 129.64 56.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.904 179.564 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -93.5 142.1 15.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.441 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -147.53 176.82 9.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.962 0.41 . . . . 0.0 110.511 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -107.34 172.51 6.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -72.53 129.57 38.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.69 -12.37 56.76 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.403 -177.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.82 165.77 0.85 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.607 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.9 mt-30 -122.38 146.24 47.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.556 0.693 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -146.61 128.2 15.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.532 ' N ' HD11 ' A' ' 103' ' ' LEU . 34.9 ttt-85 -79.94 103.86 10.12 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 66' ' ' VAL . 26.9 mm -58.23 112.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.116 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.762 HD21 ' CB ' ' A' ' 101' ' ' GLN . 26.7 mt -79.47 -46.84 16.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.777 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.82 136.29 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.634 178.331 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.6 pt20 -123.23 35.89 4.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.44 122.44 39.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.869 179.165 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.07 160.3 35.94 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.757 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 4.5 tt0 -49.84 -19.99 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.476 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 66.8 m95 -114.1 109.68 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.295 . . . . 0.0 110.794 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.3 m0 -91.48 137.41 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.122 0.487 . . . . 0.0 112.059 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -84.28 115.98 22.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.159 178.122 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 88' ' ' LEU . . . -121.08 144.12 48.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.887 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.762 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.32 110.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.6 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.91 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.162 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 89' ' ' ARG . 4.0 mp -125.76 -23.89 3.92 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.999 -178.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -82.99 -40.71 19.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.952 0.882 . . . . 0.0 108.933 178.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -35.6 6.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.549 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 82.24 -2.03 85.64 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.199 -1.819 . . . . 0.0 113.173 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.702 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -49.44 123.45 7.62 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.167 0.508 . . . . 0.0 111.104 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.88 147.68 22.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.725 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 171.46 177.87 41.49 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -86.32 144.56 27.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.651 0.263 . . . . 0.0 110.56 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 88' ' ' LEU . 4.6 pt -139.12 142.72 34.0 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.335 0.588 . . . . 0.0 112.135 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.5 Cg_endo -52.42 113.98 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.212 2.608 . . . . 0.0 111.385 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -53.9 -22.72 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.022 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' CD1' ' A' ' 113' ' ' PHE . 7.9 p-10 -101.95 32.88 3.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.705 0.288 . . . . 0.0 111.115 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -120.33 -23.91 6.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.004 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.668 HG21 HG21 ' A' ' 66' ' ' VAL . 28.4 m -114.9 147.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -177.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -134.15 139.7 46.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.57 140.72 0.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.944 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.06 50.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.104 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 66' ' ' VAL . 29.1 tp -84.19 142.27 30.44 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.025 0.917 . . . . 0.0 112.061 -178.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 90' ' ' ILE . 2.7 m -125.17 -177.17 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.576 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -144.3 124.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.816 179.15 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -55.55 147.95 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.457 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 mt -100.26 -24.96 14.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -143.46 -177.15 5.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 179.47 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.67 124.92 29.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 15.2 t80 -103.94 146.94 27.95 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.4 mt-10 -137.63 94.23 11.94 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.6 Cg_exo -37.08 127.28 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.303 3.335 . . . . 0.0 113.354 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -41.54 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.607 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 6.7 m170 -80.01 156.72 27.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.46 140.75 58.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 38.57 95.51 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -107.39 156.0 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 111.139 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 5.7 tp -111.3 131.41 55.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.23 147.79 18.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.179 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -150.69 179.05 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.009 0.433 . . . . 0.0 110.786 -179.745 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -109.76 177.92 4.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.762 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -75.38 134.79 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.68 -7.31 41.8 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.473 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -60.2 165.77 3.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.58 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.71 146.29 48.38 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.511 0.672 . . . . 0.0 111.157 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.5 128.22 15.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.143 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.4 ttt180 -79.83 104.28 10.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.802 HD11 HG21 ' A' ' 66' ' ' VAL . 29.6 mm -60.38 112.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.294 -178.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.718 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 23.6 mt -79.59 -47.76 14.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.751 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -140.15 136.27 33.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.793 178.305 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 3.7 pt20 -124.19 36.49 4.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.352 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.79 40.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.996 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.64 159.88 35.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.726 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 3.1 tt0 -49.19 -20.57 0.62 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.35 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 69.3 m95 -113.2 114.6 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.9 m0 -96.42 139.44 32.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.718 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -85.58 113.19 21.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.987 177.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.76 144.04 47.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.092 0.472 . . . . 0.0 111.697 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.684 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.9 tt0 -109.03 110.65 21.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.632 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.52 167.72 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.067 -179.475 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.4 mp -125.64 -23.32 4.07 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.003 -178.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.82 -40.89 19.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.968 0.89 . . . . 0.0 108.932 178.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.97 -36.04 6.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.342 179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.45 0.68 89.47 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.348 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.451 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.68 122.45 8.16 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.236 0.541 . . . . 0.0 110.978 179.037 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.85 143.77 26.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.493 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.59 177.02 43.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.272 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -87.98 143.34 27.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.666 0.269 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.728 HD13 HD13 ' A' ' 88' ' ' LEU . 7.5 pt -137.53 145.14 47.9 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.387 0.613 . . . . 0.0 112.125 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -55.02 116.46 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.21 2.606 . . . . 0.0 111.189 178.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -55.39 -20.01 10.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -101.98 33.94 2.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 111.154 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -121.35 -30.43 4.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.618 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 88' ' ' LEU . 29.8 m -109.44 147.32 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -135.37 139.87 44.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.143 178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.39 140.15 0.48 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.92 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.41 51.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.553 0.216 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 66' ' ' VAL . 19.0 tp -81.95 141.38 33.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.784 0.802 . . . . 0.0 111.249 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 65' ' ' LEU . 3.0 m -126.57 -178.41 2.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.229 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -142.36 124.55 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.616 179.434 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . . . -60.66 151.07 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.039 -179.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.88 13.19 12.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -168.59 141.81 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.629 -179.185 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.21 124.48 19.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.452 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.564 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 17.2 t80 -104.1 146.64 28.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 2.5 mt-10 -136.77 94.38 13.11 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.963 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.1 Cg_exo -36.4 132.93 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 124.332 3.355 . . . . 0.0 113.41 -179.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -42.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -79.91 157.55 26.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 179.882 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -67.43 133.66 49.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 35.32 55.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.373 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.422 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-20 -103.96 155.56 18.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 107' ' ' GLN . 5.7 tp -112.21 132.26 55.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.924 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.14 143.2 16.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.17 176.41 9.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.987 0.422 . . . . 0.0 110.782 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -109.27 173.47 6.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.957 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -72.22 127.71 33.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 -13.58 58.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.309 -177.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -55.32 165.64 0.72 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.1 mt-30 -123.05 147.63 46.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.405 0.621 . . . . 0.0 111.057 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -147.97 127.52 13.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.176 -179.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.515 ' N ' HD11 ' A' ' 103' ' ' LEU . 31.2 ttt180 -79.86 103.66 9.91 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.659 HD11 HG21 ' A' ' 66' ' ' VAL . 27.1 mm -59.13 111.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.223 -178.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' A' ' 101' ' ' GLN . 19.9 mt -79.5 -47.15 16.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.544 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 155.1 45.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.431 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.478 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -140.63 37.51 1.83 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.811 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 131.48 34.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.216 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.86 167.08 10.47 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.046 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.2 tt0 -47.14 -20.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.071 -0.564 . . . . 0.0 111.685 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m95 -108.86 118.45 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 110.911 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 45.4 m0 -101.82 139.87 36.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.157 0.504 . . . . 0.0 111.944 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -85.51 114.73 22.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.358 178.303 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.29 143.52 49.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.791 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.4 tt0 -108.11 111.12 22.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.627 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -50.01 167.17 0.06 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.99 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.515 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.8 mp -125.15 -23.55 4.18 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.032 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.21 -41.4 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.883 0.849 . . . . 0.0 108.894 178.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.91 -35.51 6.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.456 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.15 -0.76 86.99 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.221 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.47 ' O ' HD13 ' A' ' 80' ' ' LEU . 3.0 mp0 -50.6 121.91 6.46 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.32 0.581 . . . . 0.0 111.053 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -88.7 145.75 25.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.549 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 172.15 177.89 41.99 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.309 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -86.47 151.9 23.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.647 0.26 . . . . 0.0 110.449 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 88' ' ' LEU . 7.6 pt -147.88 143.01 17.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 112.191 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 6.3 Cg_endo -52.01 110.16 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.098 2.532 . . . . 0.0 111.161 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.08 -25.77 2.28 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 7.2 p30 -96.99 29.16 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.722 0.296 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -123.12 18.96 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.984 -179.289 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.3 m -154.1 150.65 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.4 139.03 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.615 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HD3' HG12 ' A' ' 66' ' ' VAL . 35.3 mmtm -39.49 138.84 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 112.008 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.47 54.31 0.11 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.027 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.924 179.984 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 CA--C 1.518 -0.281 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 66' ' ' VAL . 24.7 tp -80.51 141.68 34.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.936 0.874 . . . . 0.0 111.958 -178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.7 m -124.83 -177.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.657 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -143.95 125.76 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.78 179.157 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -63.47 151.78 40.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.03 14.78 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.712 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -169.32 142.28 2.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 -179.227 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.02 124.73 20.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 16.6 t80 -104.75 146.47 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 mt-10 -136.98 94.6 12.58 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.054 178.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.7 Cg_exo -37.09 128.71 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 124.43 3.42 . . . . 0.0 113.379 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -126.75 -42.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.1 m-70 -79.97 158.42 26.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.707 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.38 142.32 57.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.33 42.22 99.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -110.57 155.38 22.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.127 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 6.4 tp -111.0 133.0 53.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.054 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -98.54 143.94 16.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.453 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -146.93 175.97 10.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.407 . . . . 0.0 110.822 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -109.02 175.93 5.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.699 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -72.86 132.22 43.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.76 -10.06 48.25 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.67 -177.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.8 165.83 1.61 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.621 ' HB3' HD11 ' A' ' 65' ' ' LEU . 2.1 mt-30 -123.24 146.0 48.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.545 0.688 . . . . 0.0 111.148 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.696 HD13 HD13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -146.24 128.3 15.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' N ' HD11 ' A' ' 103' ' ' LEU . 30.7 ttt180 -79.93 103.51 9.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HG21 ' A' ' 66' ' ' VAL . 23.2 mm -59.81 111.31 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.061 -178.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 101' ' ' GLN . 22.8 mt -79.62 -48.16 14.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.722 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 136.85 35.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.803 178.276 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.564 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 4.2 pt20 -124.4 35.89 4.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 111.334 -178.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.62 122.53 39.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.823 179.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.02 159.25 35.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.671 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.8 tt0 -49.3 -20.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.442 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 67.7 m95 -113.19 110.63 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 44.8 m0 -92.48 138.36 31.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.235 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -84.73 113.37 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.138 178.147 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -119.62 143.05 47.89 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.054 0.454 . . . . 0.0 111.659 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.719 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.2 tt0 -108.48 110.52 22.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.25 168.0 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.185 -179.54 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.6 mp -125.89 -23.62 3.93 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.055 -179.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -82.71 -41.01 19.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.968 0.89 . . . . 0.0 108.876 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.67 -35.97 6.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.314 179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.26 0.62 89.25 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.362 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.56 121.98 7.29 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.991 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.36 143.4 27.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.561 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 174.06 177.16 43.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.239 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -85.2 153.93 22.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.604 0.24 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.696 HD13 HD13 ' A' ' 88' ' ' LEU . 6.6 pt -149.62 143.29 16.64 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.372 0.606 . . . . 0.0 112.125 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.523 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 5.7 Cg_endo -51.08 110.16 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 111.191 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -48.28 -26.29 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -99.08 30.81 3.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.778 0.323 . . . . 0.0 111.232 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.5 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -122.58 17.67 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.953 -179.581 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 66' ' ' VAL . 17.2 m -154.16 150.67 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -139.48 139.56 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.51 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.584 ' HD3' HG12 ' A' ' 66' ' ' VAL . 38.9 mmtm -39.56 139.33 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.42 54.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 66' ' ' VAL . 27.5 tp -81.82 142.03 32.93 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.901 0.857 . . . . 0.0 111.766 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 90' ' ' ILE . 2.6 m -124.61 -177.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.033 -1.439 . . . . 0.0 111.949 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.83 123.98 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.748 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -58.92 153.74 16.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.914 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.91 6.92 10.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.885 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -165.16 143.29 6.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 -179.163 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.22 124.27 17.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.373 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 12.9 t80 -104.96 146.39 29.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 1.5 mt-10 -138.05 94.69 11.08 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.811 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 5.0 Cg_exo -36.66 129.87 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.316 3.344 . . . . 0.0 113.365 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.9 t -128.3 -42.02 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 2.7 m-70 -79.99 158.67 26.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.8 139.2 57.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.37 40.6 96.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' OD2' ' CZ3' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -108.67 155.43 20.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.027 0.442 . . . . 0.0 111.11 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 107' ' ' GLN . 6.2 tp -111.29 133.29 53.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.042 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 74' ' ' PRO . . . -97.6 145.79 17.97 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.441 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -150.55 177.71 9.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -109.47 175.58 5.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.708 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -73.89 131.68 41.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.09 -10.8 51.88 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.355 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -57.5 165.59 1.52 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' HB3' HD11 ' A' ' 65' ' ' LEU . 1.8 mt-30 -122.55 146.55 47.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.6 0.714 . . . . 0.0 111.197 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.753 HD12 HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -146.55 127.81 14.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.504 ' N ' HD11 ' A' ' 103' ' ' LEU . 37.2 ttt180 -79.95 103.2 9.68 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.829 HD11 HG21 ' A' ' 66' ' ' VAL . 28.5 mm -59.69 111.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.264 -178.05 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 20.3 mt -79.63 -47.04 16.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.47 178.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -142.46 155.63 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.309 178.127 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' ' CG ' ' A' ' 98' ' ' TRP . 2.0 pt20 -141.47 37.39 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.09 131.96 34.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.301 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 74.44 166.5 15.57 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.992 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 1.4 tt0 -47.76 -20.75 0.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.499 ' CZ3' ' HD3' ' A' ' 112' ' ' PRO . 70.7 m95 -110.22 118.21 35.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.477 ' CG ' ' HA ' ' A' ' 93' ' ' GLN . 47.3 m0 -100.63 143.63 30.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.121 0.486 . . . . 0.0 112.033 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.748 ' HG3' ' HB2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -88.26 114.85 25.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.482 178.464 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.555 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -121.61 143.8 49.11 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.962 0.41 . . . . 0.0 111.697 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.738 ' CB ' HD21 ' A' ' 91' ' ' LEU . 13.5 tt0 -109.09 110.99 22.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.616 ' O ' ' HA2' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -49.77 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.19 -179.453 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 89' ' ' ARG . 3.7 mp -125.27 -23.25 4.2 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.663 -0.415 . . . . 0.0 112.025 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -83.18 -41.7 18.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.976 0.893 . . . . 0.0 108.943 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.13 -36.04 6.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.334 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 102' ' ' SER . . . 81.6 0.06 88.72 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 113.176 -1.829 . . . . 0.0 113.423 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.471 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -51.16 122.57 7.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.276 0.56 . . . . 0.0 111.08 179.071 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.78 146.01 25.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.616 -178.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 80' ' ' LEU . . . 170.99 177.77 41.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.54 155.53 21.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.658 HD13 HD13 ' A' ' 88' ' ' LEU . 5.5 pt -150.03 144.36 17.54 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.344 0.592 . . . . 0.0 112.205 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.499 ' HD3' ' HH ' ' A' ' 72' ' ' TYR . 8.9 Cg_endo -53.45 112.17 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.209 2.606 . . . . 0.0 111.251 178.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -54.74 -21.11 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 6.2 p-10 -101.6 30.72 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -119.25 -26.33 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 88' ' ' LEU . 17.2 m -113.22 149.6 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 67' ' ' ILE . . . -136.55 140.67 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.23 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 140.47 0.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.908 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.26 50.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.976 . . . . . . . . 0 0 . 1 stop_ save_